Kinetic Investigations of Thiolate Protected Gold Nanoparticles: Protein Interactions, Electron Transfer, and Precursor Formation by Turner, Brian Neil
Kinetic Investigations of Thiolate Protected Gold Nanoparticles:  Protein Interactions, 
Electron Transfer, and Precursor Formation 
By 
Brian N. Turner 
 
Dissertation 
Submitted to the Faculty of the 
Graduate School of Vanderbilt University 
in partial fulfillment of the requirements 
for the degree of 
 
Doctor of Philosophy 
in 
Chemistry 
December, 2011 
Nashville, Tennessee 
 
Approved: 
Professor David E. Cliffel                         
Professor John A. McLean                        
Professor James E. Crowe, Jr.                     
Professor David W. Wright                        
ii 
 
 
 
 
 
 
 
 
 
 
 
In Memory of Sharon Rose Turner and Ruth Shelton Turner 
A special thanks to Mom, Dad, April, Eric, Gramps, Keith, and Patti 
Lovingly dedicated to Mary Pat 
  
iii 
 
ACKNOWLEDGEMENTS 
 
Acknowledgements of people who helped along the way are included at the end of each 
chapter, but I would like to reserve this section to thank people who helped in unique 
ways. 
As for my committee, I will open with Dr. David Cliffel.  I have always appreciated 
your knowledge and creativity in generating new ideas.  I have also appreciated the 
freedom I have had to go in my own direction with research that seems very unique to 
this lab.  Also, I really appreciate your humanistic approach to leaves of absence, and 
never once interfering in personal business.  This was especially appreciated as many 
personal crises and family crises seemed to continually arise over the last six years, and I 
am not sure I would have been able to deal with them appropriately in a lot of other 
situations.  On a lighter note, it was a pleasant surprise to work for someone who would 
have the group over to play strategy games, volleyball, and generously provided 
wonderful food to a somewhat larger research group.  Finally, thanks for having the 
patience to allow me to work here over a six year period, all the while providing financial 
support. 
Dr. Wright, I have always secretly appreciated your no-holds-barred attitude, and tell-
it-like-it-is approach to committee meetings.  I think this is a very important trait when it 
comes to making sure that the science we practice is legitimate.  My favorite part about 
your approach is your intensity about the science because I believe that it should be 
exciting and meaningful to the researchers instead of just a means to a job.  Until I saw 
iv 
 
you lecture at a SERMACS, I had never appreciated how exciting bio-inspired materials 
design really is in terms of practical potential and elegance. 
Dr. McLean, I would like to thank you for some of the most interesting science 
conversations I have had during my stay here.  My personal favorite was the discussion 
about how to weigh an electron accurately.  I always looked forward to your classes, 
because you have a unique gift of making complicated topics seem approachable and 
exciting.  I also enjoyed hanging out with you socially in Atlanta during Pittcon.  We will 
have to meet at another conference and play that shuffleboard game again. 
Finally, Dr. Jim Crowe, until I met you, I had not met somebody who works on such a 
high level in their field that is as approachable as you are.  Additionally, I appreciate that 
you are always very thoughtful with your questions.   
It would take me way too long to thank everybody individually in my research group 
for sitting through my practice exams and the like.  Thank you to everyone, as it was 
much appreciated. 
Graduate school can be a difficult time, so I would like to thank Bill Evans, Vanessa 
Phelan, Dr. Victor Ghidu, Easton Selby, Danielle “Watkins” Kimmel, the volleyball 
crew, the soccer crew, the old Magic the Gathering crew (ignore that), and the current 
strategy gaming crew for keeping things light when times were not.  I would also like to 
thank all of my old friends back home and elsewhere for staying in touch, offering 
encouragement, and giving me an excuse to leave town every here and again, especially 
Mike Pateras, Lora Robinson, Greg Raffio, Alicia DiMarco, Mykola Bilokonsky, and 
Ryan Stolte-Sawa. 
v 
 
Finally, it would be hard to put into words the contributions of family, so I will just 
suffice it to say that when things got tough here, I would not have continued along if not 
for your encouragement and belief.  I love you all. 
And Mary Pat, I just want you to know that I would not have finished this if you hadn’t 
pushed me. And Dad, I never would have gotten into this in the first place without your 
constant support and help. 
I would like to acknowledge the following sources of funding: the National Institutes of 
Health Sections on General Medicine [NIH/NIGMS (R01 GM 076479)] and Allergies 
and Infections Disease- Southeastern Regional Center for Excellence in Biodefense 
[NIH/NIAID/SERCEB (U54 AI057157)], the Defense Threat Reduction Agency, the 
Research Coporation, the Vanderbilt University Graduate School and their Travel Grant 
Program (which provided for trips to Pittcon 2007 and ACS National Meeting Fall 2010), 
Oak Ridge National Laboratory Center for Nanophase Materials Science and the 
Vanderbilt University Department of Chemistry Teaching Assistant Program. 
 
  
vi 
 
TABLE OF CONTENTS 
 
Page 
DEDICATION ............................................................................................................ ii 
ACKNOWLEDGEMENTS ........................................................................................ iii 
LIST OF TABLES .......................................................................................................x 
LIST OF FIGURES .................................................................................................... xi 
 
I. INTRODUCTION: SYNTHESIS AND CHARACTERIZATION OF VARIOUS 
THIOLATE PROTECTED GOLD NANOPARTICLES AS PREPARED BY 
MODIFIED BRUST METHODS .........................................................................1 
Introduction ...........................................................................................1 
Background ...........................................................................................1 
Synthetic Routes ........................................................................3 
Functionalization of Thiolate Protected Gold Nanoparticles .......5 
Characterization Methods for MPCs ........................................ 11 
Methods .............................................................................................. 14 
Instrumentation for Routine Nanoparticle Characterization ...... 14 
II. LINEAR EPITOPE MAPPING APPROACH TO LOCATE BINDING “HOT 
SPOTS” IN THE CONFORMATIONAL ANTIGENIC SITE A OF HUMAN 
RESPIRATORY SYNCYTIAL VIRUS (HRSV) FUSION PROTEIN (F) ......... 15 
Introduction ......................................................................................... 15 
Background ......................................................................................... 16 
Human Respiratory Syncytial Virus ......................................... 16 
Epitope Mapping ..................................................................... 22 
Quartz Crystal Microbalance (QCM) ....................................... 24 
Methods .............................................................................................. 31 
Instrumentation ........................................................................ 31 
Materials.................................................................................. 31 
Peptide Synthesis ..................................................................... 32 
Formation of peptide SAMs ..................................................... 33 
ELISA Stepwise linear epitope mapping of the full length     
RSV F Antigenic Site A .............................................................. 36 
vii 
 
Results and Discussion ........................................................................ 38 
Peptide QCM step-wise linear epitope mapping ....................... 38 
Peptide ELISA step-wise linear epitope mapping ..................... 43 
Acknowledgements ............................................................................. 51 
III. GOLD NANOPARTICLES PRESENTING PEPTIDES AS BIOMIMCS          
OF HRSV F PROTEIN ANTIGENIC FUNCTION ............................................ 53 
Introduction ......................................................................................... 53 
Background ......................................................................................... 54 
Nanoparticles Presenting Peptides as Antigenic Mimics........... 54 
Quartz Crystal Microbalance Immunosensing .......................... 61 
Methods .............................................................................................. 62 
Materials.................................................................................. 62 
Peptide Synthesis ..................................................................... 63 
Synthesis of Au216Tiopronin129 Nanoparticles .......................... 64 
Synthesis of Au118Tiopronin71 Nanoparticles ........................... 65 
Synthesis of Au696Tiopronin265 Nanoparticles .......................... 66 
Place Exchange to Form Series 3 Peptide-Nanoparticle 
Conjugates .................................................................................. 67 
QCM Immunosensor Construction and Detection of HRSV ..... 67 
Adaptation of the QCM Immunosensor to Detect Peptide 
Presenting Gold Nanoparticles .................................................... 68 
Results and Discussion ........................................................................ 69 
QCM Immunosensor for HRSV ............................................... 69 
Development of Peptide Presenting Gold Nanoparticles........... 73 
Detection of Peptide Presenting Gold Nanoparticles with         
the QCM Immunosensor for HRSV ............................................ 74 
Acknowledgements ............................................................................. 86 
IV. SECM OF “WIRED” GOLD NANOPARTICLES TO DETERMINE 
ELECTRON TRANSFER KINETICS: PROOF OF CONCEPT FOR 
POTENTIAL COMPONENTS IN NANOMOLECULAR CIRCUITS ............... 87 
Introduction ......................................................................................... 87 
Background ......................................................................................... 88 
Molecular Electronics .............................................................. 88 
Electrochemical Properties of Gold Nanoparticles ................... 92 
Molecular Wire Molecules ....................................................... 95 
Scanning Electrochemical Microscope ..................................... 99 
Methods ............................................................................................ 107 
Materials................................................................................ 107 
Synthesis of Au1120 Dodecanthiolate690 .................................. 108 
Synthesis of Au228Octanethiol92 ............................................. 109 
viii 
 
Deprotection of S-[4-(2-
Phenylethynyl)phenyl]ethynylphenyl]thioacetate          
(PEPEPSAc) ............................................................................. 110 
Place exchange reactions with PEPEPSAc and PEPEPS2 ....... 111 
Scanning Electrochemical Microscopy Experiments .............. 111 
Nanoparticle Surface Quantitation ......................................... 113 
Results and Discussion ...................................................................... 114 
A Note About Surface Ligand Quantitation............................ 114 
SECM Qualitative Observation of AuDodecanethiol        
Electron Transfer Rates ............................................................. 116 
Improved Synthesis of Alkanethiol Nanoparticles Reduces 
Current Drift ............................................................................. 119 
SECM Quantitative Observation of AuOctanethiol Electron 
Transfer Rates ........................................................................... 121 
Acknowledgements ........................................................................... 125 
V. KINETIC INVESTIGATION OF TIOPRONIN PROTECTED GOLD 
NANOPARTICLE PRECURSOR FORMATION ............................................ 126 
Introduction ....................................................................................... 126 
Background ....................................................................................... 126 
Methods ............................................................................................ 131 
Materials................................................................................ 131 
UV-Visible Spectroscopy Kinetics Experiments .................... 131 
Results and Discussion ...................................................................... 132 
Preliminary Observations ....................................................... 132 
UV-Visible Spectroscopy ...................................................... 133 
Acknowledgements ........................................................................... 154 
VI. SUMMARY OF CONCLUSIONS AND SUGGESTIONS FOR FUTURE 
WORK ............................................................................................................. 155 
Summary of Conclusions................................................................... 155 
Suggestions for Future Work ............................................................. 157 
Biomimetic Nanoparticles ...................................................... 157 
Wired Nanoparticles .............................................................. 160 
Nanoparticle Precursor Formation.......................................... 161 
Appendix 
A. THERMAL GRAVIMETRY-MASS SPECTROMETRY AND       
ELEMENTAL ANALYSIS OF TIOPRONIN PROTECTED GOLD 
NANOPARTICLES  ........................................................................................ 148 
B. SYNTHESIS AND CHARACTERIZATION OF WATER SOLUBLE 
DENDRIMER PROTECTED GOLD NANOPARTICLES .............................. 158 
ix 
 
C. SYNTHETIC ROUTES TO                                                                                    
P-MERCAPTOPHENYETHYNYLEBENZENE ............................................. 162 
D. PURIFICATION AND CHARACTERIZATION DATA FOR PEPTIDES   
USED IN THIS STUDY OR OTHERWISE DESIGNED AND PURIFIED ..... 158 
E. ADDENDUM TO “COLOR MY NANOWORLD” EXERCISE USED AT    
THE VANDERBILT SUMMER ACADEMY ................................................. 178 
REFERENCES ............................................................................................................ 181 
CURRICULUM VITAE ..................................................................................................1 
  
x 
 
LIST OF TABLES 
 
Table               Page 
1. Summary of reported HRSV escape mutations in HRSV F antigenic site A. ............ 21 
2. Tabulated characterization data for peptides purified by this author. ........................ 33 
3. Peptides designed to be evaluated by the QCM step-wise linear epitope mapping 
method. .................................................................................................................... 35 
4. Peptides evaluated against palivizumab in an ELISA assay. ..................................... 36 
5. Student’s t-tests for peptide ELISA .......................................................................... 45 
6. Peptides that were conjugated to nanoparticles in this study. .................................... 64 
7. Nanoparticle mimics studied with the QCM HRSV immunosensor. ......................... 74 
8. Summary of mimic A detection at various concentrations, along with sensor 
characterization data ................................................................................................ 78 
9. electron transfer kinetic constants determined for Au228Octanethiol92-nPEPEPSn. ... 123 
10. Rate data for the reaction of Au(III)Cl4
-
 with tiopronin in MeOH at unfixed ionic 
strength. ................................................................................................................. 142 
11. Rate data at fixed [RSH] and [Au(III)] with variable [H+] (adjusted with perchloric 
acid/MeOH solution) and [Cl-] (adjusted with sodium chloride/MeOH solution). .. 145 
12. Rate data for conditions designed to test saturation kinetics of the 
tiopronin/tetrachloroaurate system. ........................................................................ 148 
13. Elemental analysis-calculation compared to two different TGA-TEM calculations of 
molecular formula. ................................................................................................. 167 
14. Characterization data for peptides synthesized by this author. ................................ 187 
  
xi 
 
LIST OF FIGURES 
 
Figure               Page 
15. Modified Brust reaction scheme for polar ligands. .....................................................3 
16. Examples of thiolate ligands used in the synthesis of water soluble Au MPCs ............4 
17. Scheme of the solution phase place-exchange reaction. ..............................................5 
18. The stoichiometry of incoming to exiting ligand is 1:1. ..............................................5 
19. Chart of the different relative rates at which place-exchange and (possibly) migration 
occur. .........................................................................................................................6 
20. The non-covalent interaction based place-exchange reaction.49 ..................................9 
21. Cartoon schematic of an HRSV virion. .................................................................... 18 
22. HRSV F protein, showing the head, neck, and stalk structure. .................................. 20 
23. ELISA study of synthetic peptides from Rutledge and coworkers ............................ 24 
24. QCM graph illustrating the binding of BSA to bare gold and PZ to a mixed SAM of 
peptide 2 and tiopronin. ........................................................................................... 40 
25. QCM graph illustrating the binding of BSA to bare gold and PZ to a mixed SAM of 
peptide 8 and tiopronin. ........................................................................................... 40 
26. QCM graph illustrating the binding of BSA to bare gold and PZ to a mixed SAM of 
peptide 10 and tiopronin. ......................................................................................... 41 
27. Results of the optimized peptide ELISA................................................................... 44 
28. A conceptual interpretation of PZ approaching the synthetic peptide epitope ........... 47 
29. Motavizumab peptide epitope of HRSV F (gray) interacting with the light chain 
(blue) and heavy chain (green). ................................................................................ 50 
30. Comparison of the glutathione (top) and tiopronin (bottom) ligands ......................... 56 
31. 10-amino acid HA peptide on a 3-D gold tiopronin nanoparticle .............................. 57 
32. Loop presenting MPCs (left) shown compared to the native protein ......................... 58 
xii 
 
33. Cartoon schematic of the QCM based immunosensor for HRSV detection. .............. 69 
34. Detection of HRSV with the QCM-PZ immunosensor. ............................................ 70 
35. Detection and control experiments for the QCM-PZ immunonosensor. .................... 71 
36. 
1
H NMR, with double water-gate solvent suppression, of a peptide-nanoparticle 
conjugate ................................................................................................................. 73 
37. Detection of Au696Tiopronin255Peptide(3-F)10 by the QCM immunosensor with and 
without PZ. .............................................................................................................. 76 
38. Representative QCM mass versus time curves at various concentrations of mimic A 
during the detection step. ......................................................................................... 79 
39. Plot to determine the time constant for mimic A binding to the Palivizumab sensor . 80 
40. Plot of individual time constants determined for each concentration. ........................ 81 
41. Plot to determine binding coefficients using the four lowest concentration samples.. 83 
42. Nanoparticle-bipyridine redox switch....................................................................... 89 
43. Cowpea mosaic virus-gold nanoparticle-molecular wire conjugate molecular 
electronic nanosensor. .............................................................................................. 91 
44. Square wave voltammogram of AuHexanethiolate nanoparticles. ............................ 93 
45. The molecular wire ligand ....................................................................................... 95 
46. Current-voltage profiles of molecular wires sandwiched between gold wires. .......... 97 
47. Read-write computing system with gold electrodes sandwiching molecular wires. ... 98 
48. SECM as a useful imaging technique in biological and materials applications. ....... 101 
49. SECM experimental design .................................................................................... 102 
50. SECM approach curves of AuAlkanethiolate nanoparticles .................................... 103 
51. Proof of concept experiments to confirm whether “wired” AuDodecanethiol 
nanoparticles (left) exhibit faster electron transfer than their “unwired” precursors 
(right) .................................................................................................................... 107 
52. MALDI-IM mass spectrum of AuDodecanethiolate nanoparticles functionalized with 
the molecular wire. ................................................................................................ 115 
xiii 
 
53. SECM approach curve with 1V Pt UME through larger AuDodecanethiolate 
nanoparticles .......................................................................................................... 117 
54. SECM approach curve with 1V Pt UME through larger “wired” AuDodecanethiolate 
nanoparticles .......................................................................................................... 118 
55. Comparison of 1H NMR spectra of dodecanethiol gold nanoparticles synthesized by 
the Brust method (blue), and by the method of Rowe and coworkers (red) ............. 120 
56. SECM approach curve through Au228Octanethiol90PEPEPS2, 
Au228Octanethiol90PEPEPS2.6, and Au228Octanethiol92. .......................................... 122 
57. Nanoparticle and ring complex structures............................................................... 128 
58. Time resolved UV-Vis spectra of AuCl4
-
 undergoing reduction by tiopronin. ......... 134 
59. UV-Vis region containing the saddle at 289 nm for the gold(III)/tiopronin system. 135 
60. Time resolved UV-Vis spectra of tetrabromoauric acid undergoing reduction by 
tiopronin. ............................................................................................................... 137 
61. Dynamic reaction profiles of Au(III)Cl4
-
 with tiopronin ......................................... 138 
62. Plots to determine the order of reaction with respect to Au(III)Cl4
−
 ........................ 140 
63. Plot to determine the reaction order and pseudo first order rate constant with respect 
to [Au(III)]............................................................................................................. 141 
64. Plot to determine the order of reaction with respect to [RSH], n, and the overall rate 
constant, knet. .......................................................................................................... 142 
65. Saturation behavior was suspected when kAu(III),1 lost a linear relationship with [RSH] 
at higher [RSH]. ..................................................................................................... 148 
66. Determination of parameters a and b for the saturation kinetics rate law. ............... 149 
67. Thermogravimetric profiles of gold hexanethiol cluster (red) and gold tiopronin 
cluster (black). ....................................................................................................... 166 
68. Thermal gravimetric spectrum generated on the TG-MS instrument at Oakridge .... 169 
69. Selective ion scan of elemental and small molecule fragments thermally lost from 
AuHexanethiol nanoparticles. ................................................................................ 170 
70. Larger mass peaks thermally lost from AuHexanethiol nanoparticles. .................... 171 
71. Small mass fragments thermally lost from AuTiopronin nanoparticles. .................. 172 
xiv 
 
72. 1H NMR of G1 dendrimer protecting a gold nanoparticle ...................................... 175 
73. TEM micrograph and size distribution of AuG1S NCDs. ....................................... 176 
74. 
1
H NMR data G1 place exchanged onto AuTiopronin. ........................................... 177 
1 
 
CHAPTER I 
INTRODUCTION: SYNTHESIS AND CHARACTERIZATION OF VARIOUS 
THIOLATE PROTECTED GOLD NANOPARTICLES AS PREPARED BY 
MODIFIED BRUST METHODS 
 
Introduction 
The practical focus of this dissertation is the adaptation of stable, chemically versatile, 
easy to synthesize thiolate protected gold nanoparticles to medicine (Chapters II and III) 
and molecular electronics (Chapter IV).  In the course of the studies aimed at these goals, 
a number of questions arose about fundamental aspects of nanoparticle synthesis, their 
mechanism of formation, and characterization techniques used to describe them.  These 
secondary interests came to define much of the content of this dissertation (especially 
Chapters I and V, and Appendices A and B). 
Background 
(Note: much of this background material appears in a previously written review article by 
this author, Brian Huffman, and David Cliffel.  It has been rewritten and truncated for 
clarity).
1
 
The scientific study of colloidal metal particles dates back to Faraday in the mid-19
th
 
century.
2
 The synthesis and characterization, notably by electron microscope, of water 
“soluble” gold colloids as small as 18 nm was completed by Turkevich and co-workers in 
2 
 
1951.
3
  Monolayer protected clusters (MPCs), a term used by Royce Murray to describe 
small gold nanoparticles that are identical or similar to those first synthesized by Brust 
and coworkers,
4
 differ from metal colloids in that they can be repeatedly dried, isolated 
from, and redissolved in common solvents without decomposing or aggregating.
5
  For the 
duration of the dissertation, the term nanoparticle will be used instead of cluster, so as not 
to confuse these nanomaterials with smaller cluster structures of discrete morphology.  
These small gold nanoparticles are obtained using a bottom-up approach (as opposed to a 
top-down approach such as lithography), implying that the creation of a great variety of 
nanomaterials is possible from a small number of building block materials.
6
  
Nanoparticles are created with a variety of core types and, furthermore, capping ligands, 
to create water or organic soluble products with desired functions.  Both metallic and 
non-metallic starting materials are used in the creation of nanoparticle structures, such as: 
thiolate protected gold,
4, 5, 7-11
 organic polymers,
12-15
 virus-like particles,
16-21
 protein 
particles,
22
 colloidal particles,
3, 23, 24
 and semiconductor quantum dots.
25
  Thiolate 
protected gold nanoparticles have been the focus of studies in our research group because 
of their ease of creation, water and air stability, electrochemical and optical properties, 
biocompatibility, and their ability to be surface functionalized by straightforward 
techniques with a variety of sulfur containing ligands.  Thiolate protected gold 
nanoparticles of the type focused on in this dissertation can range in size from 1-10 nm, 
containing approximately 55-1000 gold atoms which correlates with molecular weights 
between 20 – 200 kDa.26  
 
3 
 
Synthetic Routes 
 The Brust reaction is a standard method to produce small gold nanoparticles that 
can be tuned to a number of organic solvents.  Nanoparticles prepared by this method are 
most commonly synthesized with alkanethiolate protecting molecules, which lead to 
relatively stable nanoparticles.  More recently, water solubility of gold nanoparticles was 
easily accomplished by using  water-solubilizing protecting thiolate ligands in a modified 
Brust reaction as depicted in Scheme 1.
4, 8
  In the single phase Brust reaction, 
tetrachloroauric acid is reduced from Au(III) to Au(I) 
 
in the presence of the thiol capping 
ligand in a polar solvent, yielding an orange, brown, or ruby red solution that fades to 
clear over time.  The color change has been attributed to a Au(III)-thiol complex which is 
reduced to a Au(I) complex over time which ultimately forms either a gold-thiol 
polymer,
5
 oligomer, or cyclic tetramer.
27
  Precursor formation in the context of water 
soluble tiopronin protected gold nanoparticles is the subject of Chapter V.  Following the 
initial reduction, the Au(I) is further reduced to Au
0
 in the presence of sodium 
borohydride (NaBH4), yielding a black to dark brown or purple solution.  Other reducing 
agents have been used for other metal cores, such as lithium aluminum hydride (LiAlH4) 
or lithium triethylborohydride.
10, 11
   
 
Figure 1:  Modified Brust reaction scheme for polar ligands. 
 
4 
 
Key examples of thiolate ligands that have been used to produce water soluble, long-term 
air and solvent stable clusters are tiopronin,
8
 glutathione,
28
 4-mercaptobenzoic acid,
29
1-
thio--D-glucose,30 and N,N,N-trimethyl(mercaptoundecyl)ammonium (TMA),31 as 
shown in Figure 2.    
  
Figure 2:  Examples of thiolate ligands used in the synthesis of water soluble Au MPCs.  
(A) tiopronin, (B) glutathione, (C) 4-mercaptobenzoic acid, (D) 1-thio-β-D-glucose, (E) 
N,N,N-trimethyl(mercaptoundecyl)ammonium. 
 
In Chapter III, tiopronin (3-mercaptopropionyl glycine, Figure 2(A)) protected gold 
nanoparticles will be used as a scaffold to present synthetic peptide epitopes to a 
commercial antibody immobilized on a novel immunosensor platform.  Tiopronin has 
been popular in our lab as it produces high yield, long-lasting nanoparticles in a 
straightforward synthesis with robust results. 
 
5 
 
Functionalization of Thiolate Protected Gold Nanoparticles 
Transformation of these gold nanoparticles into materials with relevance to biology and 
engineering has been accomplished by a variety of synthetic functionalization strategies, 
out of which, the most widely used and thoroughly studied method is the thiol place-
exchange reaction depicted in Figure 3. 
 
Figure 3:  Scheme of the solution phase place-exchange reaction.  The stoichiometry of 
incoming to exiting ligand is 1:1. 
 
Place-exchange involves an incoming ligand, such as a thiol containing biomolecule, 
taking the place of one of the original capping ligands in a 1:1 ratio. Place-exchange was 
first described by Murray and co-workers,
32
 using alkanethiolate-clusters with -
functionalized thiols in toluene.  This reaction has since been expanded to aqueous 
solutions
9
 and can be carried out in aqueous buffer solutions.  Multiple research groups 
have studied the dynamics by which place-exchange occurs in ligand solutions.  
According to Murray’s work, the rate of ligand exchange depends both upon the 
concentration of incoming and exiting ligands, implying an associative (Sn2-like) 
mechanism.
33
  Lennox and co-workers,
34
 on the other hand, report the reaction is zero-
order with respect to the incoming lingand.  Zerbetto’s lab found that the associative 
mechanism is accurate, but that the interactions of the newly introduced chains interact 
6 
 
with multiple chains on the cluster, causing the kinetics to change as the reaction 
proceeds.
35
 
The reaction rate increases with smaller sized entering ligands and shorter chain length of 
the protecting ligand.
33
  Consequently, it is favorable to place-exchange a large 
biomolecule (such as a peptide) with a small protecting ligand (such as tiopronin), 
although the process will proceed at a slower rate. It is still practical to place exchange 
similar sized ligands in shorter time courses, as will be shown later with small molecule 
wire-like molecules and small alkanethiols, but the extent of exchange is expected to be 
lower in these cases.  Furthermore, it is important to consider that subtle differences in 
the structure of the incoming ligand, such as branching, can have a significant effect on 
both the rate of place-exchange, and the stability of the monolayer.
36
  Additionally, it 
should be noted that the reaction proceeds more favorably at different sites on the core; 
vertex sites > edge sites > near-edge sites > terrace sites 
33
 as shown in Figure 4. 
 
Figure 4:  Chart of the different relative rates at which place-exchange and (possibly) 
migration occur.  Copyright 1999 of the American Chemical Society. 
 
7 
 
The differences in reactivity due to thermodynamics and kinetics originate from the 
electron density differences
37
 and steric accessibility differences
38
 of these sites.  These 
unique properties of nanoparticles lead to some degree of predictability, and therefore 
control, of where place-exchanged functional groups will anchor on the gold core.  The 
rate of exchange is also increased by oxidative electronic charging of the core by 
electrochemical means
39
 or in the presence of dioxygen.
40
 The extent of reaction can be 
enhanced by increasing the incoming ligand concentration, but it should be noted that the 
extent of exchange rarely approaches 100%, due to the difficulty of exchange at terrace 
sites.
33
  
It is also important to note that the rate of ligand place-exchange on MPCs becomes 
slower as the particles age, probably due to a prolonged rearrangement of the ligands on 
the surface.
41
 To date, no kinetic or mechanistic study of place-exchange has considered 
new findings about the presence of gold thiolate tetramer rings on the surface of MPCs as 
reported by our group using mass spectrometry
27
 and Häkkinen and co-workers in a 
theoretical paper.
42
 These nuances in surface structure could help to better explain the 
complexities of the place-exchange mechanism. 
More recently, a number of crystal structures of thiolate protected nanoparticles
43, 44
 have 
been published, revealing that terrace, vertex, and edge sites, as described earlier, may 
not be as important as ring and staple
45
 structures that project out of a tightly packed, 
central core (termed the “grand core”).  It should be noted, however, that the available 
crystal structures describe smaller cores than those commonly used, and the vertex, edge, 
terrace description may hold more relevance for these materials. 
8 
 
It is difficult to use first principles to predict the extent and location of place exchange.  
In practice, a place exchange study in sufficient excess of incoming ligand to the 
protecting monolayer (e.g. 10-50 fold in excess of protecting groups in solution) over a 
long reaction time (e.g. 3 to 7 days) is used.  This allows for determination of the “feed 
ratio” that is required for a given exchange percentage, and conditions can be tuned either 
by varying the reaction time or ligand concentration.  Once exchanged, there is not a 
straightforward technique to determine the location of the exchanged ligands.  Recent 
efforts by Harkness and coworkers have, however, led to the development of a method 
for the determination of ligand microstructure on the surface of a polyfunctionalized 
nanoparticle.
46
 
As an alternative to the solution phase place-exchange discussed above, Huo and co-
workers have studied solid phase place-exchange reactions.  In their original report of a 
solid phase place-exchange reaction, they employ a polystyrene Wang resin with acetyl 
protected 6-mercaptohexanoic acid attached via an ester bond.
47
  The thiol groups are 
deprotected and allowed to undergo place-exchange with butanethiolate-protected gold 
nanoparticles, followed by washing away of unexchanged product, and cleaving of the 
exchanged particles.  The same group has compared this solid phase approach to the 
solution phase approach and found the solid phase approach to be advantageous in terms 
of controlling the number of ligands attached per cluster and preserving the order of 
ligands on the surface.
48
 Recently, the same group has reported a solid phase approach 
using a non-covalent interaction of the incoming ligand with silica gel
49
 (see Figure 5). 
9 
 
The solid phase approach employs milder reaction conditions, thus making it amenable to 
a wider class of molecules, such as large biologically relevant functional groups. 
 
Figure 5:  The non-covalent interaction based place-exchange reaction.
49
  Reprinted with 
permission of John Wiley & Sons. 
 
While this strategy has not been employed in the current research, there are certainly 
situations where it would be useful.  For instance, the future of Chapter IV involves 
studying how small an amount of a functional ligand it takes to achieve an electronic 
effect.  Solid phase exchnage would be a more effective way to reach the minimum 
exchange (possibly one ligand per particle) than constantly reducing the concentration 
and stirring time of a solution phase place exchange reaction. 
Macromolecules often contain thiols, for example, cysteine residues in proteins or 
adenosyl phosphothiolate residues in DNA oligonucleotides,
50
 and are readily adaptable 
to the place-exchange reaction. Strategies to introduce thiol groups into macromolecules 
include, but are certainly not limited to, the use of Traut’s reagent (2-iminothiolane)51 in 
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the case of proteins, the inclusion of terminal cysteine residues during the synthesis of 
peptides, and the conversion of phosphates to phosphorothioates using 3H-1,2-
benzodithiole-3-one 1,1-dioxide.
52
 It is also possible to introduce ligands into the MPC 
monolayer which undergo electrostatic interactions with biomolecules, for example, the 
use of biotin-streptavidin interaction or biotin-anti-biotin interaction.
53
  All of these 
routes provide straightforward methods to ready a group for place-exchange and create 
functional nanoparticles. 
Following the place exchange reaction, the material consists of unbound thiols from both 
the incoming and outgoing ligands, consequently requiring an additional purification 
step.  Removal of these impurities is a unique challenge as the different molecules not 
only have different preferences for solvents (in the case of classical wet chemical 
purification techniques) or pore sizes (in the case of a size-exclusion technique), but 
properties that are similar to the nanoparticle.  Options that are explored in subsequent 
chapters are washing with a battery of solvents, solvent immersion and sonication on 
glass, suspension and centrifugation given the availability of a sufficient solvent for this 
purpose, suspension and precipitation from cold solvent, dialysis, and molecular weight 
cut-off centrifuge filters.  Some other suggestions for purification are continuous free-
flow electrophoresis,
54
 and diafiltration.
55
 
Besides the place-exchange strategy, there are other strategies to functionalize MPCs.  An 
important class of these strategies, which is beginning to gain popularity, is the use of 
simple organic reactions on ligands already bound to the MPC.  Examples include 
triazole cycloaddition to a bromine functionality
56
 and direct functionalization of a 
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hydroxyl group,
57
 amide coupling and ester coupling.
58
  All of these methods allow for 
post-exchange reaction chemistry to occur, yielding surfaces that can be modified in a 
controlled fashion. 
Another popular option, not explored in this dissertation, is polyfunctionalization in situ.  
When the properties of the given ligands will allow it, a mixed ligand nanoparticle 
synthesis is also an option.  Mixed ligand synthesis refers to a reaction where a certain 
percentage mixture of two or more thiolated ligands are added to the gold salt prior to 
reduction, resulting in polyfunctionalized nanoparticle similar to those produced via 
place-exchange. Mixed ligand synthesis has the advantage of not requiring additional 
mixing and purification steps, but it is more difficult to control the pre-reduction 
chemistry and therefore more difficult to control the extent of exchange. 
 
Characterization Methods for MPCs 
A thorough characterization of mono- and polyfunctionalized nanoparticles is critical 
before applying them in biological or materials uses.  Determination of core size (greater 
than about 1 nm, depending upon the substrate used) and dispersity is easily 
accomplished via transmission electron microscopy (TEM).
4
  Core sizes have also been 
determined by mass spectrometric methods, but this is limited to smaller cores with 
charge carrying ligands.
59, 60
  Scattering techniques and zeta-potential instruments are not 
as helpful for this class of nanomaterial due to the complexities that come with combined 
absorbance and scattering.  Thermogravimetric analysis (TGA)
61
 provides an easy 
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method to determine the ratio of organic ligand to inorganic core material. Combining the 
core size and organic/inorganic ratio data yields an approximate average molecular 
formula for homofunctionalized nanoparticles.
60
 Nuclear magnetic resonance 
spectroscopy (NMR) is useful for determining the structure and composition of the 
protecting monolayer, as well as the purity of the final material.  Protecting ligands have 
broadened peaks in both 
1
H and 
13
C spectra due to spin-spin relaxational (T2) broadening, 
dispersity in binding sites, and dipolar broadening due to packing density gradients.
62, 63
 
Once functionalized into a useful conjugate material, it is critical to characterize MPCs in 
terms of the quantity of biological relevant functional groups attached per cluster (on 
average) and the secondary structure of the biomimics post-conjugation.  
1
H NMR is a 
simple way to semi-quantitatively determine the number of antigen peptides per cluster 
via integration of known protecting ligand peaks versus new broadened biomolecule 
peaks.  The accuracy of this method can be enhanced through the use of I2-induced MPC 
decomposition (termed the “death reaction”) which leads to sharper peaks with less 
overlap.
64
  A newer technique that has been developed in our group for relative surface 
quantitation of polyfunctionalized nanoparticles is matrix assisted laser desorption 
ionization-ion mobility-mass spectrometry (MALDI-IM-MS).
65
  This specific mass 
spectrometric technique has the advantage of sorting out impurities with small collisional 
cross sections from the gold complexes actually used to quantify the surface (see the 
methods section of Chapter IV for more information).  Secondary structure determination 
has proven to be more difficult.  Drobny and co-workers describe the use of novel solid-
state NMR techniques to investigate the secondary structure of peptides immobilized on 
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gold MPCs via amide coupling.
66
  In an elegant study, they were able to use cross-
polarization magic angle spinning (CPMAS) with double-quantum dipolar recoupling 
with a windowless sequence (DQDRAWS) to show that a peptide maintained a helical 
structure upon conjugation, but with a slight change in backbone torsion angle.  Mandal 
and Kraatz recently described similar characterizations of peptides place-exchanged onto 
MPCs using Fourier transform infrared spectroscopy (FT-IR) and Fourier transform 
reflection absorption spectroscopy (FT-RAIRS).
67
  Using amide I bands, they were able 
to observe that the secondary structure of a leucine rich peptide bound to gold transitions 
from α-helical to β-sheet with greater surface curvature.  Helix forming free peptides, 2D 
SAMs on gold, and peptides on 20 nm gold MPCs (less curvature) showed α-helical 
structure while 10 nm, and especially 5 nm gold MPCs (more curvature) showed 
increasing amounts of β-sheet conformation.  An excellent review of characterization 
techniques for peptide-nanoparticle conjugates was written by Slocik and Naik.
68
  In this 
review, they describe a number of methods based on NMR, CD, FT-IR, and binding 
assays to reveal or confirm secondary structure of the conjugated peptides.  Consideration 
of these techniques should prove vital in improving the characterization quality of 
biomolecule conjuagated nanomaterials in our research group. 
 
 
 
 
 
14 
 
Methods 
Instrumentation for Routine Nanoparticle Characterization 
Nanoparticle characterization was accomplished with a variety of instrumentation.  
1
H 
NMR spectra for synthetic characterization and purity confirmation were collected using 
a Bruker AV 400 MHz NMR.  Surface ligand quantitation was accomplished with Bruker 
DRX 500 MHz, and AV 600 MHz instruments.  Ultraviolet/Visible spectroscopy was 
performed using a Cary 100 Bio UV/Visible spectrophotometer.  Thermogravimetric 
analysis (TGA) was performed in the Vanderbilt Institute of Nanoscale Science and 
Engineering (VINSE) Biomolecular Nano-Structure lab using an Instrument Specialist’s 
TGA 1000 with N2 or air as the chamber gas.  Transmission electron microscopy was 
performed using a Philips CM20 TEM with a LaB6 tip operating at 200 kV.  Samples are 
prepared by a variety of methods on formvar or ultrathin holey carbon supported on 
copper mesh grids, purchased from Ted Pella.   
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CHAPTER II 
LINEAR EPITOPE MAPPING APPROACH TO LOCATE BINDING “HOT SPOTS” 
IN THE CONFORMATIONAL ANTIGENIC SITE A OF HUMAN RESPIRATORY 
SYNCYTIAL VIRUS (HRSV) FUSION PROTEIN (F) 
 
Introduction 
Having discussed the synthesis and characterization of thiolate protected nanoparticle 
synthesis, the application of these materials in a biological context will be discussed.   
The question, “How can you make a small gold nanoparticle resemble a protein in a way 
that it “tricks” a system into thinking that it really is one?” will be asked.  Some answers 
to this question will be covered in the next two chapters.  Chapter II deals with a 
biological system that is mimicked, and the results of that study are important to the 
construction of a bio-nano-conjugate material, discussed in Chapter III.  Specifically, the 
research aimed to determine which piece of a full protein is necessary to achieve a 
specific function.  In the current case, it was desirable to know which peptide segment 
from HRSV F protein is necessary for recognition of a specific antibody and whether it 
still behaves in the same way when not part of the native protein.  Furthermore, the 
impact of removing or adding amino acids in a stepwise fashion on the strength of the 
recognition was studied.  The effect of removing and adding terminal amino acids was 
initially probed using the quartz crystal microbalance, and later with enzyme-linked 
immunosorbant assay (ELISA).   
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It is important to note that, ultimately, this research came together in a non-linear fashion.  
Summarily, preliminary experiments with the QCM to examine the antibody binding 
properties of relevant peptides were attempted with little success, prompting the research 
to pursue peptide conjugated nanoparticles not informed by epitope mapping 
experiments.  Having not found a strong, specific nanoparticle biomimic in the first round 
of experiments, epitope mapping was revisited with ELISA.  The second round of epitope 
mapping resulted in more informative data, presented in this chapter, which allowed for 
construction of an improved nanoparticle mimic.  The improvements and results to the 
nanoparticle mimic are presented in Chapter III.  The results were then put back together 
in a more readable account of the research than if they were presented chronologically.  
Therefore, while experiments from Chapter II and III alternate in time and inform each 
other, they are more cohesive in the current structure. 
 
Background 
Human Respiratory Syncytial Virus 
Acute respiratory tract infection is the leading cause of death by infectious disease 
worldwide and HRSV is the leading cause of acute respiratory tract infection in infants.
69
 
A 13-year surveillance of Washington DC infants and young children showed that HRSV 
was present in 43% of patients with bronchiolitis and 25% of patients with pneumonia.
70
  
Diagnosis of HRSV can be difficult during the cold season due to an increased patient 
load, especially given the high volume of young patients with associated symptoms from 
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other infections.  The insufficient pace of clinical diagnosis often results in longer than 
necessary hospital stays for afflicted children and their families, and an increased 
financial burden for hospitals.  Our research group is focused on strategies to develop 
quick and accurate diagnostic platforms, to analyze immunological interactions of HRSV 
with the commercial pharmaceutical IgG Palivizumab (PZ), and to design biological 
mimics of this immunological interaction. 
The HRSV virion is in the family Paramyxoviridae and of the order Mononegavirales, 
making it a non-segmented negative sense RNA virus.
69
 HRSV is in the subfamily 
Pneumovirinae along with bovine respiratory syncytial virus (BRSV), pneumonia virus 
of mice (PVM), and avian and human metapneumovirus (AMPV and HMPV).
69
 The 
diversity in this family of viruses allows researchers to tune strategies developed for one 
virus to a number of different diseases because of structural similarities.   
A general understanding of the protein structure and function is vital to understanding the 
goals and approaches of this project.  A structural schematic of HRSV is shown in Figure 
7.  
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Figure 7:  Cartoon schematic of an HRSV virion.  The RNA and associated proteins are 
housed by a matrix protein which is covered with a protective lipid bilayer.  The lipid 
bilayer projects three different surface glycoproteins that are important targets for the 
immune system: fusion (F), attachment (G), and small hydrophobic (SH).  Figure from 
the Katholieke Universiteit Leuven, used with permission.
71
 
 
The viral genome encodes three surface glycoproteins (fusion [F], attachment [G], and a 
small hydrophobic protein [SH]).  Also encoded are a non-glycosylated matrix protein 
(M), a nucleoprotein (N), a phosphoprotein (P), transcription processivity factors, two 
non-structural proteins, and a large viral RNA polymerase unit (L).  The structure of the 
virion houses a nucleoprotein/RNA complex payload at its core (L, N, P and possibly 
transcription processivity factors).
69
 The RNA is thought to be surrounded by a protective 
coat of M.  HRSV is an enveloped virus; therefore it collects a lipid bi-layer upon 
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budding from infected cells, making it more difficult for the immune system to recognize 
and destroy.  The three surface glycoproteins project from the surface of this envelope as 
11-20 nm spikes spaced at about 6-10 nm apart.
69
 The total size of the virus varies from 
100-350 nm diameter spherical particles to 10 m long filamentous particles having a 
radius of 60-200 nm.
69
 Analysis of the proteins encoded for by HRSV RNA has allowed 
researchers to identify appropriate targets for detection and treatment strategies. 
Of all the encoded HRSV proteins, F and G are the only two that induce neutralizing 
antibodies, as steric hindrance at certain areas of these sites will block cell entry.
72
  The 
importance of the third surface glycoprotein (SH) is not clear, and it has been shown to 
be non-essential both in vitro and in vivo.
73, 74
 G is important for viral attachment and F 
accomplishes viral fusion; therefore, if an antibody binds either one of these antigens at 
an epitope that is simultaneously involved in a critical function, viral replication will be 
neutralized by sterics and the prevention of necessary conformational changes.  
Consequently, a wide variety of neutralizing monoclonal antibodies are known for each.  
G, which is heavily glycosylated, has a highly variable amino acid sequence from strain 
to strain, whereas neutralizing antibodies targeted against F are cross reactive between 
various strains and across antigenic subgroups.
75
 These properties render F a superior 
target for antibody-based detection strategies.   
In the absence of an available crystal structure of HRSV F protein, the best resource to 
gain structural insights to aid this project is a Newcastle Disease Virus (NDV) fusion 
protein homology model of HRSV F.
76, 77
 A structural schematic of the protein illustrates 
the trimeric structure, and presence of stalk, neck, and head regions (see Figure 8). 
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Figure 8:  HRSV F protein, showing the head, neck, and stalk structure.  The head docks 
with the cell wall during infection, and is the site of epitopes for neutralizing mAbs.  
Figure from Morton, et. al.
76
  Copyright 2003, Elsevier, used with permission. 
 
Competitive binding studies of HRSV F using libraries of monoclonal IgG’s have 
revealed three unique antigenic sites (A, B, C) with various epitopes (including one in a 
bridge site AB).
78
 The A and C sites are conserved while the B site is variable.
78
 
Monoclonal antibody resistant mutants (MARMs) in the A site are understood in terms of 
specific amino acid changes.  Coincidentally, a number of MARMs of RSV type A 
exhibit amino acid changes between residues 258 and 276.
75, 78-85
  Specific amino acid 
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changes in the F protein of RSV type A MARMs are shown in Table 1 with reference as 
to which monoclonal antibody was used to select the MARM. 
Table 1:  Summary of reported HRSV escape mutations in HRSV F antigenic site A.  The 
colored boxes refer to the study in which the escape mutation was reported:  Crowe,
85
 M 
or Q from Zhao and Chen 2004,
81
 I from Zhao; Chen; Megaw 2004,
80
 R from Zhao 
2005,
83
 Suzich,
84
 Beeler,
78
 Arbiza.
75
 
 
 
Epitopes in antigenic site A are conformational epitopes, and are, therefore, difficult to 
mimic in such a way that elicits antibody binding similar to the native structure.
75, 78
  
Failure to reproduce to secondary structure is further compounded when the epitope is 
highly discontinuous. 
Synagis, often called by its pharmaceutical name Palivizumab (PZ), is prescribed to 
prevent HRSV infection in children during the cold season, and is commercially available 
from MedImmune.  This designer monoclonal pharmaceutical IgG is a humanized form 
of murine monoclonal antibody (mAb) 1129,
78
 where certain regions are identical to the 
murine structure to conserve the structural integrity of the binding sites, and the rest of 
Position 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277
Residue N D M P I T N D Q K K L M S N N
other mAb S N Y
Fab 19 M
mAb 1129 F
S I Q F Y
Y M
K R
E
N
T
D
Crowe
M or Q from Zhao and Chen 2004
I from Zhao; Chen; Megaw 2004
R from Zhao 2005
Suzich
Beeler
Arbiza
Sullender
PZ 
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the mAb is that of a well characterized human mAb MCPC603.
86, 87
 Palivizumab was 
determined to have at least as strong of an affinity for RSV F as chimeric 1129 via 
ELISA.
86
 The commercial availability of this mAb and its high affinity for RSV F protein 
makes it a desirable tool for constructing immunosensors, mapping HRSV F epitope 
sequences, and screening antigenic mimics (see Chapter III) presenting HRSV F epitope 
peptides. 
Since this study was completed, crystal structures of HRSV F in complex with mAb 
F101,
88
 post-fusion HRSV F,
89
 and the HRSV F motavizumab peptide epitope bound to 
the antigen-binding fragment (Fab) of motavizumab
90
 have been published.  
Motavizumab is the next generation of PZ, with 10 fold higher activity but the same 
epitope region.
91
  These crystal structures should prove instrumental in understanding the 
structural basis of the antigen-antibody interaction, and will aid future efforts to construct 
biomimetic agents. 
 
Epitope Mapping 
In the construction an antigenic mimic, it is useful to understand the specific 
intermolecular forces that are responsible for binding HRSV F to PZ.  Specifically, the 
goal is to determine which amino acid side chains are involved and how they are spatially 
organized.  Given this information, a nanomaterials scientist can imagine and create a 
synthetic system which copies the important parameters without the need to use 
complicated techniques, expensive and fragile biological systems, and exotic reagents. 
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Epitope mapping describes any technique where antigens or fragments thereof are 
analyzed for their affinity to an antibody in order to gain information about which parts 
of the whole are important for the antigen-antibody interaction.  Linear epitope mapping 
refers to techniques which solely interrogate primary structure while conformational 
epitope mapping considers the effects of secondary and tertiary structure as well.  In the 
current study, a linear epitope mapping approach to investigate synthetic antigenic site A 
peptides against PZ was used, but information about the secondary structure was inferred 
from other studies. 
The discovery by Rutledge and coworkers of binding “hot spots” in a proposed long C-
terminal epitope sequence of Ebola glycoprotein
92
 lead this research to apply similar 
methodology to antigenic site A of HRSV F.  Briefly, the researchers discovered that 
there were two discrete regions in a longer peptide sequence which had local maxima in 
an ELISA assay against the monoclonal antibody 15H10 that appeared to be centered 
about two spatially distinct three amino acid sequences, as is shown in Figure 9. 
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Figure 9:  ELISA study of synthetic peptides from Rutledge and coworkers 
demonstrating that two spatially separate three amino acid sequences are likely to provide 
the strongest interactions between the glycoprotein of Ebola and the antibody 15H10.
92
  
Copyright 2008, the Materials Research Society, used with permission. 
 
These “hot spots,” TDK and FID, were validated by place exchanging cysteine-PEG 
terminated versions of the three amino acid sequences onto tiopronin protected gold 
nanoparticles and detecting them with a home-made Ebola QCM immunosensor 
presenting 15H10. 
 
Quartz Crystal Microbalance (QCM) 
The QCM consists of a piezoelectric quartz resonator with metal electrodes on either 
side.  The combination of electrodes and resonator is attached to an oscillator circuit.  
QCM has become a useful analytical technique due to the linear relationship between 
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mass deposited on the crystal and the frequency of the crystal resonance.
93
 Oscillator 
circuits that permit liquid measurements have made the technique useful in the area of 
bioanalytical chemistry.
94, 95
 The ideal oscillator for this technology is quartz because it 
has desirable mechanical, electrical, chemical, and thermal properties.
94
 Specifically, AT-
cut quartz crystals have a temperature coefficient that is nearly zero between 0 and 50 ºC, 
making them ideal for QCM measurements at ambient temperatures without sophisticated 
temperature control.
96
  
Electrode wrapped quartz crystals manufactured by Maxtek Inc. resonate at different 
frequencies depending upon their thickness.  Conventionally, quartz crystals used in 
QCM measurements are identified on the basis of this resonant frequency.  For example, 
a 5 MHz QCM crystal is 333 µm thick and a 9 MHz QCM crystal is 185 µm thick.  The 
crystals are 1” in diameter, the oversized front electrode is ½” in diameter and the 
concentric electrode located on the reverse side (contact electrode) is ¼” in diameter.97 
The overlapping area of the contact electrode and front electrode is 0.3419
 
cm
2
.  The 
overlapping region has been shown to be the sensitive area by scanning electrochemical 
mass sensitivity experiments.
98
 The consequences of this are that deposited mass (mass 
added to the crystal by covalent, electrostatic, physical etc. interactions) has a maximum 
effect on resonant frequency in the overlapping region and a small effect outside of the 
overlapping region (known as field fringing).  Such an electrode geometry sacrifices 
some sensitivity in order to negate fringing field effects from non-specific binding on the 
quartz itself.
99
 Fringing field effects refer to mass loading that is outside of the fully 
overlapping area between the two electrodes that still affects the electric field and thus 
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elicits a small, but significant effect on crystal frequency.  The manual for the Maxtek 
RQCM cites that the particular electrode geometry (small contact electrode with an 
oversized sensing electrode) was chosen to ensure a “more consistent deposition across 
the active area of the crystal.”97 
In order to calculate mass loading using the QCM, one takes advantage of the following 
relationship between mass and frequency shift, proposed by Sauerbrey and henceforth 
named the Sauerbrey equation: 
 

f C fm
 (2-1)
 
where Δf [Hz] is the frequency shift of the quartz crystal, Δm [kg] is the mass loaded onto 
the crystal, and Cf is known as Sauerbrey’s sensitivity factor and has units of Hz kg
-1
.
93
 
Sauerbrey’s sensitivity factor is defined by the following equation: 
 
 (2-2)
 
where f0 is the first harmonic resonant frequency of the unloaded crystal, A is the active 
(sensitive) area [m
2
] of the QCM crystal, ρq is the density of quartz (2.648 kg/m
3
) and μq 
is the shear modulus of AT-cut quartz (2.95 x 10
11
 N/cm
2
).
93, 97
 The sensitive area, again, 
is the overlap area of the large front electrode with the small rear electrode.  Cf for our 
crystals are 0.0566 Hz cm
2
/g for a 5 MHz crystal and 0.1834 Hz cm2/g for a 9 MHz 
crystal. When calculating mass, it is important to recognize that frequency is not 

C f 
2 f0
2
A qq
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dependent upon mass loading alone in a liquid system.  Viscosity has a major effect on 
the frequency, as shown by the following equation: 
 
 (2-3)
 
where ηL [N s m
-2
] is the viscosity of the liquid in contact with the crystal, and ρL is the 
density of the liquid in contact with the crystal.
100
  This specific component of the total 
frequency change is directly related to a change in resistance, given by the following 
equation: 
 
  (2-4)
 
where ΔR [Ω] is the change in resistance, and e26 [kg V s
-2
]
 
is the piezoelectric constant of 
quartz.
100, 101
  Therefore, frequency shift due to viscosity can be calibrated to separate 
frequency due to mass loading by use of solutions of a non-loading analyte, such as 
sucrose, leading to a concentration dependent decrease in frequency, which results from 
viscosity.  The slope of a plot of Δf versus ΔR is used as a correction factor to subtract out 
viscosity induced frequency shift. 
The practical equation to be used for data analysis in the current studies involves first 
rearranging equation 2-1: 
   
 (2-5)
 

f   fq
3 / 2 LL
qq

R  f
2 (qq )
3 / 2
32 f 3Ar(qe26)
2

m 
f
C f
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Subtracting out frequency due to resistance yields: 
   
 (2-6)
 
where c is the calibration factor in units of Hz/Ω attained from the plot of frequency 
versus resistance for solutions of varying viscosity.  The value for c should be 
independently determined for each crystal used.   Typical c values for the Maxtek crystals 
used in this research are 2.095 Hz/Ω for a 5 MHz crystal and 15.3 Hz/Ω for a 9 MHz 
crystal. 
QCM data can also be used to extract thermodynamic parameters for the systems being 
studied.  For the generic system Ag + Ab ⇄ AgAb where Ag is an antigen and Ab is an 
antibody, the equilibrium constant, K, is defined by: 
   
 (2-7)
 
K can be determined from mass loading data using the either of the following equations: 
   
 (2-8)
 
   
 (2-9)
 
where C is the adsorbate concentration, and mmax is the maximum mass that can be 
adsorbed by the monolayer, and m/mmax = , the degree of surface coverage.
102
  

m 
f  (Rc)
C f

K 
[AgAb]eq
[Ag]eq[Ab]eq

m  K1
m
C





 mmax

C
m






C
mmax






1
Kmmax






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Determination of K from either of the above equations (8 or 9), allows calculation of the 
Gibb’s free energy of adsorption, Gads using the following equation: 
    (2-10) 
where R is the gas constant and T is the temperature of the system.  Studying the variation 
of the system with temperature, the enthalpy of adsorption, Hads, can be determined 
using the following equation: 
   
 (2-11)
 
Finally, determination of the entropy of adsorption, Sads, can be determined using the 
following equation: 
   
 (2-12)
 
The full process from data collection to thermodynamic quantities is rigorous, but allows 
for determination of whether various biological processes are entropy or enthalpy driven.  
Thermodynamic understanding, in turn, allows for better understanding of the structure-
function relationship in biological molecules.  From an evolutionary perspective, this 
allows researchers to understand how a protein used to be structured, what modifications 
it made to get where it is, and exactly how those changes made the protein function better 
than its predecessor. 

GadsRT lnK

d lnK
d(1/T)






Hads
R

Sads 
(HadsGads)
T
30 
 
The ability to determine real time kinetic and thermodynamic parameters is only one 
aspect that makes the construction of QCM based immunosensors desirable.  QCM also 
had the advantages of low cost, portability, and a number of analytical advantages.  A 
good case for comparison is surface plasmon resonance (SPR).  Whereas QCM uses 
acoustic waves and measures frequency, SPR uses optical waves and measures reflection 
minimum.  Either instrument provides data that can be used to study protein interactions 
in real time.  SPR performs at least as well as QCM in terms of detection limit, 
sensitivity, and detection time;
103, 104
 however, QCM instrumentation is less expensive 
(about $5,000 compared to about $100,000 for the lowest specifications of either 
instrument) and, reportedly, easier to use, and can make measurements on thicker layers 
without loss of sensitivity (200 nm for SPR versus 400 nm for QCM).
105-107
 Either 
technique measures up well in terms of analytical figures of merit when compared to 
many techniques employed in the field.  In terms of time consumption, culture of a nasal 
swab takes about four days for detection and polymerase chain reaction (PCR) takes one 
to two days for detection.  Rapid ELISA techniques can be employed with total analysis 
time of 30 minutes to 1 hour, but the cost to the patient is about $300.00 per test, and the 
pieces, such as antibody solutions and control samples, are not reusable.
108
 The cost could 
be lowered by a platform like QCM or SPR because of their amenability to reusability, as 
solid-phase stabilized biomolecules have longer shelf lives.  Additionally, all of the above 
techniques are largely qualitative or semi-quantitative at best, and therefore give less 
information about total viral load.  The dominant RSV immunoassay in the clinical 
environment, direct fluorescent antibody (DFA), takes about 2 hours.
109
 A QCM 
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immunosensor that is reusable should be much quicker and cheaper than this technique, 
while providing more information about the disease. 
 
Methods 
Instrumentation 
Solution phase resistance and frequency measurements to characterize biological 
interactions were made using a Maxtek, Inc. 3-channel Research QCM operating at a 
driving voltage of 125 mV RMS and using Maxtek 5 or 9 MHz AT-cut quartz crystals 
with gold electrodes.  Flow cells were also purchased from Maxtek.  Solutions were 
delivered through the flow cells using a Cole Parmer Masterflex console drive peristaltic 
pump. 
 
Materials 
Reagent and optima grade solvents, N-2-mercaptopropionylglycine (tiopronin), bovine 
serum albumin (fraction V, 96%), tween-20 (molecular biology grade), α-cyano-4-
hydroxycinnamic acid, 3,3',5,5'-Tetramethylbenzidine (TMB, liquid substrate, super-
sensitive, for ELISA), thioanisole, and anisole were purchased from Sigma-Aldrich.  
Common laboratory salts and concnetrated ammonium hydroxide were reagent grade and 
purchased from Fisher scientific.  Concentrated sulfuric acid was purchased from EMD.  
Absolute ethanol was purchased from Pharmco-AAPER.  Immulon 2HB well plates, 
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maleimide coated well plates, and cysteine-HCl were purchased from Thermo scientific.  
Hydrogen peroxide (30% v/v) was purchased from Acros. Peptide synthesis materials (f-
moc protected and side-chain protected amino acids, coupling reagents, and resins) were 
provided generously by the research group of David Wright.  18 MΩ Water was obtained 
from a U.S. Filter Modulab water system with a 0.2 µm external filter, or from a 
Barnstead NANOpure Diamond water purification system.  Dry nitrogen is provided in 
house.  Monoclonal antibody 1214, 1129, Palivizumab, and human respiratory syncytial 
virus were provided generously by the Dr. James Crowe, Jr. research group.  Work areas 
that contained HRSV were cleaned thoroughly with bleach and 70% isopropyl alcohol 
solution. 
 
Peptide Synthesis 
Most peptides were synthesized by standard solid phase f-moc procedures using an Apex 
automated peptide synthesizer.  The series of peptides used in the QCM experiments 
were synthesized, purified, and characterized by Malgorzata Broncel.  Subsequent 
peptides that were utilized in the ELISA experiments were synthesized by Joshua Swartz.  
The peptides were cleaved from the resin and side-chain-deprotected using Reagent R 
(90% trifluoroacetic acid, 5% thioanisole, 3% ethanedithiol, 2% anisole).  Following 
extraction in cold diethyl ether with cold centrifugation (0° C), cleaved peptides were 
further purified using a Waters semi-prep HPLC with a reverse phase column in a 
continuous gradient of water:acetonitrile following injection in water/acetonitrile/dilute 
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ammonium hydroxide.  Samples were collected with a Waters fraction collector, operated 
manually.  (Note:  ammonium hydroxide must be used sparingly, < 100 mM, to avoid 
damaging the column or corroding the pumping lines).  Following lyophilization, 
peptides were diluted in 20% acetonitrile and water, occasionally with the addition of 
ammonium hydroxide to increase solubility, and characterized by MALDI MS on a 
Voyager MALDI mass spectrometer with α-cyano-4-hydroxycinnamic acid.  
Characterization data for peptides used in this study that were not fully characterized by 
other coworkers are displayed in Table 2.   
Table 2:  Tabulated characterization data for peptides purified by this author.  The data 
has been relocated to Appendix D. 
 
[Located in Appendix D] 
 
Formation of peptide SAMs 
Clean gold electrode surface was achieved by mixing 3 drops concentrated sulfuric acid 
to 1 drop 30% hydrogen peroxide (piranha) on the gold electrode three times, each time 
completely covering the surface and rinsing away with deionized water.  The crystal was 
then rinsed with copious amounts of absolute ethanol and blown dry with cool nitrogen.  
Self-assembled monolayers (SAMs) of RSV F A site peptides terminated with cystiene 
were created on the surface of QCM crystal electrodes by soaking the crystal face in a 
mixture of 3 parts tiopronin to 1 part peptide (1 mM combined) solution in absolute 
ethanol with a minimum of deionized water (to aid solubility).  The peptide/tiopronin 
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solution was immediately transferred to the QCM crystal in a glass cell clamped on top of 
the oversized gold electrode.  The total time of soaking varied from 3 to 24 hours.  The 
solution was then discarded and the crystal rinsed with copious amounts of absolute 
ethanol and blown dry with cool nitrogen. 
 
QCM experiment 
The QCM crystal presenting the SAM on the gold electrode, or just the clean gold 
presenting crystal was placed in a flow cell interfaced with the Maxtek, Inc. RQCM.  
Phosphate buffer solution (25 to 50 mM sodium phosphate with 0 to 150 mM sodium 
chloride pH adjusted to 7.1) was pumped across the crystal face in a laminar flow until a 
minimum in frequency and resistance drift is measured.  A ten-minute baseline was then 
collected.  Following collection of a baseline, a solution of bovine serum albumin (BSA) 
(1 mg/mL) was switched with the buffer solution and pumped 5 to 10 minutes beyond 
when a decrease in frequency was observed.  The buffer flow time assures that there are 
no available gold sites which could participate in non-specific binding.  Buffer was then 
pumped in order to purge the system of BSA.  Then, solutions of antibody in buffer (10-
20 g/mL) were flowed for 10 minutes and the frequency response was observed.  All 
solutions were pumped at a flow rate of approximately 40 L/min.  The following 
peptide sequences in Table 3 were evaluated. 
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Table 3:  Peptides designed to be evaluated by the QCM step-wise linear epitope 
mapping method.  Odd numbered sequences were made to correlate QCM experiments 
with ELISA experiments in an Immulon well plate.  Even numbered peptides are 
designed for the QCM experiment itself, having a cysteine residue for thiol linkage to the 
gold surface.  Spaces allow for easy visualization of the stepwise differences between 
peptides.  The amino acid numbering sequence for HRSV F protein is displayed in the 
top row.  Known MARMs against PZ or related mAbs are indicated in bold organge.  
Residues that bind to motavizumab are indicated in bold blue. 
 
ID     Peptide Sequence 
 
RSV F   255  260  265  270  275  
                |         |      |       |       |    
A)     NSELLSLINDMPITNDQKKLMSNN  (not evaluated) 
1)         LSLINDMPITNDQKKLMS 
2)        CLSLINDMPITNDQKKLMS 
3)          SLINDMPITNDQKKLMSN 
4)         CSLINDMPITNDQKKLMSN 
5)           LINDMPITNDQKKLMSNN 
6)          CLINDMPITNDQKKLMSNN 
7)            INDMPITNDQKKLMSNNV 
8)           CINDMPITNDQKKLMSNNV 
9)             NDMPITNDQKKLMSNNVQ 
10)           CNDMPITNDQKKLMSNNVQ 
 
 
 
 
36 
 
ELISA Stepwise linear epitope mapping of the full length RSV F Antigenic Site A 
Linear fragments and full length linear peptides of antigenic site A were evaluated for 
their ability to bind Palivizumab in a peptide ELISA assay using maleimide coated well 
plates.  The design of the peptides has been improved by amination of the C terminus, 
and acylation of the N terminus to better represent the fact that the antigenic site A is an 
internal sequence.  Serine-glycine-serine-glycine spacers were used in favor of PEG-6 for 
improved synthetic yield, solubility, and ease of purification.  The following synthetic 
peptides were evaluated by the assay (Table 4 lists peptides used for the ELISA assay and 
Table 3 lists peptides used in the QCM assay): 
Table 4:  Peptides evaluated against palivizumab in an ELISA assay.  Spaces allow for 
easy visualization of the stepwise differences between peptides.  The amino acid 
numbering sequence for HRSV F protein is displayed in the top row.  “Linker” indicates 
the inert CSGSG sequence added for peptide immobilization and projection.  Known 
MARMs against PZ or related mAbs are indicated in bold organge.  Residues that bind to 
motavizumab are indicated in bold blue. 
 
ID     Peptide Sequence 
 
RSV F  linker    255      260       265      270         275   linker 
                           |           |             |           |              |    
A      CSGSG NSELLSLINDMPITNDQKKLMSNN 
B                     NSELLSLINDMPITNDQKKLMSNN  GSGSC 
1      CSGSG  NSELLSLIND 
2      CSGSG     SELLSLINDM 
3      CSGSG        ELLSLINDMP 
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4      CSGSG          LLSLINDMPI 
5      CSGSG             LSLINDMPIT 
6      CSGSG               SLINDMPITN 
7      CSGSG                  LINDMPITND 
8      CSGSG                     INDMPITNDQ 
9      CSGSG                       NDMPITNDQK 
10     CSGSG                         DMPITNDQKK 
11     CSGSG                            MPITNDQKKL 
12     CSGSG                                PITNDQKKLM 
13     CSGSG                                   ITNDQKKLMS 
14     CSGSG                                     TNDQKKLMSN 
15     CSGSG                                       NDQKKLMSNN 
1b                    NSELLSLIND                                              GSGSC 
2b                      SELLSLINDM                                           GSGSC 
3b                         ELLSLINDMP                                        GSGSC 
4b                            LLSLINDMPI                                      GSGSC 
5b                              LSLINDMPIT                                    GSGSC 
6b                                SLINDMPITN                                  GSGSC 
7b                                   LINDMPITND                               GSGSC 
7      CSGSG                  LINDMPITND 
8      CSGSG                     INDMPITNDQ 
9      CSGSG                       NDMPITNDQK 
10     CSGSG                         DMPITNDQKK 
11     CSGSG                            MPITNDQKKL 
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12     CSGSG                              PITNDQKKLM 
13     CSGSG                                ITNDQKKLMS 
14     CSGSG                                  TNDQKKLMSN 
15     CSGSG                                    NDQKKLMSNN 
1b                    NSELLSLIND                                         GSGSC 
2b                      SELLSLINDM                                       GSGSC 
3b                        ELLSLINDMP                                     GSGSC 
4b                          LLSLINDMPI                                    GSGSC 
5b                            LSLINDMPIT                                  GSGSC 
6b                               SLINDMPITN                               GSGSC 
7b                                  LINDMPITND                           GSGSC 
 
 
Results and Discussion 
Peptide QCM step-wise linear epitope mapping 
Self-assembled monolayers of synthetic peptide epitopes 2, 4, 6, 8, and 10 showed small 
(barely greater than three times the noise) amounts of mass loading when mAb 1214 (20 
g/mL) in PBS was flowed across the SAM.  The small amount of mass loading was not 
observed when the electrode was blocked with BSA prior to antibody addition, 
suggesting that mAb 1214 binds to the gold electrode surface.  Experiments 
demonstrating mAb 1214 binding to the clean gold surface of the QCM crystal confirmed 
this observation.  There were significant amounts of mass loading observed when peptide 
epitopes were mixed with tiopronin prior to addition; however, this was later discovered 
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to be non-specific binding to tiopronin.  11-mercapto-1-undecanol and 6-mercapto-1-
hexanol, as alternatives to tiopronin as a diluting agent, also exhibited significant 
amounts of binding to mAb 1214. 
It was concluded that neither Synagis nor mAb 1214 binds self-assembled monolayers of 
synthetic peptide epitopes 2, 4, 6, 8, nor 10 on gold in a high ionic strength (200 mM salt) 
environment.  Additionally, mAb 1214 and PZ fail to bind to synthetic peptide epitopes 
1, 3, 5, 7, or 9 on Immulon.  Possibly, mAb 1214 will not bind to the conformation 
adopted by the peptide on Immulon well plate, whereas it might bind to the same peptide 
in a different context. 
Synagis was found to bind synthetic peptide epitope monolayers of 2, 8, and 10 on gold 
in a low ionic strength (50 mM salt) environment (4 and 6 were not evaluated due to a 
lack of remaining material) (Figures10-12).   
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Figure 10:  QCM graph illustrating the binding of BSA to bare gold and PZ to a mixed 
SAM of peptide 2 and tiopronin. 
 
Figure 11:  QCM graph illustrating the binding of BSA to bare gold and PZ to a mixed 
SAM of peptide 8 and tiopronin. 
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Figure 12:  QCM graph illustrating the binding of BSA to bare gold and PZ to a mixed 
SAM of peptide 10 and tiopronin. 
All three of these epitopes demonstrated a reversible binding event with Synagis, which 
differs from the irreversible binding of synagis with the diluting agent, tiopronin.  Of 
particular interest, Synagis bound in a highly reversible fashion to peptide 8 (Figure 11).  
Reversible binding can be associated with biological activity.  At the very least, it 
distinguishes itself from the other peptides.  To be sure that the binding is specific, a new 
diluting agent that does not bind Synagis must be evaluated and mixed with the peptide 
epitopes. 
As these experiments were performed a number of years ago and abandoned in order to 
pursue other research directions, it would be appropriate to reflect on the results and 
conclusions with a fresh perspective in order to aid a future student reading this 
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dissertation for guidance.  In retrospect, these studies could have been improved with a 
number of modifications.  Additionally, peptides discussed in the following section could 
be evaluated with the QCM technique in order to corroborate the results below.  Most 
importantly, the full length sequence of peptide A, in the following section, should be 
evaluated first with varying amounts of the diluting agent, whether it is tiopronin or a 
more inert molecule towards PZ.  The amount of diluting agent used in these experiments 
(3:1 molar ratio) was likely too low, not allowing enough space between peptides to 
avoid steric hindrance to the approach of PZ.  Another approach would be to biotinylate 
the linked terminus of the peptide and conjugate the biotinylated peptide to a layer of 
streptavidin.  The alternative immobilization strategy may allow for more space around 
each peptide (governed by the surface area and packing density of streptavidin), avoiding 
the steric problems without the need to vary the quantity of diluting agent.  The 
experiments should be performed at the high ionic strength only,  and possibly with the 
addition of a surfactant such as Tween 20 to cut down on non-specific binding.  Low 
ionic strength binding is near irrelevant in the scope of mimicking a real biological event.  
The reversible nature of some of the different peptides (2,8, and 10), while interesting, is 
difficult to fully explain.  One possible explanation is that the peptides are in such a 
conformation as to cast an alpha helical “umbrella” over the tiopronin layer below, which 
is known to bind to the antibodies discussed, allowing the antibody to reversibly bind the 
peptide instead of irreversibly and non-specifically sticking to the tiopronin layer.  
Another important problem with these studies was that the peptides were not amidated 
and acetylated at the C and N termini, not accurately reflecting the fact that antigenic site 
A is an internal section of the protein. 
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Peptide ELISA step-wise linear epitope mapping 
Peptides were evaluated in an ELISA assay at various concentrations of peptide, primary 
antibody (PZ), and labeled secondary antibody and with different wash solutions and 
development conditions until optimum conditions were obtained for the sequence A.  
These optimum conditions were determined to be 50 µg/mL peptide in PBS with 10mM 
EDTA, 5 µg/mL PZ in wash buffer, goat-anti-human diluted 1:5,000 in wash buffer, and 
10 minutes of developing time with TMB substrate followed by quenching with 1N 
H2SO4.  The results of this assay are presented in Figure 13.  
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Figure 13:  Results of the optimized peptide ELISA. The peptide IDs are listed in Table 
4.  Multiple null/alternate hypothesis pairs were evaluated from the ELISA data using 
Student’s t-tests at a 95% confidence interval, assuming unequal variances, and a two-
tailed distribution.  The results are displayed in Table 5.  Analysis of the true hypotheses 
allowed conclusions about which parts of the full peptide sequence A are important to the 
binding of PZ to HRSV F to be drawn.  
 
Student’s t-tests were performed on the data in order help make arguments about which 
peptides or groups of peptides binds more or less strongly to PZ than others, displayed in 
Table 5. 
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Table 5:  Student’s t-tests for peptide ELISA of whether a given null hypothesis or 
alternate hypothesis is supported.  H0 is supported if tstat ≤ tcritical given a two tail 
distribution at a 95% confidence interval assuming unequal variances.  Here x refers to 
the mean absorbance for the set of peptides indicated by its/their ID #(s) from Table 4.  0 
means that H0 is supported or A means that HA is suggested to be true with reasonable 
confidence.  HA is assumed to be the opposite case of H0.  For instance, for x5 ≤ x(7-15), 
H0 means that peptide 5 binds PZ less or equally as efficient as peptides 7 through 15, 
and A indicates that HA is supported, which would be taken to be that peptide 5 binds PZ 
more efficiently than the pooled results of peptides 7 through 15. 
H0 tstat 
tcritical  
(two-tail) 
supported 
hypothesis 
x1 ≤ x(7-15) 2.51 3.18 0 
x2 ≤ x(7-15) 3.92 2.78 A 
x3 ≤ x(7-15) 4.46 3.18 A 
x4 ≤ x(7-15) 2.57 2.78 0 
x5 ≤ x(7-15) 3.36 3.18 A 
x6 ≤ x(7-15) 7.19 3.18 A 
x(1-6) ≤ x(7-15) 6.92 2.05 A 
x(7-15) ≤ x(b) 3.78 2.02 A 
xA ≤ x6 3.22 2.57 A 
xA ≤ xB 8.34 3.18 A 
 
 
The first significant finding of these tests is that four out of six peptides (2, 3, 5, and 6) 
are more active towards PZ than peptides oriented in the same direction but missing 
amino acids earlier in the chain (peptides 7 through 15).  Furthermore, the pooled results 
of peptides 1-6 are significantly more active towards PZ than 7-15.  The implication of 
this hypothesis is that HRSV F amino acids 254-268 represent a “hot spot” for binding of 
46 
 
HRSV F to PZ.  The conclusion is reasonable to expect given that there are six hydrogen 
bond donors (two serine, three asparagine, and one threonine residues) and two 
negatively charged residues at physiological pH (one each glutamic acid and aspartic 
acid).  There are, however, a higher proportion of these residues in the region represented 
by peptides 7-15: two positively charged lysine residues, two asparagine residues, and 
one additional serine residue.  Furthermore, escape mutations are present in either region.  
In the regions represented by peptides 1-6, the following escape mutations have been 
reported: N262S/Y/K, I266M, andN268I (previously mentioned in Table 1).  In the area 
represented by peptides 7-15, K272N/Q/M/R/E/N/T/D, N276F, and N277Y (previously 
mentioned in Table 1) have been reported.  Peptide A, a representation of the full region, 
binds PZ stronger than any of the peptide fragments.  Joining the regions together gives 
an estimated, albeit semi-quantitative, increase in affinity of nearly 50% (peptide A 
versus peptide 6, based on a single concentration of PZ to an identical mass of peptide).  
The same sequence presented in the reverse direction, peptide B, binds as effectively as 
sequences from peptides 7-15.  Comparing segments from peptides 1-6 and 7-15 to the 
reversed sequence peptides 1b-7b, and the full length peptide A to B, it is clear that the 
orientation in which the peptides are displayed to PZ has a dramatic effect on binding 
affinity.   
In conclusion, the most important observations to be made are that the full length epitope 
with the linker at the C terminus (B) shows little binding activity in ELISA (A = 0.195 
±0.019), while the full length epitope with the linker at the N terminus (A) shows 
significant binding (0.618 ± 0.086).  The difference in binding was attributed to a 
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directionally dependent misalignment in the case of peptide B, as demonstrated in Figure 
14. 
 
 
Figure 14:  A conceptual interpretation of PZ approaching the synthetic peptide epitope 
in forward (left) and reverse (right) presentations.  The illustrated concept might explain 
why PZ has such a strong preference for peptide A over peptide B.  
 
Fragments 2,3,5, and 6 are more active than any of the peptides in fragments 7-15, 
suggesting that the sequence NSELLSLINDMPITN (amino acids 254-268) represents a 
significant binding motif for mAb interaction with HRSV F, particularly with PZ.  The 
approach of PZ to the protein (or peptide fragment thereof) during recognition is, 
therefore, hypothesized to occur in a manner where the Fab region of PZ is pointing 
against the sequence NSELLSLINDMPITN, which constitutes an alpha helical and then 
kinked part of the native protein.  While it was tempting to speculate that the 
hypothesized approach was due to projection of binding residues further from the surface 
in fragments 2, 3, 5, and 6, this was not consistent with identical experiments that used 
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the same primary epitope sequences presented in the reverse direction.  As the segments 
representing amino acids 269-278, which bend opposite from the direction of the earlier 
part of the sequence in the native protein structure, it was reasonable that presenting them 
in the same direction eliminated binding.   
Given these conclusions, it would be interesting to study peptides 8-15 in reverse.  
Alternative presentation might face these sequences in the same direction as they are 
presented to PZ in the native protein.  Studying the two alpha helical portions with the 
following sequences would be informative: CSGSG-NSELLSLINDM and 
NDQKKLMSNN-GSGSC.  These peptides would allow for interrogation of either alpha 
helix on its own without the non-interacting loop region (PIT).  Chapter III discusses the 
possibility of placing these sequences together on a single nanoparticle of a specific size 
to mimic the distance between the two helices in the native protein. 
If both halves appear to be distinct “hot spots” that bind the strongest when oriented in 
opposite direction of each other, this would confirm the importance of the loop 
conformation of this region in the native protein.  In the full length linear sequence, an 
amorphous loop conformation might be represented by the natural kink introduced by the 
proline residue at position 265.  If this theory is true, the data stands in sharp contrast to 
the work of Gerdon, et. al.
110
  In their study of a loop peptide epitope of anthrax 
protective antigen, they had to use a bidentate attachment strategy in order for their 
antibody to bind to its nanoparticle immobilized synthetic peptide epitope, purportedly in 
order to force the peptide into the loop conformation of the native structure.  Considering 
that the peptide used in their study also featured a proline residue in the middle of the 
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sequence does not necessarily mean that it is kinked into a favorable conformation in the 
free peptide or in the monodentate immobilized peptide, therefore still requiring the 
bidentate attachment for antigenic binding.  The PZ epitope peptide epitope has two alpha 
helices, which might help control the conformation without bidentate attachment.  The 
conformation of peptide A is therefore thought to be more identical to the PZ epitope in 
the native protein than synthetic anthrax PA epitope is to the native epitope.  The 
conformational differences could be confirmed by observing the secondary structure of 
both peptides in solution, bound to maleimide coated plastic with a sing terminal 
cysteine, and also to a gold surface and analyzing with circular dichroism or solid state 
NMR. 
Alternatively, peptide A has a terminal asparagine residue which is capable of forming 
either an electrostatic or salt bridging interaction with cysteine carboxylate groups, 
available from the blocking agent used.  Van der Waals bonding of this nature might also 
act to hold the peptide into a loop conformation more similar to the native structure.  
Contrary to this theory is the observation that the C-terminal linked peptide B, which also 
presents a terminal asparagine residue, does not exhibit as much activity towards 
palivizumab.  Notwithstanding, in this form the terminal asparagine may be held at an 
angle where the steric hindrance to moving the asparagine within close proximity of the 
blocking cysteine molecules is greater than the steric hindrance encountered in peptide A.  
Another possibility is that other residues on that terminal would produce repulsive forces 
against the well-plate surface.  Notably, the glutamic acid residue near the N terminal 
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would electrostatically repel the like-charged carboxylate group.  If this model holds true, 
peptide A might adopt a loop conformation on the well plate whereas peptide B does not. 
Since these conclusions were drawn, crystal structures of HRSV F, post-fusion HRSV F, 
and the motavizumab peptide epitope (identical to the full peptide sequence used in this 
study) bound to HRSV F have been published.  The authors determined that N262, N268, 
D269, K272, and S275 all have hydrogen bonding or salt bridge interactions with 
residues in CDRs of both the heavy and light chain of the motavizumab Fab.   
 
Figure 15:  Motavizumab peptide epitope of HRSV F (gray) interacting with the light 
chain (blue) and heavy chain (green).  Labeled amino acids are those participating in 
hydrogen bonds or salt bridges.  From McClellan, et al.
90
  Copyright 2010, Nature 
Publishing Group, reprinted with permission. 
 
Considering the importance of these residues, it is worth noting that peptide 6 represents 
the step where N268 is just included along with N262.  Unexpectedly, binding is lost 
upon adding the next important binding residue, D269, in peptide 7, without losing any 
other important binding residues or escape mutants.  At this point along the stepwise path 
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it is possible that alpha helicity in the early part of the chain is lost with the disappearance 
of S259, forcing N262 out of a position suitable to bond formation.   
The data collected in the peptide ELISA experiments was subsequently used to design 
antigenic mimics with small gold nanoparticle scaffolds.  Chapter III will go on to 
describe the conjugation of peptides A and 6 to tiopronin protected gold nanoparticles 
and applying these conjugates in a QCM immunoassay.  Furthermore, a loop 
configuration, with CSGSG linkers on both ends of the sequence, will be evaluated on 
two sizes of nanoparticle.  Additionally, it would be useful to see if the full length peptide 
maintains the helix-loop-helix structure in solution with the linkers attached, as glycine 
residues can disrupt helicity.  If it does, it would be interesting to see whether certain 
deletions off of either end disrupt this secondary structure.  
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CHAPTER III 
GOLD NANOPARTICLES PRESENTING PEPTIDES AS BIOMIMCS OF HRSV F 
PROTEIN ANTIGENIC FUNCTION 
 
Introduction 
Having a better understanding of the nature of peptide epitopes based on HRSV F 
antigenic site A, the research went on to employ these materials in combination with 
tiopronin protected gold nanoparticles, discussed in Chapter I.  The research aimed to 
determine whether or not different peptide epitopes were active (bound by an antibody) 
on gold nanoparticles, whether the recognition was specific, the effect of simultaneously 
changing the size of the nanoparticle and identity of an inert spacer between the 
nanoparticle and peptide, and quantifying the resulting binding interaction for a working 
“mimic” that was produced.  The significance of these results lies in the fact that if an 
antibody can recognize a nanoparticle, then it is possible that an immune response to the 
same nanoparticle could result in serum specific to both the nanoparticle and the native 
protein that inspired it.  A nanoparticle conjugate of this design may even be capable of 
evoking the production of memory cells in vivo, validating it as a novel subunit 
nanovaccine.  Additionally, as the peptide and nanoparticle research progressed, a novel 
immunosensor platform for the diagnosis of HRSV was developed. 
As was discussed in Chapter II, some of the early results in this chapter were not 
informed by information from literature or research presented in Chapter II.  However, 
54 
 
the results that are most emphasized and the future directions that are suggested, 
presented later in this chapter, follow the findings discussed in Chapter II. 
 
Background 
Nanoparticles Presenting Peptides as Antigenic Mimics 
(Note: much of this background material appears in a previously written review article by 
this author, Brian Huffman, and David Cliffel, however rewritten and truncated for 
clarity and a narrowed focus).
1
 
 
Given their similar size dimensions to biological macromolecules such as enzymes, 
receptors, immunoglobulins, antigens, DNA, and carbohydrates, small gold nanoparticles 
have gathered much interest as biomimetic platforms.  These nanomaterials can be 
surface functionalized during particle assembly with a biomolecule in situ, by direct 
covalent attachment, or by place-exchange with the biomolecule after particle assembly.  
In many cases, these conjugate materials have long-term stability.  Additionally, 
nanoparticles can impart conformational structure to a biomolecule, contain a number of 
different biomolecules within a single supramolecular structure, and are often non-toxic.  
Furthermore, the methods by which these materials are made provide simpler routes to 
biofunctionality than classical biological methods such as genetic engineering and 
directed evolution.  Given these fundamental ideas and motivations, the research took 
from the work of interdisciplinary scientists and proceeded to adapt their concepts to the 
problem of HRSV, discussed in the previous chapter.  It is thought that, ultimately, there 
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are a number of situations in which nanotechnology will prove more effective than the 
currently used clinical technology. 
A significant body of work exists describing the application of nanomaterials to 
biological problems.  Here, the focus is on a subset of this work that concentrated on 
using peptides and small metal nanoparticles to mimic the antigenic behavior of whole 
proteins.  An early and straightforward example of this is the synthesis of nanoparticles 
with a protecting peptide from the histidine-rich protein II (HRP-II) of Plasmodium 
falciparum.
111
  Using standard fmoc procedures, Wright and co-workers recreated this 
peptide and used it as a stabilizing ligand on different metal core particles: ZnS, Au
0
, 
Ag
0
, TiO2, and AgS.  These particles were recognized with good specificity by a 
monoclonal antibody specific for Plasmodium falciparum.  Their group was able to 
detect the peptide-encapsulated particles as they would the whole protein with a 
colorimetric antigen capture assay, showing that their particle mimics the protein-protein 
interaction of the intact native structure.    
Recently, our group has developed several gold nanoparticles that mimic antigens of 
clinical interest.  The first was a glutathione (GSH) passivated gold cluster (GS-MPC) 
that was then detected with a polyclonal anti-GSH antibody.
105
  The antibody very 
specifically recognized the GSH-MPC compared to a tiopronin protected nanoparticle, 
even though both surface ligands only differ by, effectively, one amino acid, as seen in 
Figure 16.  While glutathione is not a traditional antigen, it serves as a proof of concept 
that a very small (< 3 nm) MPC can be functionalized with a surface peptide, and then 
specifically recognized by a corresponding antibody.   
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Figure 16:  Comparison of the glutathione (top) and tiopronin (bottom) ligands used to 
functionalize MPCs.  Tiopronin is a truncated form of the tripeptide glutathione, with 
overlap shown in red.
105
  Copyright of the American Chemical Society. 
 
Another study from our group focused on a tiopronin gold nanoparticle with a well 
characterized epitope from the hemagglutanin (HA) protein of influeneza.
112
  The 10-
amino acid peptide was synthesized with a terminating cysteine residue to promote place-
exchange chemistry.  The specific peptide sequence was selected because it is present in 
a neutralizing site for influenza and there is a commercially available monoclonal 
antibody specific for this epitope.  The same study also compared 2-D SAMs to 3-D 
nanoparticles, as illustrated in Figure 17.  The HA-MPC was more efficient in presenting 
the peptide to the antibody as it resulted in a higher ratio of antibody to peptide binding 
when compared to the 2-D surface.   
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Figure 17:  10-amino acid HA peptide on a 3-D gold tiopronin nanoparticle (at left) and 
the same 10-amino acid sequence as a 2-D SAM with tiopronin spacers (at right).
112
  
Reprinted with permission. Copyright 2005 of the American Chemical Society, reprinted 
with permission. 
 
An important aspect of nanoparticles presenting peptide epitopes is whether the 
nanoparticle bound peptide conformation reflects that of the peptide in the native antigen.  
Specifically, in our research group, Gerdon and coworkers studied the protective antigen 
(PA) of B. anthracis
110
, which is one of three precursors of the anthrax toxin.  PA was 
selected for because it precedes the other two proteins (edema factor and lethal factor) in 
their transport for infection, which makes it an ideal target for neutralizing antibodies.  
Specifically, the C-terminus and two internal loops of the PA protein were identified as 
cell-receptor sites, making them ideal candidates for the study.  As in previous studies in 
our group, tiopronin MPCs were place-exchanged with three relevant peptides from the 
regions on PA mentioned previously.  As two of the three PA epitopes selected were loop 
regions, corresponding peptides were designed so that they could mimic the epitope’s 
native conformation by integrating cysteine residues on both the N and C-terminus.  
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Cysteine residues at both termini allowed for bidentate attachment across the nanoparticle 
surface to reconstruct the natural loop.  Previous work by Murray and coworkers had 
reported that ligands attached to the surface will migrate across the MPC to find the most 
stable conformation possible, as they are in a dynamic equilibrium with the solution 
phase.
33, 58, 113
  Migration of peptides at a nanoparticle surface suggested that the 
bidentate peptide was capable of “walking” itself into a conformation similar to the 
native antigen.  Other nanoparticles were synthesized using the same peptide, except with 
a single cysteine residue on the C-terminus for monodentate attachment, allowing for 
comparison with the bidentate peptide nanoparticle.  Figure 18 illustrates the bidentate 
versus the monodentate attachment strategy.   
 
Figure 18:  Loop presenting MPCs (left) shown compared to the native protein (middle) 
and the linear presenting MPCs (right).
110
  Reprinted with permission of John Wiley & 
Sons, Inc. 
 
Nanoparticle peptide conjugates were analyzed using a quartz crystal microbalance 
platform.  The results from this study were that the loop-presenting (bidentate peptide) 
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nanoparticle was strongly recognized by one of seven commercially available 
monoclonal antibodies, while the linear epitope nanoparticle was recognized only 
weakly.  The loop epitope had a higher affinity (Ka) for this particular antibody than the 
linear epitope, especially at physiological pH and ionic strength, confirming that the loop-
presenting nanoparticle was more readily recognized by the antibody.  Preferential 
recognition of the loop epitope suggests that the commercial antibody has a more 
structurally constrained paratope, or that the loop presented less steric interference 
between the antibody and the critical binding residues. 
Given their high density of functional groups, peptides are not limited to use as only a 
biological recognition agent.   For example, Naik and co-workers used multifunctional 
peptides as both the reducing agent, gold-protecting ligand, and presented epitope.
114
  
Peptide A3 was selected from a phage display library and found to both bind to gold and 
reduce it.  Flg, a peptide commonly used in tagging proteins with a biomolecular 
recognition domain, was also found to reduce gold.  Resulting Flg-A3 and A3-Flg 
conjugated gold nanoparticles prepared in a one pot synthesis were capable of binding to 
anti-Flg IgG on glass slides. 
As previously mentioned, nanoparticles are useful scaffolds for holding multiple 
molecules into one supramolecular structure.  As an extension of peptide epitope 
protected gold MPCs, in collaboration with the research group of David Wright, tiopronin 
MPCs containing, in their monolayer, flag epitope (flag-MPC), HA epitope (HA-MPC), 
flag and HA epitope (flag/HA-MPC), or no epitope were synthesized.
115
  The peptide 
epitopes were attached to the cluster via a cysteine terminated polyethylene glycol 
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hexamer, via place exchange, to provide enhanced accessibility.  QCM immunosensors, 
as previously described, using either anti-flag or anti-HA IgG were used to evaluate the 
immunological activity of the mimics synthesized.  Detection of the HA-MPC and 
flag/HA-MPC using the anti-HA immunosensor, and the flag-MPC and HA/flag-MPC 
using the anti-flag immunosensor was subsequently accomplished.  Neither one detected 
the tiopronin MPCs without peptide epitopes.  In all these trials, biological recognition 
serves as a quick means to identify useful peptide nanoparticles and to determine binding 
constants. 
More recently, Mancin and coworkers described a variety of metal cores coated with a 
helical 11 amino acid peptide.
116
  H-Ala3-(Aib-Ala)4-OMe, where Aib is α-
aminoisobutyric acid, was grafted onto a variety of metal cores (with 
tritylmercaptopropionic acid) and onto silica nanoparticles.  The specific primary 
sequence has been known for holding an α-helical structure in a variety of media.  In 
Mancin’s experiments, the peptide held the helical structure after grafting onto all of the 
tested nanoparticles, as was confirmed by circular dichroism.  For the metal 
nanoparticles, the peptide was used as the primary protecting ligand during reduction 
with sodium borohydride.  These nanoparticles were recognized effectively by immune 
cells, according to observations with confocal microscopy.  These peptide conjugated 
nanoparticles, and control nanoparticles with a non-helical pentapeptide were taken up 
equally as well by macrophages.  When tested with monocytes, the undecapeptide 
outperformed its uncoiled counterpart by a factor of two or three in terms of amount of 
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material taken up in cells.  The conducted experiments are an interesting example of how 
these conjugates can be employed in living systems. 
The research group of David Cliffel is currently engaged in adapting nanoparticle mimics 
in vivo.  Particularly, much of the research focuses on toxicity and antigenicity.  Simpson 
and coworkers showed that while gold-tiopronin nanoparticles are toxic in mice, the 
addition of a small amount of tetraethylene glycol into the nanoparticle monolayer 
eliminates this toxicity.
117
  Antigenicity is currently being investigated, and there has yet 
to be a published study showing the generation of native antigen specific sera production 
in mice after challenge with a peptide-nanoparticle conjugate. 
The current investigation utilizes water soluble tiopronin nanoparticles, bidentate and 
monodentate place exchange strategies with peptides, QCM immunosensing, and 
information gathered from epitope mapping (discussed in the previous chapter).  The 
resulting data supports the synthesized nanomaterial as a further example of how 
straightforward methods can be used to mimic the effects of complex biological agents. 
 
Quartz Crystal Microbalance Immunosensing 
The QCM instrument has been described previously in Chapter II.  A useful review on 
piezoelectrics in analytical life sciences, written by Janshoff and coworkers,
94
 describes 
piezoelectric immunosensors, such as the QCM, and their advantages and disadvantages.  
Summarily, the QCM is a scaled down version of the SPR in terms of analytical 
capability in biosensing, with somewhat lower sensitivity, and more medium-related 
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complications (signals affected by solution conductivity, viscosity, non-rigid interactions, 
etc.).  Ultimately, it is still a sensitive, label-free technique that has been well-established 
for the detection of antigens.  The strategies described have been useful to our research 
group in a number of other disease detection studies
118-120
 and in the validation of 
antigenic nanoparticle mimics.
92, 105, 110, 112
  Adapting some of these strategies, the 
construction of a QCM immunosensor platform for HRSV detection, centered on the 
commercial IgG Palivizumab(PZ), was undertaken.  This work was extended to validate a 
gold nanoparticle antigenic mimic of HRSV F protein.  
 
Methods 
Materials 
HAuCl4
- • 3H2O was synthesized according to standard methods from electrochemically 
purified Canadian gold maple leaf coins (99.99%).
121
  Reagent and optima grade 
solvents, N-2-mercaptopropionylglycine (tiopronin), bovine serum albumin (fraction V, 
96%), sodium borohydride, thioanisole, and anisole were purchased from Sigma-Aldrich.  
Common laboratory salts and concenetrated ammonium hydroxide were reagent grade 
and purchased from Fisher scientific.  Concentrated sulfuric acid was purchased from 
EMD.  Absolute ethanol was purchased from Pharmco-AAPER.  Hydrogen peroxide 
(30% v/v) was purchased from Acros. Peptide synthesis materials (f-moc protected and 
side-chain protected amino acids, coupling reagents, and resins) were provided 
generously by the David Wright research group.  18 MΩ Water was obtained from a U.S. 
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Filter Modulab water system with a 0.2 µm external filter, or from a Barnstead 
NANOpure Diamond water purification system.  Dry nitrogen is provided in house.  
Monoclonal antibody 1214, 1129, Palivizumab, and human respiratory syncytial virus 
were provided generously by the Dr. James Crowe, Jr. research group.  Work areas that 
contained HRSV were cleaned thoroughly with 70% isopropyl alcohol solution.  Amicon 
Ultra molecular weight cut-off centrifuge tubes were obtained from the molecular 
biology core at Vanderbilt University.  Snakeskin pleated dialysis tubing (10,000 
MWCO) was purchased from Thermo Scientific.  Deuterated solvents (99.9% D) were 
purchased from Cambridge Isotope Laboratories. 
 
Peptide Synthesis 
Peptides were synthesized as discussed in Chapter III.  Some peptides were purified by 
size exclusion chromatography instead of semi-prep HPLC.  Peptides used in this study 
are displayed in Table 6. 
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Table 6.  Peptides that were conjugated to nanoparticles in this study.  Series represents 
the set of experiments in which they were used.  Each series evolved based on the results 
of the last series, as discussed later.  The ID will be used to refer to peptides later in 
shorthand (e.g. peptide 2-L represents the peptide with ID “L” from series 2).  N-
terminus describes whether or not the N terminus was acetylated (AcNH is acetylated and 
NH2 is not acetylated), if a cysteine residue (C) was added here for place exchange, or 
whether serine-glycine-serine-glycine (SGSG) or hexaethylene glycol (PEG6) spacer was 
incorporated.  Primary epitope sequence indicates the amino acid sequence that was 
adapted from HRSV F antigenic site A.  C-terminus indicates whether or not the C-
terminus was amidated (CONH2 is amidated and COOH is not), whether a cysteine 
residue was incorporated, and if a spacer was used.  Projection follows from the location 
of the cysteine residue, indicating whether the peptide is immobilized by monodentate 
attachment at the N-terminus thus projecting the C-terminus away from the nanoparticle 
surface (N to C) or vice versa (C to N), or whether it is immobilized by bidentate 
attachment at both termini (looped). 
 
 
 
Synthesis of Au216Tiopronin129 Nanoparticles 
Tiopronin MPCs were synthesized as previously described.
122
  5.25 g (15.4 mmol) 
HAuCl4  3H2O was dissolved in 500 mL 6:1 methanol:acetic acid and chilled in an ice 
bath for 30 minutes, giving a yellow solution.  7.56 g (46.2 mmol) tiopronin was then 
added to the solution, forming a ruby red intermediate.  Upon dissolution of the tiopronin, 
5.84 g (154 mmol) sodium borohydride in approximately 10 mL water was immediately 
Series ID N terminus Primary Epitope Sequence C terminus Projection
1 F H2N-C LSLINDMPITNDQKKLMSNNVQ COOH N to C
1 L H2N-C LSLINDMPITNDQKKLMSNNVQ C-COOH looped
2 F AcNH-PEG6C NSELLSLINDMPITNDQKKLMSNN CONH2 N to C
2 R AcNH NSELLSLINDMPITNDQKKLMSNN PEG6C-CONH2 C to N
2 L AcNH-PEG6C NSELLSLINDMPITNDQKKLMSNN PEG6C-CONH2 looped
3 F AcNH-CSGSG NSELLSLINDMPITNDQKKLMSNN CONH2 N to C
3 L AcNH-CSGSG NSELLSLINDMPITNDQKKLMSNN GSGSC-CONH2 looped
3 F AcNH-CSGSG SLINDMPITN CONH2 N to C
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and rapidly added to the mixture.  A violent, exothermic reaction results, leaving a black 
solution.  The solution is stirred overnight, yielding polydisperse nanometer sized 
clusters.  The resulting solution is rotary evaporated in vacuo to remove the methanol.  
The resulting precipitate/viscous acetic acid solution is redissolved in water, pH adjusted 
to 1 with concentrated hydrochloric acid and placed in dialysis tubing (cellulose ester, 
MWCO = 10 kDa).  The dialysis proceeds for 2 weeks changing the water at least twice 
daily until the water does visually turn a color.  
1
H NMR: 4.00 ppm broad singlet 
(tiopronin methylene on cluster), 3.76 ppm broad singlet (tiopronin CH on cluster), 1.66 
ppm very broad singlet (tiopronin methyl on cluster).  TEM: average particle diameter of 
2.2 nm  0.6 nm.  UV/Visible spectroscopy: no surface plasmon resonance band 
observable.  TGA: 33 weight percent organic (tiopronin).  Average formula: 
Au216Tiopronin129.  
 
Synthesis of Au118Tiopronin71 Nanoparticles 
Tiopronin MPCs were synthesized as previously described.
122
  500 mg HAuCl4  3H2O 
was dissolved in 70 mL 6:1 methanol:acetic acid and chilled in an ice bath for 30 
minutes, giving a yellow solution.  620 mg tiopronin was then added to the solution, 
forming a ruby red intermediate.  Upon fading of the solution to near colorless, 500 mg 
sodium borohydride in a minimum of water was immediately and rapidly added to the 
mixture.  A violent and exothermic reaction results, leaving a black suspension.  The 
solution is stirred overnight, yielding polydisperse nanometer sized particles.  The 
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resulting solution is centrifuged, and the solvent decanted.  The particles were then 
resuspended in methanol, and centrifuged a second time.  
1
H NMR: 4.00 ppm broad 
singlet (tiopronin methylene on cluster), 3.76 ppm broad singlet (tiopronin CH on 
cluster), 1.66 ppm very broad singlet (tiopronin methyl on cluster).  TEM: average 
particle diameter of 1.8 nm  0.7 nm.  UV/Visible spectroscopy: no surface plasmon 
resonance band observable.  TGA: 33 % by mass organic (tiopronin).  Average formula: 
Au118Tiopronin71. 
 
Synthesis of Au696Tiopronin265 Nanoparticles 
Tiopronin MPCs were synthesized as previously described.
122
  500 mg HAuCl4  3H2O 
was dissolved in 70 mL 6:1 methanol:acetic acid and chilled in an ice bath for 30 
minutes, giving a yellow solution.  110 mg tiopronin was then added to the solution, 
forming a ruby red intermediate.  Upon fading of the solution to near colorless, 500 mg 
sodium borohydride in a minimum of water was immediately and rapidly added to the 
mixture.  A violent, exothermic reaction results, leaving a black suspension.  The solution 
is stirred overnight, yielding polydisperse nanometer sized particles.  The resulting 
solution is centrifuged, and the solvent decanted.  The particles were then resuspended in 
methanol, and centrifuged a second time.  
1
H NMR: 4.00 ppm broad singlet (tiopronin 
methylene on cluster), 3.76 ppm broad singlet (tiopronin CH on cluster), 1.66 ppm very 
broad singlet (tiopronin methyl on cluster).  TEM: average particle diameter of 2.9 nm  
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0.8 nm.  UV/Visible spectroscopy: no surface plasmon resonance band observable.  
TGA: 24 % by mass organic (tiopronin).  Average formula: Au696Tiopronin265. 
 
Place Exchange to Form Series 3 Peptide-Nanoparticle Conjugates 
20 mg of Au696Tiopronin265 was dissolved in 2 mL water.  Then, a 1:10 stoichiometric 
peptide:tiopronin mass of peptide was dissolved in 3 mL of water.  The solutions were 
mixed together and stirred for 72 hours.  The resulting nanoparticle-peptide conjugate 
solutions were subsequently transferred to 10,000 MWCO centrifuge filters, and 
centrifuged a total of 10 times.  The resulting clean solutions were analyzed by 
1
H NMR 
to determine purity and exchange percentages and by UV-Vis to determine nanoparticle 
concentrations by Beer’s law.  Drying of the solution was avoided in order to reduce 
particle agglomeration.   Series 1 and 2 peptides (see Table 6) were place exchanged by 
similar methods, except that dialysis in 10,000 MWCO membranes was used in place of 
centrifuge filters, and the use of buffers during place exchange and purification was 
utilized if there was a solubility or stability problem.  Series 1 peptides were exchanged 
with Au216Tiopronin129, and series 2 peptides were exchanged with Au118Tiopronin71. 
 
QCM Immunosensor Construction and Detection of HRSV 
A stable frequency baseline was collected while PBS was pumped through the flow cell 
with a peristaltic pump.  Protein G (200 µg/mL) was pumped through the flow cell until 
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saturation was reached as indicated by a level frequency reading, at which point the 
solution was switched back to PBS.  In the same manner, BSA (1 mg/mL) was then 
flowed, followed by Palivizumab (40 µg/mL).  HRSV, diluted in PBS from growth 
medium to the desired concentration, was then flowed for a period of about 10 minutes.  
All solutions were in PBS and flowed at a rate of 20 µL/min.  After HRSV was flowed 
through the cell, all lines and flow cells were purged with 20% bleach solution to 
decontaminate. 
 
Adaptation of the QCM Immunosensor to Detect Peptide Presenting Gold Nanoparticles 
The above Scheme was followed for sensor construction, except that some concentrations 
were changed to optimize sensitivity and/or save on material.  Protein G was used at 50 
µg/mL, BSA at 1mg/mL, and PZ at 10 µg/mL.  Detection of the nanoparticle solution 
was achieved by diluting the water solution in PBS to a minimum of 4:1 to avoid drastic 
differences in solution conductivity and viscosity, which causes inaccuracies in 
converting the frequency signal to bound mass.  The nanoparticle solution was then 
flowed through the cell as normal. 
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Results and Discussion 
QCM Immunosensor for HRSV 
(Note: In concert with Dr. Yibin Zhang, a QCM based immunosensor for HRSV was 
developed.
123
  As the data is largely that of Dr. Zhang’s, only the major results that are 
necessary to the understanding of the peptide presenting gold nanoparticle data that 
follows are discussed.) 
 
A QCM immunosensor strategy for SARS-associated coronavirus
124
 was adapted to 
specifically and quantitatively detect HRSV.  The platform, depicted in Figure 19, is 
composed of an Fc binding cell wall protein such as Protein A, G, or L from 
Staphylococcus Aureus, a blocking agent such as bovine serum albumin (BSA), and a 
polyclonal or monoclonal (mAb) detection antibody. 
 
Figure 19:  Cartoon schematic of the QCM based immunosensor for HRSV detection.  
Gold electrodes wrapped about piezoelectric quartz are functionalized with Protein G, 
which binds PZ in an orientation amenable to HRSV detection.  BSA is used to fill in 
bare gold spaces left after adsorption of Protein G. 
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Dr. Yibin Zhang was responsible for determining the ideal combination of sensing 
antibody and Fc binding protein (data not provided here), and determined that the 
combination of Protein G and Palivizumab optimized the sensitivity and specificity of the 
instrument towards HRSV.  The sensor construction and subsequent detection of HRSV 
from cultured growth medium diluted in PBS is displayed in Figure 20.   
 
Figure 20:  Detection of HRSV with the QCM-PZ immunosensor.  Light blue indicates 
that PBS is being flowed without any analyte.  Prot G indicates that 200 µg/mL Protein G 
is flowed through the cell for the corresponding time duration in white giving a total 
immobilized protein mass of 99 ng on the gold electrode surface, BSA is 1 mg/mL and 
gave a mass of 35 ng, Palivizumab is 40 µg/mL and gave a mass of 229 ng, and RSV is 8 
x 10
5
 PFU/mL yielding a detected viral mass of 210 ng.  All solutions were in PBS and 
flowed at a rate of 20 µL/min.  Figure designed by Dr. Yibin Zhang. 
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Experiments to evaluate the specificity of the sensor are displayed in Figure 21.  These 
experiments looked at replacement of the antibody and antigen to investigate non-specific 
binding, associated with false positives.   Anti-HA and anti-PA were compared to PZ for 
detection of HRSV and HRSV growth medium and human metapneumovirus (HMPV), a 
close relative of HRSV, were compared to HRSV for detection by PZ.  All detection 
steps were run for 10 minutes.    
 
 
Figure 21:  Detection and control experiments for the QCM-PZ immunonosensor.  
Experiments 1 and 2 are sensors detecting HRSV with anti-HA(mouse monoclonal 
12CA3 from the Vanderbilt antibody core) and anti-PA (mouse monoclonal anti-PA83 
from Alpha Diagnostics) replacing PZ.  Experiment 3 is the detection experiment with 
HRSV and PZ (labeled as Synagis in this figure).  Experiments 4 and 5 use the PZ 
immunosensor, but RSV growth medium and HMPV are substituted for HRSV during 
the detection step.  Figure designed by Dr. Yibin Zhang. 
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The results from the HRSV growth medium are taken as a negative background because 
it is present in the positive HRSV sample.  A negative background was therefore 
determined as the signal of HRSV growth medium plus three standard deviations, which 
is 59.3 ng.  Anything below this was determined to be a negative result for detection.  
Neither of the control antibodies provided significant signal when compared to PZ and to 
the negative threshold, indicating that HRSV is not electrostatically or physically sticking 
to other proteins in the sensing layer.  Also, none of the other antigens provided a 
significant signal.  The lack of HRSV growth media binding would indicate that the 
signal is not from contaminants in the HRSV sample that originate from the viral culture.  
The lack of HMPV binding suggests that the interaction between the Fab region of PZ 
and the antigenic surface protein of HRSV, in this case F, is of a nature dependent upon 
the specific primary and secondary structure of the HRSV F protein. 
  
In conclusion, a QCM platform using the combination of protein G and PZ was found to 
be sufficient for the specific detection and quantitation of HRSV in buffer.  The sensor 
was also found to be capable of detection of HRSV in infected MDCK cells and in 
human patient nasal wash samples.  The sensor had a limit of detection of 9 x 10
3
 
PFU/mL. 
 
 
 
73 
 
Development of Peptide Presenting Gold Nanoparticles 
Peptides listed in Table 6 were place exchanged successfully onto tiopronin protected 
gold nanoparticles.  TGA and TEM yielded the number of gold atoms in the nanoparticle 
core and the number of tiopronin molecules in the unexchanged material, and 
1
H NMR 
yielded the ratio of peptide to tiopronin on the surface, as demonstrated in Figure 21. 
 
Figure 22:  
1
H NMR, with double water-gate solvent suppression, of a peptide-
nanoparticle conjugate, in this case Au696Tiopronin255Peptide(3-F)10.  The extent of 
peptide exchange is determined by integrating the peak at 0.8 ppm, which represents 
leucine, isoleucine, and valine methyl protons and comparing that to the peak at 1.5 ppm, 
which represents tiopronin methyl protons. 
 
Table 7 lists nanoparticle mimics that were synthesized and evaluated with the QCM 
immunosensor.   
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Table 7:  Nanoparticle mimics studied with the QCM HRSV immunosensor.  Peptide IDs 
refer to Table 3-x.  nAu, ntiopronin, and npeptide refer to the number of gold atoms, tiopronin 
molecules, and peptide molecules per nanoparticle, respectively.  dTEM is the diameter of 
the gold core as determined by TEM.  PZ detection qualitatively describes the relative 
amount and nature of detection. 
Peptide  
ID nAu ntiopronin npeptide 
dTEM  
(nm) 
MW  
(kDa) 
PZ  
detection 
3-F 696 261 4 2.7 191 strong 
3-L 696 253 6 2.7 198 negligible 
3-FS 696 259 6 2.7 187 none 
2-F 216 126 3 1.8 72.1 weak, non-specific 
2-R 216 127 2 1.8 69.1 none 
2-L 216 127 2 1.8 69.6 none 
1-F 118 69 2 2.2 40.3 none 
1-L 118 67 2 2.2 39.9 none 
none 696 265 0 2.7 178.9 none 
none 118 71 0 1.8 34.6 negligible, non-specific 
 
Detection of Peptide Presenting Gold Nanoparticles with the QCM Immunosensor for 
HRSV 
As previously summarized in Table 7, many of the nanoparticle mimics evaluated did not 
interact significantly with PZ.  The two notable exceptions were 
Au696Tiopronin261Peptide(3-F)4 (mimic A) and Au118Tiopronin71Peptide(2-F)3 (mimic B).  
As Mimic B was found to non-specifically bind to the non-sensing proteins on the gold 
surface (data available upon request), Mimic A will be the focus of the remainder of this 
chapter.  Of importance, one should recall that mimic A was functionalized with the same 
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peptide that gave the strongest signal in a peptide ELISA assay, as discussed in Chapter II 
(referred to there as peptide A, and here as peptide 3-F).  The primary sequence of this 
peptide and of peptide 2-F contains the same sequence as peptides studied by 
MedImmune
79
 and, more recently, by McLellan and coworkers.
90, 125
  The authors were 
not aware of the latter two works at the time that the following studies were conducted. 
Mimic A is of the most interest as it bound strongly and specifically to the QCM HRSV 
immunosensor.  A proof of concept experiment was performed in which a sensor was 
constructed in the usual way (see methods), except that PZ was left out entirely.  In this 
instance, mimic A was not detected by the sensor.  Upon addition of PZ, however, the 
mimic was detected by its strong binding to the sensor, as shown in Figure 23.   
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Figure 23:  Detection of Au696Tiopronin255Peptide(3-F)10 by the QCM immunosensor 
with and without PZ.  Blue sections represent the flow of PBS without analyte.  White 
sections indicate the binding of protein G (50 µg/mL, 192 ng bound), BSA (1 mg/mL, 53 
ng bound), nanoparticle mimic (818 µg/mL, no detectable amount of material bound), PZ 
(10 µg/mL, 92 ng bound), and nanoparticle mimic again (409 µg/mL, 150 ng bound after 
15 minutes of flow), respectively. 
 
In order to further characterize the affinity of mimic A for the PZ sensor, a concentration 
study was undertaken.  Six concentrations of mimic A in PBS were evaluated for their 
bound mass and binding on rate in order to determine kf, kr, and Ka for Scheme 3-1. 
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Scheme 3-1:  Langmuirian binding model for an antigen and antibody.  The first case is 
appropriate for large antigens, such as virions, and the second case better describes 
smaller antigens (peptides, small proteins, nanoparticles). 
 
The data for mimic detection, along with data for the construction of the sensor layer for 
each experiment is summarized in Table 8.   
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Table 8:  Summary of mimic A detection at various concentrations, along with sensor 
characterization data for each experiment.  n is the number of bound molecules of the 
corresponding protein.  θ is the percent coverage of Protein G by PZ.  NP is the mass of 
mimic A bound after the 3 minutes in the middle of the binding curve.  mmax is the 
theoretical maximum mass of nanoparticle that could bind in either a 1:1, 2:1, or 4:1 
model (see Scheme 3-1).  None of the sample concentrations analyzed provided an 
empirical mmax in the time durations allowed, which were limited by the amount of 
sample available for analysis.  * indicates that the data could not be determined due to an 
instrumental error.  Sensor construction data for 818 µg/mL was lost due to a crash of the 
data logging program before the detection step. 
 
Normally, it is straightforward to determine equilibrium association (Ka) and dissociation 
(Kd) from m vs. C data, but in our case, the inability to determine saturation data renders 
this method unfeasible.  Binding coefficients were instead determined from the maximum 
on rates at each concentration.  Figure 24 illustrates the concentration dependence of the 
on rate. 
[Mimic A] nG nBSA PZ nPZ NP3m mmax mmax mmax
(µg/mL) x10
11
x10
11
(ng) x10
11
(ng) 1:1 (ng) 2:1 (ng) 4:1 (ng)
32.7 69 19.2 * * 45 1.81 9.39% 8.9 61 122 244
32.7 101 28.1 40 3.6 43 1.73 6.13% 9.2 58 116 233
32.7 42 11.7 66 5.95 26 1.04 8.91% 7.1 35 70 141
78.8 145 40.4 65 5.86 108 4.33 10.70% 12 146 292 584
78.8 * * * * 99 3.97 * 20 134 268 536
78.8 106 29.5 53 4.78 98 3.93 13.30% 17 133 265 530
315 69 19.2 * * 45 1.81 9.39% 35 61 122 244
315 101 28.1 40 3.6 43 1.73 6.13% 43 58 116 233
315 42 11.7 66 5.95 21 0.84 7.20% 23 28 57 114
409 192 53.5 53 4.78 92 3.69 6.90% 42 124 249 498
409 149 41.5 49 4.42 76 3.05 7.34% 43 103 206 411
409 141 39.3 28 2.52 68 2.73 6.94% 43 92 184 368
492 64 17.8 82 7.39 99 3.97 22.30% 81 134 268 536
492 * * 141 12.7 133 5.34 * 113 180 360 720
818 * * * * * * * 365 * * *
818 * * * * * * * 305 * * *
818 * * * * * * * 334 * * *
ProG
 (ng)
BSA
(ng)
θG:PZ
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Figure 24:  Representative QCM mass versus time curves at various concentrations of 
mimic A during the detection step.   
 
For any binding model in Scheme 3-1, the kinetics are characterized by: 
  (  
  
    
)   (   )  
(3-1) 
 
where mt is the bound mass at time t, mmax is the maximum mass that can bind to the 
sensor, the total quantity in the natural logarithm is the uncovered surface percentage and 
the fractional quantity is the surface coverage percentage at a given time, and τ is the time 
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constant associated with a given concentration of antigen.
126, 127
  In order to determine 
mmax in the absence of data at saturation, a calculated value is used based on the average 
number of PZ molecules bound to the sensor.  For a 2:1 binding model, which is expected 
for this system, mmax = 210 ng.  This value of mmax provides better fits of data to theory 
than if individually calculated values for each sensor are used, probably because bound 
mass is not expected to track linearly with immobilized antibody due to the “hook 
effect.”128, 129 The negative inverse time constant can be determined from the slope of the 
linear portion of a linear plot of equation 3-1, in the form of the logarithmic quantity 
versus t, as illustrated in Figure 25 for one of the 409 µg/mL experiments. 
 
Figure 25:  Plot to determine the time constant for mimic A binding to the Palivizumab 
sensor, τ, for a single experiment.  For this 409 µg/mL experiment, -τ-1 = -6.50 x 10-4 s-1.  
The slope is only determined for the linear portion (black), where the binding rate has 
reached a maximum. 
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The binding coefficients are determined from the equation: 
           
(3-2) 
 
where C is the bulk concentration of mimic A.  A linear plot of τ-1 versus C (in mol/L) 
yields a slope equal to kf and a y-intercept equal to kr.   For a 2:1 binding model, this 
looks like Figure 26. 
 
 
Figure 26.  Plot of individual time constants determined for each concentration.  
Assuming a Langmuir isotherm, a linear plot will give a slope equal to kf and a y-
intercept equal to kr.  Above  ~ 2 µM, linearity is broken, and the use of those data points 
to determine binding coefficients is not feasible.  The data for the most concentrated 
sample, 3.90 µM, is questionable, as it quickly violates the 2:1 binding model (as in 
Figure 24). 
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From the data, it appears that the 2:1 Langmuir binding model is not valid for the entire 
process of mimic interacting with the sensor surface.  A plausible explanation is found 
when the assumptions of the Langmuir isotherm are examined.  The model assumes that 
surface coverage is restricted to a single monolayer and that interactions between 
adsorbates are negligible and all binding sites are equivalent.  The equivalence of binding 
sites is violated to a certain extent, as there is no unidirectional relationship between the 
number of PZ molecules and the mass bound to the surface (see Table 8).  Deviations 
were attributed to negative steric effects overtaking positive effects of increasing the total 
number of binding sites.  Steric effects do not, however, explain the data in Figure 26.  A 
more informed explanation was found by breaking the other two assumptions of the 
Langmuir isotherm.  It was, therefore, assumed that the mimics could interact with each 
other, which would, in turn, lead to multilayer coverage.  If true, one would expect that a 
2:1 Langmuir model is insufficient.  Plausibly, the system follows Langmuirian 
adsorption up to a certain concentration, which was defined as the point at which linearity 
is broken.  If true, multilayer adsorption is catalyzed by surface immobilization of the 
first monolayer in a fashion similar to systems that follow a BET isotherm.
130, 131
  This 
theory also explains the reason why it was difficult to achieve saturation of the sensor 
(indicated by a plateau in the signal) after a somewhat lengthy period of time and use of a 
significant amount of material.  Examining the four lowest concentrations, the plot in 
Figure 27 is produced. 
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Figure 27:  Plot to determine binding coefficients using the four lowest concentration 
samples. 
 
If the four lowest concentrations are assumed to follow a Langmuirian isotherm, which 
they appear to, then, for a 2:1 binding model, it is determined that kf = 6.74 x 10
2
  ± 0.88 
x 10
2
 M
-1
 s
-1
, kr = 1.84 x 10
-4
 ± 1.09 x 10
-4
, and, therefore, when one considers that 
   
          
[     ] 
      
 
  
  
 
 
  
 
(3-3) 
 
then Ka = 3.66 ± 2.22 x 10
6
 M
-1
, and Kd = 292 ± 177 nM.  These values are in the range 
expected for mAb/antigen interaction.  The value of Kd suggests that the affinity of PZ for 
the mimic is between ~100 and ~300 fold weaker than PZ for the F protein (Kd = 1.4 
nM).
86
  The binding is competitive with that of epitope scaffolds constructed by 
McLellan and coworkers (Kd = 87 to 3950 nM) with the same primary epitope 
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sequence.
125
  The advantage of this mimic is that it does not require recombinant genetic 
techniques to produce; rather, it involves straightforward laboratory techniques and 
automated peptide synthesis equipment.  While nanoparticle and peptide synthesis have 
their own unique challenges, it is suspected that this is much more straightforward and 
cost effective on the basis of materials costs and training time of mentored students. 
The most significant problem that was encountered with this material was its poor 
solution stability at ambient conditions.  After a few weeks the solutions lost their activity 
and visible amounts of precipitate could be seen in the stock solution.  Observed 
agglomeration of this nature might be inhibited by refrigeration, freezing, or purging with 
inert gas.  Chemical modification is another option that is worth exploring in the future.  
Tiopronin carboxylate groups on one nanoparticle can form salt bridges with peptides on 
another nanoparticle, leading to agglomeration. The effect of salt bridges was suspected 
on the basis of having worked with similar peptides on tiopronin nanoparticles in the 
past, and using pH 8.4 borate buffer to avoid precipitation, presumably by deprotonating 
side chains and allowing for charge shielding.  Similar problems with p-mercaptobenzoic 
acid protected nanoparticles was reported in the literature.
29
  Borate buffer was not used 
here because the nanoparticles were initially stable at pH 7.  The use of an alternative 
water solubilizing ligand, such as 1-mercaptotetraethylene glycol,
132
 could solve this 
problem. 
In conclusion, a strong binding HRSV F protein mimic has been synthesized using 
straightforward and relatively cost effective techniques that can be taught to a novice 
science student.  Mimic A performs nearly as well as the state of the art subunit mimic 
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(Kd = 87 nM),
125
  but not as well as the native protein antigen (Kd = 1.4 nM), for 
palivizumab binding.
86
  The performance of this mimic could be improved by optimizing 
the size of the mimic, experimenting with bidentate attachment on different sizes of 
nanoparticles, modifying the protecting ligand (1-mercaptotetraethylene glycol),
132
 and 
optimizing the peptide loading.  Given this performance, the mimic should be 
investigated as a novel subunit vaccine, which is needed in the clinic during the RSV 
season.  This novel material could also be studied as a non-infectious calibration standard 
for a number of HRSV immunosensors. 
The QCM platform that has been developed, while novel and cost-effective, 
underperforms the SPR in a number of regards.  One issue that was not formally raised in 
the previous discussion is the lack of a stable signal.  Often times the signal will drift, and 
has to be mathematically corrected.  Furthermore, it is also problematic that the QCM 
signal tracks with temperature, which may be the source of the drift.
133
  Additionally, the 
difficulty in keeping air bubbles out of the solution leads too often to useless data, 
increasing the number of experiments to reach a sufficient N value for most studies.  The 
immobilization strategy used is too inconsistent, and is suspected to be responsible for the 
variance in detection data.  That being said, the QCM was effective at detecting the 
HRSV virion and the nanoparticle mimic with sufficient specificity. 
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CHAPTER IV 
SECM OF “WIRED” GOLD NANOPARTICLES TO DETERMINE ELECTRON 
TRANSFER KINETICS: PROOF OF CONCEPT FOR POTENTIAL COMPONENTS 
IN NANOMOLECULAR CIRCUITS 
 
Introduction 
The current chapter continues with the theme of kinetic studies of gold nanoparticles, but 
turns the attention from matters of clinical interest to the realm of materials science, as 
well as moving away from more classical understandings of kinetics to quantum 
mechanically defined electrons.  More specifically, the practical application associated 
with the experiments that follow lies within the field of molecular electronics, where 
electron transfer rates are among attributes that define what a given material can and 
cannot accomplish.  The chapter begins with small gold nanoparticles, as in the preceding 
chapters, but now functionalized with ligands not amenable to aqueous solution.  The 
ligands used are interesting and potentially useful for their electronic properties; straight 
chain alkanethiols as insulators and a relatively new class of molecule deemed 
“molecular wires” which are known for their metal-like conductivity or, more accurately, 
resonant tunneling.  The nanoparticles themselves are known for their electronic 
properties, and therefore, the combination of the two should yield interesting 
nanomaterials for integration into miniaturize and efficient electronic devices.  In the 
following pages, the electronic properties of these materials and how they fit into the 
field of molecular electronics, the way in which they can be brought together into a single 
unit, and characterization of the electronic properties of these nanoparticle conjugates in 
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solution by the scanning electron microscope are discussed.  It was hypothesized that 
integrating a “molecular wire” into the protecting monolayer of otherwise insulated gold 
nanoparticles should increase the electron transfer rate, as conductance happens faster, or 
more often, than tunneling. 
 
Background 
Molecular Electronics 
In a 2000 editorial in Nature, Daniel Feldheim suggested that more research into the 
effect of structure on electronic properties of nanomaterials in circuits would lead to the 
discovery of new electronic properties and new applications.
134
 Specifically, he cites 
applications such as the development of miniaturized devices at a rate that smashes 
Moore’s law, energy efficient memory storage devices, and extremely sensitive chemical 
and biological sensors.  In the decade that followed, a great number of advances have 
been made towards these ends, even if molecular and nanoscale electronics are not yet 
commercially available.  These technological advances, along with the excitement 
surrounding the versatility of gold nanoparticles as previously discussed, motivated the 
current study which marries the two fields of molecular electronics and nanoparticle 
science. 
The idea of using thiolate protected gold nanoparticles in nanomolecular electronics is 
not a new one.  For instance, in the same year, Schiffrin and coworkers reported on a 
molecular switch that consisted of a single gold nanoparticle with 60 redox active 
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bipyridine ligands attached to it and a gold electrode.  A schematic of this device is 
shown in Figure 28. 
 
Figure 28:  Nanoparticle-bipyridine redox switch.
135
 Copyright 2000, Nature Publishing 
Group, reused with permission. 
 
Self-assembled dinonanethiol-bipyridine molecules (molecule (1) in Figure 28) on gold 
attach the nanoparticle to the surface, and their redox state can be tuned by controlling the 
voltage.  An STM tip measures a current-voltage ratio of about 30 nA when the 
bipryidine is in its reduced state, but decreases markedly when it is in its oxidized state.  
When the bipyridine ligand is replace with hexanedithiol, an insulator and non-redox 
active compound, negligible current is measured at the STM tip.  The proposed low 
voltage molecular switch, similar to a Schmitt trigger, was estimated to require a mere 30 
electrons to operate, only 60 redox active molecules, and occupied a volume of about 9 x 
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9 nm.  As Feldheim points out, however, this device could never fill the role of a Schmitt 
trigger as it operates too slowly and the gain is too low to be considered commercially 
feasible.
134
  (A Schmitt trigger is a switching circuit that changes an output signal when a 
positive feedback voltage input signal is sufficiently high.)  Instead, he suggested that 
biosensors are a feasible application area for these types of devices. 
Recently, Blum and coworkers showed that nanoparticle-molecular wire networks can be 
assembled with extraordinary spatial regularity using well defined cowpea mosaic virions 
(CPMV).
136
  In this study, CPMV is genetically engineered to include cysteine residues at 
repeated amino acid positions that are fixed by the folding in the virus to well defined 
spatial coordinates.  Addition of 5 nm gold nanoparticles allows for binding at each 
cysteine residue with 2 and 3 nm gaps between nearest and second nearest neighbor 
nanoparticles, respectively.  The gaps are then filled with 3 nm di-Pt molecular wires and 
2 nm OPV molecular wires (defined in Figure 29). 
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Figure 29:  Cowpea mosaic virus-gold nanoparticle-molecular wire conjugate molecular 
electronic nanosensor.   (a) Model of EF–CPMV based on crystallographic data. Cysteine 
mutation sites shown in white. (b) Model of EF–CPMV with bound 5 nm gold 
nanoparticles. (c) Model of EF–CPMV showing molecular network of gold nanoparticles 
with di-Pt (shown in brown) and OPV molecules (shown in white). Conducting 
molecules used to assemble the nanosensor. di-Pt; 1,4-C6H4 [trans-(4-AcSC6H4C 
CPt(PBu3)2C C]2 is 3 nm long, and OPV; oligophenylene-vinylene is 2 nm long.
136
  
Copyright 2011, Elsevier, used with permission. 
 
Lysine residues are then biotinylated, resulting in an avidin capturing nanosensor.  The 
sensing is accomplished by measuring current-voltage curves of these nanosensors before 
and after avidin exposure.  The proximity of charges on various avidin proteins changes 
the conductance of the overall nanoparticle-molecular network in a way that tracks with 
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the protein charge.  The sensors exhibited good specificity when compared to non-
biotinylated controls. 
Given this background literature in nanomolecular electronics, it would be useful to 
describe the electronic properties of the separate components discussed in the above 
devices: gold nanoparticles and molecular wires. 
 
Electrochemical Properties of Gold Nanoparticles 
Gold nanoparticles have often been cited for having interesting and useful 
electrochemical properties.  One of the more interesting properties gold nanoparticles 
possess, in this regard, is their ability to act as a nanoscale capacitor; that is, they are 
small and soluble like molecules but can undergo a relatively great many redox events 
within a given voltage window with respect to a small molecule.  Using square wave 
voltammetry, Hicks and coworkers were able to generate voltammograms displaying a 
great number of charging and discharging events for highly monodisperse hexanethiolate 
protected gold nanoparticles (AuHexanethiolate).
137
  Figure 30 shows a similar 
experiment performed in our lab.
138
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Figure 30:  Square wave voltammogram of AuHexanethiolate nanoparticles.
138
  Within 
the voltage range shown (-0.9V to +1.6V), the nanoparticle stores and reversibly 
discharges 10 electrons. 
 
These peaks are associated, more specifically, with double layer charging.  The 
capacitance on a single nanoparticle is, therefore, equal to the series capacitance of the 
stern layer and the diffuse layer.  In the case of more polydisperse nanoparticles, the 
charging behavior still occurs, but the observation of discrete peaks is obscured, as a 
greater number of redox events are occurring and overlapping in the voltammogram.  
Therefore, while the behavior is only observed for highly monodisperse nanoparticles, 
polydisperse nanoparticles should be useful as nanoscale capacitors as well.  In order to 
use this property in a molecular electronics application, it is prudent to assess electron 
transfer dynamics associated with this charging. 
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In the solid phase, a number of studies have examined electron transfer with 
nanoparticles.  The Murray group studied the electron self-exchange in deprotonated 
Au140(MUA)20(C6)33/Zn nanoparticle multilayer films on mercaptoundecanoic acid 
(MUA) self-assembled monolayers (SAMS) on Au disk electrode.  Using Cottrell 
experiments, electron diffusion coefficients in the range of 10
-8
 cm/s, electron hopping k 
values in the range of 10
6
 s
-1
, and electron self-exchange k values of 10
8 
M
-1
 s
-1
 were 
determined.
139
  Later, the same research group published a study proving that 
arenethiolate protecting ligands lead to films with faster electron transfer rates and higher 
conductivities than alkanethiolate ligands.
140
  Furthermore, lengthening an alkyl spacer 
before the aryl group decreased the electron transfer rate.  Other groups have investigated 
gold nanoparticle films with cytochrome C,
141
 at a mercury junction,
142
 on 3-
mercatopropyltrimethoxysilane functionalized glass slides,
143
 and on SAMs of 2-
(Dimethylamino)ethanethiol,
144
 to highlight some of the many important contributions.  
The difference between the molecules discussed emphasizes the importance of ligand 
structure to electron transfer.  The importance of the current study, in the scope of the 
discussed investigations, is the characterization of nanoparticle electron transfer kinetics 
in the solution phase in order to eliminate effects associated with the solid phase such as 
packing geometry, interparticle interactions, film thickness, and solid-solid interfaces. 
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Molecular Wire Molecules 
Molecular wires are a class of small molecule that are characterized by delocalized 
HOMO orbitals, energetically contained within the Fermi level of an attached metal 
electrode.  In the context of a metal-molecule-metal junction, this allows electrons to 
flow through the molecule in a manner known as “resonant tunneling.”  Resonant 
tunneling is similar in speed to conductance in metals, and certainly faster than through-
space tunneling.  Resonant tunneling exists in molecules that are rigid, conjugated, and 
fully coplanar with themselves.  These structural properties lead to a high degree of π-
conjugation and, therefore, molecular orbitals that extend across the length of the 
molecule.  The concept of a molecular wire is visually is illustrated in Figure 31.
145
 
 
Figure 31:  The molecular wire ligand  (top, (S-[4-(2-
Phenylethynyl)phenyl]ethynylphenyl]thiol, PEPEPSH)) features closely spaced 
molecular orbitals (bottom) that are energetically within the Fermi level of a metal.
145
 
Copyright 2003, American Association for the Advancement of Science, reused with 
permission. 
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When thought of as a series of within molecule electron transfers, it is also important to 
note that these molecules tend to have low reorganization energies from a neutral to 
oxidized or reduced state, corresponding with small changes in bond angles and 
lengths.
146
 
Theories on the electronic behavior of molecular wires have been evaluated in a number 
of studies, usually involving the formation of a metal-molecule-metal junction or 
junctions.  Of note, Ratner and co-workers self-assembled mono- and dithioacetates on 
the tip of a 10 µm gold wire, and approached it within a small distance of a second gold 
wire, end to end.
147
  The approach of the two wires was controlled by a deflection wire 
within a magnetic field, bent by a Lorentz force provided by a small DC current.  The 
approach was monitored by measuring current at 0.5 V.  Having constructed such an 
apparatus allowed them to measure current-voltage profiles in a circuit that were 
dependent on how electrons negotiated the gap between the two wires, which was filled 
by the SAM molecules.  Their experimental setup represents a multi-molecule version of 
the single molecule junction described previously.  Current voltage profiles obtained 
using SAMs of monothioalkyl (2), dithioalkyl (1), conjugated monothiolalkynylaryl (4), 
and conjugated dithioalkynylaryl (3) molecules are displayed in Figure 32, along with 
structures of evaluated molecules (1-4). 
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Figure 32:  Current-voltage profiles of molecular wires sandwiched between gold wires.  
Two covalent sulfur-gold contacts shows higher current than single sulfur gold contacts 
for either case.  The conjugated system (3 and 4, at right) shows greater current (µA vs. 
nA) than the alkane system (1 and 2, at left) (molecular lengths are similar).  Copyright 
2003, John Wiley and Sons, reused with permission. 
 
Summarily, this study found that having a thiol contact on the other end of the molecule 
(in addition to the one attached to the gold surface), as in molecules 1 and 3, improved 
conductivity by at least an order of magnitude over the monothio- molecules 2 and 4.  
Additionally, the alkynylaryl “molecular wire” molecules, 3 and 4, had conductivities 
two orders of magnitude higher than the alkyl molecules.  This important study highlights 
the concepts of a molecular wire attached to a classical conductor by use of sulfur 
“alligator clips” as a viable strategy for nanomolecular electronic device construction. 
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Tour and coworkers successfully integrated these types of molecules into a functional 
device.
148
  Using gold electrodes sandwiching a molecular wire, they were able to create 
a binary memory device with write, read, and erase capabilities, as shown in Figure 33.  
 
Figure 33:  Read-write computing system with gold electrodes sandwiching molecular 
wires.
148
  Writing is accomplished by reductive current, and erasing is accomplished by 
oxidative current.  Copyright 2001, John Wiley and Sons, reused with permission. 
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Memory, in this case, is in the form of a stored conductance instead of a stored voltage.  
The increased conductance state that is stored is the result of electron injection into the 
molecule.  The device was designed as a way for their laboratory to test potential 
molecular wires in a pass/fail evaluation.  Interestingly, the device was found to be 
robust, as no drop off in read signals occurred after an appreciable amount of time, and 
some devices can last continuously through a year of operation, which correlates with 
approximately one billion cycles.  Aside from its use as a testing, the read/write system 
was a great proof of concept that small molecule molecular wires can be integrated into a 
useable device.  With this motivation, the research proceeded to adapt molecules of this 
class to gold nanoparticles with the hope that both components could be integrated into a 
functional device for a materials or biological application. 
 
Scanning Electrochemical Microscope 
Our group developed a method to evaluate electron transfer kinetics in the solution phase 
by using the scanning electrochemical microscope (SECM).  The SECM was first 
described in 1989 by Bard and Kwak.
149
  The instrument consists of an 
ultramicroelectrode in a glass sheath that comes to a tip, controlled by a piezoelectric 
motor (or some other motor capable of micron spatial resolution).  In feedback mode, it is 
operated in a solution that contains an electroactive substance, and it registers a normal 
chronoamperometric response when far away from a given substrate (it,∞), but it measures 
a differential feedback current as it approaches.  The direction of the current difference 
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depends on the substrate: positive for a conductive surface and negative for an insulating 
surface.  Alternatively, one can measure redox active species generated at spatially 
discrete areas of a substrate by using the instrument in substrate generation/tip collection 
mode.  The SECM has found use in a number of studies as an imaging technique in 
biological and materials applications.  In an imaging study, the tip is rastered across a 
substrate, and differences in current are observed depending on whether it is over an 
insulator or conductor, or whether it is over an area of the substrate that is generating an 
electroactive species.  Some brief examples should help clarify this concept.  Mauzeroll, 
Bard, and coworkers were able to examine single cell metabolism of the cytotoxic 
compound menadione in Hep G2 cells (Figure 34a) using the substrate generation/tip 
collection mode.
150
  Wilburn and coworkers were able to image pores formed in lipid 
bilayer membranes by alamethicin (Figure 34b) using electroactive Ru-hex leakage from 
below the membrane as an imaging indicator.
151
  Using feedback mode, Black and 
coworkers examined libraries of ruthenium-platinum thin films, potential fuel cell anode 
catalysts, in a 25 x 25 mm array (Figure 34c) with acid as the redox mediator.
152
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Figure 34:  SECM as a useful imaging technique in biological and materials applications.   
(A)  SECM image superimposed on a transparent optical image of Hep G2 cells 
challenged with menadione.  Challenge causes Hep G2 cells to metabolize this compound 
into the redox active thiodione, which is ejected from the cell by ATP dependent pump 
(higher current, lighter green area).
140
 Copyright 2004, National Academy of Sciences, 
reused with permission.  (B)  Alamethicin pore formation in a bilayer lipid membrane 
allows leakage of redox active Ru-hex, which is detected by the SECM tip.
141
  Copyright 
2006, Royal Society of Chemistry, reused with permission (DOI: 10.1039/B510649D). 
(C)  Combinatorial library of ruthenium-platinum thin films, imaged by SECM, in 
feedback mode, with H2SO4 containing buffer to look for optimal anode catalysts for fuel 
cells.
143
 Copyright 2005, IOP Publishing, Ltd., reused with permission. 
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SECM can also be used in the approach mode in order to determine information about the 
electroactive species in solution, as supposed to using the electroactive species to probe 
the substrate, as displayed in Figure 35.   
 
Figure 35:  SECM experimental design to measure electron transfer between platinum 
electrodes and solvated gold nanoparticles.  Nanoparticles are initially oxidized at the tip 
by a cathodic voltage.  Diffusion, mainly, carries the oxidized nanoparticles to the 
substrate electrode, where they are subsequently reduced.  The tip current (it) increases as 
the tip approaches (i.e. distance, d, decreases) due to a higher local concentration of 
reduced species as the electrical double layers of both electrodes begin to merge. 
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Notably, in the scope of this study, Murray and coworkers showed how this technique 
was capable of measuring electron transfer kinetics between Au38 clusters and aqueous 
redox species at a liquid/liquid interface.
153
   
Using similar methodology in a single-phase organic solvent system, our lab was able to 
show that, for increasing alkanethiol chain length on a gold nanoparticle, the electron 
transfer rate slows.
138
  Approach curves for increasingly longer alkanethiolate protecting 
groups are displayed in Figure 36. 
 
Figure 36:  SECM approach curves of AuAlkanethiolate nanoparticles in anhydrous 
dichloromethane with 1V Pt UME, 0V substrate electrode (vs. Ag/Ag
+
).  Solutions were 
20 mg nanoparticle in 5 mL dichloromethane with 0.1 M TBAPF6.
138
  The dark blue line 
for mass transfer theory represents a case where feedback is not limited by diffusion and 
electron transfer rate, calculated from equation 4-6.  Kinetic theory represents curves that 
are best fit from equation 4-5.  Approach curves for nanoparticles fall further off of this 
line as electron transfer is slowed due to lower tunneling probabilities. Copyright 2006, 
American Chemical Society, reused with permission. 
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Peterson reasoned that the electron transfer rate became slower with protecting 
alkanethiol chain length because the tunneling probability is reduced with greater 
tunneling distance.  This is represented in Figure 36, qualitatively, by the falling off of 
approach curves from that predicted by mass transfer theory, given by equation 4-5 in the 
discussion that follows. 
The unique attributes of UMEs allow for examination of limiting effects on total current.  
Quantitatively, the electron transfer rate can be backed out by modeling a best fit to the 
approach curve.  Steady-state current is defined by: 
         
   
(4-1) 
 
where it,∞ is the steady-state tip current far from the substrate, n is the number of 
electrons transferred, F is Faraday’s constant, D is the diffusion coefficient of the 
electroactive species, C* is the bulk concentration of electroactive species, and a is the 
radius of the disk UME.  Mass transfer limited current as the tip approaches the surface is 
given by: 
        ( ) 
  
(4-2) 
 
where it is the tip current while approaching the substrate, and m(L) is the mass transfer 
coefficient as a function of L, the normalized tip to substrate distance (L = d/a, where d is 
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the raw tip to substrate distance).  If current is kinetically limited, and the process is 
unidirectional at the electrode, which is assumed to be true for a biased electrode, then: 
          
  
(4-3) 
 
where kf is the forward electron transfer rate constant.  In the case where the current is 
both kinetically limited and mass transfer limited, it is useful to use: 
  
 
      
 
 
   
 
 
   
 
(4-4) 
 
where it,exp is the experimental tip current at a given distance that is limited by both 
electron transfer kinetics and mass transfer. 
The dimensionless normalized tip current is used to evaluate limiting behavior: 
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where IT(L) is a computational fit to a non-limited experimental system,
154
 given by: 
   ( )       (
       
 
)                   
(4-5) 
106 
 
In equation 4-5, it is important to note that because IT(L) is a ratio of currents, n and C 
cancel out.  Equation 4-4 implies that the shape of an approach curve is not dependent 
upon concentration or the number of electrons transferred.  Ultimately, the approach 
curve is only dependent upon the diffusion coefficient, the electron transfer rate constant, 
and the electrode geometry. 
Using this approach, it was hypothesized that integrating a “molecular wire” into the 
protecting monolayer of alkanethiolate protected gold nanoparticles should increase the 
electron transfer rate at a biased platinum electrode, as conductance happens faster, or 
more often, than tunneling, as illustrated in Figure 37. 
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Figure 37:  Proof of concept experiments to confirm whether “wired” AuDodecanethiol 
nanoparticles (left) exhibit faster electron transfer than their “unwired” precursors (right). 
 
Methods 
Materials 
HAuCl4
-
 •3H2O was prepared as described previously.
121
  HAuCl4
- •3H2O was 
synthesized according to standard methods from electrochemically purified Canadian 
gold maple leaf coins (99.99%).
121
  Reagent and optima grade solvents, alkanethiols 
(90%), sodium borohydride, lithium borohydride, tetrabutylammonium 
hexafluorphospate (TBAPF6) and S-[4-(2-
fast
er 
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phenylethynyl)phenyl]ethynylphenyl]thioacetate (PEPEPSAc) were purchased from 
Sigma-Aldrich.   Anhydrous dichloromethane (99%) from Sigma Aldrich was used from 
a sure-sealed bottle.  Common laboratory salts were reagent grade and purchased from 
Fisher scientific.  Concentrated sulfuric acid was purchased from EMD.  Absolute 
ethanol was purchased from Pharmco-AAPER.  Hydrogen peroxide (30% v/v) was 
purchased from Acros. Chemicals for peptide synthesis (f-moc protected and side-chain 
protected amino acids, coupling reagents, and resins) were provided generously by the 
David Wright research group.  18 MΩ Water was obtained from a U.S. Filter Modulab 
water system with a 0.2 µm external filter, or from a Barnstead NANOpure Diamond 
water purification system.  Electrodes were purchased from CH instruments, or were 
previously fabricated in this research group and handed down.  Diamond paste was 
purchased from.  Alumina was purchased from.  Deuterated solvents (99.9% D) were 
purchased from Cambridge Isotope Laboratories. 
 
Synthesis of Au1120 Dodecanthiolate690 
1.5 g of tetraoctylammonium bromide (a phase transfer agent) was dissolved in 80 mL of 
toluene.  0.31 g of HAuCl4 was dissolved in 25 mL of water.  To the vigorously stirring 
tetraoctylammonium bromide solution, the gold solution was added slowly.  The 
resulting orange gold-containing organic phase was isolated and chilled in an ice bath for 
30 minutes and stirred vigorously.  0.38 g of NaBH4 was dissolved in 25 mL of water.  
To the stirring organic solution, 260 L of 1-hexanethiol was added.  Immediately, the 
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NaBH4 solution was added over a period of 10 seconds.  The resulting black solution was 
stirred for 30 minutes on ice, and then additionally overnight at room temperature.  The 
organic phase was isolated and rotary evaporated to yield a black solid.  The solid was 
dissolved in a minimum of toluene and precipitated in 400 mL of ethanol at -20 C 
overnight, which was then decanted and centrifuged.  The precipitate was collected on 
the walls of a round bottom flask by dissolution and rotary evaporation and sonicated in 
400 mL of acetonitrile and then ethanol. 1H NMR: 1.45 ppm, 0.98 ppm broad peaks.  
TEM: 3.4 ± 1.1 nm.  UV/Vis:  slight surface plasmon band observed.  TGA: 34.5 % 
organic material. 
 
Synthesis of Au228Octanethiol92 
HAuCl4 (300 mg) and 160 mg LiBH4 were dissolved separately in freshly distilled THF 
(30 mL total), and then purged with argon.  The gold solution was chilled to near 0°C in 
an ice bath.  Then, 1-octanethiol (280 µL) was added via syringe to the gold solution.  
After a few seconds, the LiBH4 solution was added dropwise to the mixture.  It is 
important to add the LiBH4 shortly after addition of the 1-octanethiol, or precipitation of 
oligomeric precursor material will decrease the yield and increase the polydispersity and 
size of the nanoparticles.  CAUTION:  LiBH4 reacts with gold very exothermically; 
therefore caution should be observed during addition, and care should be taken to quench 
and clean the area of any excess LiBH4 as it tends to float during weighing.  The resulting 
black to brown solution was stirred overnight.  To this, 30 mL of water were added, and 
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this was extracted into 60 mL diethyl ether and washed with brine 3 times.  After 
rotoevaporation of the solvent, the nanoparticles were suspended in acetonitrile, 
centrifuged, suspended in ethanol, centrifuged, and washed by drying on a round bottom 
flask and sonicating in a large excess of acetonitrile and/or ethanol until spectroscopically 
clean.  Characterization data:  TEM:  2.0 ± 0.8 nm.  TGA:  25.0% organic material.  UV-
Vis: slight SPR band observed at 520 nm.  1H NMR:  0.98 and 1.50 ppm broad 
resonances. 
 
Deprotection of S-[4-(2-Phenylethynyl)phenyl]ethynylphenyl]thioacetate (PEPEPSAc) 
100 mg of PEPEPSAc was dissolved in 8 mL of dichloromethane and 2 mL of methanol.  
4 drops of concentrated sulfuric acid was added to this.  The reaction was stirred 
overnight under a reflux condenser to slow solvent evaporation.  The volume was 
reduced, if necessary, and poured onto a silica gel plug topped with a filter paper.  
Fractions were collected in increasing gradients of dichloromethane in hexanes.  
Fractions that yielded a white solid upon evaporation were collected first (in low 
dichloromethane).  Yellow solids were collected in later fractions (increasingly higher 
dichloromethane).  White fraction (S-[4-(2-phenylethynyl)phenyl]ethynylphenyl]thiol, 
PEPEPSH): 1H NMR 7.51 ppm, m, 7H (aromatic); 7.38 ppm, m, 6H (aromatic); 3.54 
ppm, s, 1H (thiol).  First yellow fraction (di-S-[4-(2-
Phenylethynyl)phenyl]ethynylphenyl]disulfide, PEPEPS2): 7.52 ppm, m, 14H (aromatic); 
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7.36 ppm, m, 12H (aromatic).  
1
H NMR were taken on a Bruker AV 400 MHz 
instrument. 
 
Place exchange reactions with PEPEPSAc and PEPEPS2  
20 mg of Au1120 Dodecanthiolate690 was dissolved in 4 mL toluene with 8 mg PEPEPSH 
and stirred for 7 days.  The product was dried onto a round bottom flask and sonicated in 
100 mL acetonitrile for 20 minutes, 3 times, and with ethanol for 20 minutes, 3 times. 
20 mg of Au228Octanethiol92 was dissolved in 4 mL toluene with and stirred for 72 hours.  
These particles were suspended and then centrifuged from acetonitrile and then from 
ethanol.  Further purification was accomplished by drying them in a round bottom flask, 
and then sonicating in an excess of acetonitrile and then ethanol, once each. 
 
Scanning Electrochemical Microscopy Experiments 
Nanoparticle samples were dissolved in anhydrous dichloromethane (20 mg in 5 mL) 
with 200 mg TBAPF6.  These solutions were pushed through nylon syring filters (0.45 
µm).  2 mm Pt substrate electrode was treated by polishing with successively smaller grit 
diamond paste, and then finally polished on a polishing wheel (0.1 and 0.05 µm 
Micropolish II with 8” Microcloth on a Metaserv 2000 Grinder/Polisher (Buehler)). The 
polished tip was then sonicated in deionized water and then in ethanol.  A smooth surface 
was observed using an Olympus BX4 optical microscope (< 1000x magnification).  
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Occasionally, it was cleaned by holding in piranha solution for 1 minute.  Finally, it was 
cleaned by constant scanning from -0.4 to 1.4 V (vs. silver wire quasi-reference 
electrode, with a Pt counter wire) in 0.1 M H2SO4 with 0.1 M KCl until a lack of 
hysteresis in the cyclic voltammogram was observed.  The tip was rinsed with water and 
ethanol.  The 25 µm Pt UME was treated similarly.  During polishing of the UME, care 
was taken not to create a tip surface with an RG > 5 (usually around 2-3 in these studies). 
Ag/Ag
+
 quasi-reference wire electrode was prepared by applying a potential of 1V across 
the wire for about 1 minute, resulting in a blackened layer of AgCl.  The AgCl layer was 
lightly scraped with fine grit sand paper to reveal some uncoated surface. 
The UME was fitted into the plastic holder of a piezoelectric motor and visually 
positioned over the center of the Pt substrate electrode, which is fitted into a plastic well 
with the reference electrode.  The well was filled with the nanoparticle solution and 
approached at a faster rate until an increase in current was observed (UME @ 600 mV, 
substrate at 0 mV), at which point it was stopped and backed up a minimum 80 µm.  
Approach curves were collected with the UME at 200-600 mV and the substrate always 
at 0 mV (vs. Ag/Ag
+
).  Dichloromethane was replenished when necessary to a visually 
identical volume (close to the brim).  In between sample changes, the chamber and 
electrodes were rinsed with anhydrous dichloromethane until the rinsate was not colored. 
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Nanoparticle Surface Quantitation 
For dodecanethiolate nanoparticles, samples were prepared in DCTB matrix in toluene at 
approximately 400:1 matrix/analyte ratio.   All MALDI-IM-MS analyses were performed 
using a Synapt HDMS (Waters Corp., Manchester, UK), equipped with a frequency-
tripled Nd:YAG (355 nm) laser operated at a pulse repetition frequency of 200 Hz. All 
spectra were acquired in the positive ion mode at laser energy settings approximately 
10% above threshold values. 
Gold-containing ion signals were extracted and identified using the MassLynx 4.1 
(Waters Corp.) software package. Processed spectra were exported to Microsoft Excel, in 
which a custom spreadsheet was constructed for the remainder of the data processing.  
three stoichiometries identified previously: Aux+1Lx, AuxLx, and AuxLx+1.32 Within 
these stoichiometries, an appropriate list of permutations was constructed with every 
possible combination of ligands and modifications such as sodium coordination and 
methyl esterification. Protons were added or subtracted as necessary to achieve a +1 
charge state. Each processed spectrum was filtered by abundance, with any signal below 
1% relative abundance with respect to the base peak discarded to reduce false positive 
identification. The remaining peaks were compared to the expected gold-thiolate ion list. 
Any observed peak within 30 ppm mass accuracy of an expected peak was matched and 
used for quantitation. 
For octanethiolate nanoparticle samples, a concentrated solution in CDCl3 was prepared, 
and standard 
1
H experiments run on a 500 MHz Bruker NMR, 64+ scans.  Non-solvent 
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residual peaks in the aromatic region were calibrated to 13 for the 13 aromatic protons in 
PEPEPS, and compared to the combined peaks for the alkane chain, representing 17 
protons for octanethiol.  The stoichiometric ratio was matched to the original nanoparticle 
formula to yield an estimation of average nanoparticle composition (semi-quantitative).  
 
Results and Discussion 
A Note About Surface Ligand Quantitation 
In the research group of David Cliffel, a methodology for ion mobility-MALDI mass 
spectrometry (IM-MALDI-MS) to quantify the relative composition of the protecting 
monolayer of gold nanoparticles was developed.
65
  As the technique was new, and the 
instrument was often used for other applications, it was only applied to a couple of the 
samples referred to in this chapter, but was proven effective in the analysis of similar 
samples not discussed here.  Example data is shown below in Figure 38 for Au1120 
Dodecanthiolate690. 
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Figure 38:  MALDI-IM mass spectrum of AuDodecanethiolate nanoparticles 
functionalized with the molecular wire.  The intensity ratio of the tetrameric species with 
no wire and the tetrameric species with one wire molecule yields the ratio of 
dodecanethiolate to molecular wire in the protecting monolayer.  
IM-MALDI-MS allows for the separation of organic impurities from gold complexes, 
improving the signal to noise ratio for species important to quantify the surface 
composition.  It was shown that the relative ratios of tetrameric Au4Ligand4 ratios yields 
accurate quantitation when compared to the standard 
1
H NMR analysis that has been used 
to accomplish this task in the past.  In the particular sample in Figure 37, two ions were 
identified as tetramers: Au4Dodecanethiol4 and Au4Dodecanethiol3PEPEPS1.  The ratio 
of the two peaks yields a result of 7 % PEPEPS was present in the nanoparticle 
monolayer.  A second sample with a greater feed ratio of PEPESH (during place 
exchange) yielded a result of 20% PEPEPS.  1H NMR quantitation was obscured with 
this sample, as the solvent residual peak in the spectrum (CDCl3) interfere with accurate 
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quantitation, so the values for the average molecular formula of place exchanged 
AuOctanethiol nanoparticles, discussed later, are treated as only good estimates when 
compared to the quantitation in the AuDodecanethiol samples that will be discussed. 
 
SECM Qualitative Observation of AuDodecanethiol Electron Transfer Rates 
SECM approach curves for Au1120 Dodecanthiolate690 exhibited a constant negative 
current drift through most of the approach, and terminated in a negative feedback, similar 
to that of the approach to a non-conductive surface.  The approach is displayed in Figure 
39, below. 
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Figure 39:  SECM approach curve with 1V Pt UME through larger AuDodecanethiolate 
nanoparticles, 0V Pt substrate electrode (vs. Ag/Ag
+
), in dichloromethane with 0.1M 
TBAPF6.  Total tip current instead of normalized tip current is displayed as an accurate, 
stable value for it,∞ could not be determined due to the constant current drift. 
 
The negative feedback was, in this case, attributed to a combination of slow electron 
transfer and slow diffusion.  Essentially, when the tip was near the substrate electrode, 
there was not a higher local concentration of reduced species.  It was thought that a layer 
of oxidized nanoparticle, which has continually diffused from the tip electrode over the 
course of the entire approach, has created an insulating thin layer cell over the substrate 
electrode. 
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When the solution is removed from the cell and replaced with a solution of 
Au1120Dodecanethiolate660Wire30 an entirely different result is obtained, as demonstrated 
in Figure 40. 
 
Figure 40:  SECM approach curve with 1V Pt UME through larger “wired” 
AuDodecanethiolate nanoparticles, 0V Pt substrate electrode (vs. Ag/Ag
+
), in 
dichloromethane with 0.1M TBAPF6. 
 
While the constant drift was still observed in this experiment, a positive feedback finally 
arose under a half tip diameter away from the substrate electrode.  In this instance, it was 
proposed that the wire imparted fast electron transfer kinetics upon the nanoparticles, and 
a feedback loop was established close to the surface.  The positive feedback result was 
repeated three times in the same cell with the same electrode.  Eventually, the results 
became irreproducible as absolute tip current was continually lower with each 
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experiment.  Constantly drifting current over the course of multiple experiments 
suggested that the electrodes were increasingly fouled by excess thiol impurities. 
 
Improved Synthesis of Alkanethiol Nanoparticles Reduces Current Drift 
Cleaner preparations of gold nanoparticles were anticipated to solve the problem of 
negative current drift, presumably due to self-assembly of excess ligand on the UME 
surface.  The improved single phase synthesis discussed below allowed for cleaner 
nanoparticles without the use of excessive washes with a battery of solvents. 
Tetraoctylammonium bromide has been known to stick to the alkanethiolate monolayer 
in these preparations, as stated by David Schiffrin, one of the authors of the original Brust 
synthesis paper.
155
  TOABr, in turn, presumably holds on to excess thiols present in 
solution, making purification difficult.  To get around this problem, Schiffrin used a 
lengthy soxhlet extraction which reduced the overall yield.
155
   
A better way to attain cleaner alkanethiolate nanoparticle preparations that was found was 
to eliminate the phase transfer reagent completely.  Elimination of the phase transfer 
reagent was accomplished by substituting lithium borohydride for sodium borohydride, 
allowing for as solvent system of purely anhydrous tetrahydrofuran, instead of a two 
phase system.  Consequently, nanoparticles which were easier to clean post-place 
exchange were produced.  Upon further review of the literature, a very similar method to 
the one employed had already been published by Rowe and coworkers.
7
  To illustrate 
how much easier to purify these preparations are, 
1
H NMRs of two samples of 
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AuDodecanethiol nanoparticles (from the two different preparatory methods) prepared 
with the same stoichiometric amounts of reactants and purified with identical methods are 
displayed in Figure 41. 
 
Figure 41:  Comparison of 
1
H NMR spectra of dodecanethiol gold nanoparticles 
synthesized by the Brust method (blue), and by the method of Rowe and coworkers (red) 
after identical purification methods.  The red spectrum is visibly cleaner than the blue 
spectrum judging by the peak width and smoothness. 
 
Both nanoparticle preparations were purified by the same steps of centrifuging out of 
ethanol once, and then sonicating on glass three times with acetonitrile.  Broader and 
more well-defined peak shapes for the nanoparticles prepared by the method of Rowe and 
coworkers versus those of the Brust method indicate lower remaining excess thiol, and 
the lack of tetraoctylammonium.  The place exchanged products of these preparations 
were remarkably easier to clean, very amenable to centrifugation, and if additional dry 
sonication steps were required, they were generally fewer. 
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SECM Quantitative Observation of AuOctanethiol Electron Transfer Rates 
Using AuOctanethiol nanoparticles produced with the improved method discussed above, 
it was possible to generate positive feedback approach curves that could be fit to equation 
4-5 with some success for both wire functionalized and unfunctionalized samples.  Three 
samples were studied in the same manner as described above (generating approach 
curves, switching solutions, generating approach curves, switching back to the original 
solution, repeat ad infinitum) at three different voltages: 200, 400, and 600 mV.  The 
three different samples were Au228Octanethiol92 (unfunctionalized), 
Au228Octanethiol90PEPEPS2 (from exchange with disulfide, PEPS2), and 
Au228Octanethiol89PEPEPS2.6 (from exchange with free thiol, PEPSH). 400 and 600 mV 
experiments gave comparable results, but the 200 mV experiments were markedly 
different.  The data for the Au228Octanethiol92 was baseline corrected, and a numerically 
identical correction was applied to the other samples in order that equation 4-5 could be 
fit.  The correction eliminated negative current drift due to moisture, impurities, or 
electrode irregularities; therefore, the values for kf are relative.   The best corrected 
approach curves generated for wired and unwired gold octanethiol nanoparticles, all at a 
tip bias of 400mV, are displayed in Figure 42.  
122 
 
 
Figure 42:  SECM approach curve through Au228Octanethiol90PEPEPS2, 
Au228Octanethiol90PEPEPS2.6, and Au228Octanethiol92.  Conditions: 25 µm Pt tip at 0.4 V, 
2 mm Pt substrate electrode at 0 V (vs. Ag/Ag
+
), 1 mL aliquot of a solution of 5 mg 
nanoparticle in 20 mL dichloromethane with 0.1M TBAPF6.  The black curve represents 
the expected result of mass-transfer-only limited system, in accord with equation 4-6, 
while the purple curve is the kinetic and mass transfer limited theory with kf = 0.0040 
cm/s.  Bot wire functionalized particles (red and green) have faster electron transfer 
kinetics than the unfunctionalized particles (blue). 
 
It would be expected that the place exchange percentage from the disulfide would be 
lower than that of the thiol, but that given a long reaction time, the values of disulfide 
place exchange would approach that of the thiol place exchange. 
Using equation 4-5, it was possible to determine values for kf, assuming a diffusion 
coefficient calculated using the Stokes-Einstein equation, DSE = 2.52 x 10
-6
 cm
2
/s.  The 
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value of DSE is not dissimilar to values obtained for the diffusion coefficients of other 
gold-alkanethiolate nanoparticles of a similar core diameter by the Taylor dispersion 
method.
156
  The values for kf calculated from the curve are gathered in Table 9. 
Table 9:  Approximate electron transfer kinetic constants determined for 
Au228Octanethiol92-nPEPEPSn.   
n PEPEPS kf (10
-3
 cm s
-1
) 
0 1.2 
2 3.2 
2.6 4.0 
 
In all of these experiments, it should be considered that the mixed kinetic and mass 
transfer limited model described by equation 4-5 might not entirely describe the system, 
due to the applied baseline corrections.  Additionally, it should be noted that the 
difference between kf values obtained for AuOctanethiolate nanoparticles in these 
experiments (1.2 x 10
-3 
cm/s) and AuOctanethiol nanoparticles from the Peterson study 
(2.4 x 10
-2
 cm/s).  A number of possibilities were considered.  Initially, experiments were 
hampered by a constant drift, and that was, correctly attributed to a dirty nanoparticle 
preparation.  Having identified and dealt with this problem, further deviations and their 
possible causes were considered.  Absorption of water from air by the dichloromethane is 
one possible source of deviation.  It is thought that water can act as an electron sink, 
stealing electrons from reduced material as it diffuses back to the tip, causing a drop in 
feedback current.  Another possibility is that the shape of the positive feedback curve is 
slightly different than expected due to a hemispherical electrode surface or a recessed 
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electrode surface.  The equations used in calculations of electron transfer rate and current 
are derived assuming a flat disk geometry.  Differences in nanoparticle structure are also 
possible, but difficult to probe or comment on.  Possible factors resulting from this are 
ligand packing, organization, and nanoparticle geometries with more or less edge and 
vertex sites resulting from slightly different synthetic conditions.  Structural differences 
may have caused the electrons to find slightly different paths to the nanoparticle from a 
change in distance between the nanoparticle core and the electrode, from a change in the 
presentation of the ligand orbitals to the electrode, and/or a change in the nature of the 
double layer.   
In conclusion, the data supports the hypothesis that molecular wire molecules behave as 
conductors on gold nanoparticles in soltuion, consequently increasing electron transfer 
kinetics.  These functionalized materials can be obtained by straightforward place 
exchange reactions with the free thiol or disulfide of PEPEPSAc.  It seems that a small 
increase in surface concentration of the wire molecule resulted in a small increase in 
electron transfer.  Much work remains on this topic to characterize the effects of surface 
concentration, wire size, and wire functional group chemistry.  Additionally, MALDI-
IM-MS should be more useful than 
1
H NMR for quantifying relative amounts of surface 
ligands due to less interference. 
The wired nanoparticle project is currently ongoing.  Dave Crisostomo is currently 
investigating the effects of alkanethiol ligand length, nanoparticle size and dispersity, and 
PEPEPS surface concentration.  Additionally, other electrochemical properties of wired 
versus unwired alkanethiol nanoparticles are being probed.  From there, it would be 
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valuable to study the variation of molecular wire length by comparison with PEPEPSH to 
the molecule PEPSH (shorter by one phenylethynyl unit).  Due to a lack of success with 
the standard method to produce PEPSH,
157
 which was complicated by the lack of 
commercial availability of the starting material, alternative synthetic methods for PEPSH 
are included in Appendix E. 
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CHAPTER V 
KINETIC INVESTIGATION OF TIOPRONIN PROTECTED GOLD 
NANOPARTICLE PRECURSOR FORMATION 
 
Introduction 
Much interest as has been paid to the variation of synthetic parameters and the 
consequences on nanoparticle formation;
63, 158-165
 however, the approaches have not 
adequately addressed fundamental issues about the formation of intermediate species on 
the way to the final nanomaterial.  The experiments that follow attempted to gain insights 
into the make-up of the precursor material and how it is formed.  Short of proposing a full 
mechanistic understanding of all aspects of gold nanoparticle precursor formation, this 
work addressed a number of important questions along this path.  This chapter focuses 
primarily on the precursor formation during the synthesis of tiopronin protected gold 
nanoparticles as first synthesized by Templeton and coworkers
122
, but slightly modified 
to better interrogate the system. 
 
Background 
The modified Brust method employed by Templeton and coworkers had long been 
theorized to proceed by Scheme 5-1: 
 
127 
 
 
Scheme 5-1:  General reaction scheme for the Brust method of nanoparticle synthesis.  
The reactions are unbalanced and Cl
-
 and H
+
 are not shown as products.  Aup(RS)q 
represents the final nanoparticle with a core of p Au atoms and a shell of q RS molecules. 
 
On the basis of a mass spectrometry study by Geis and coworkers
27
 and a later powder 
diffraction study by Simpson and coworkers (43c),
166
 the tiopronin system is thought to 
go through the stable Aun(RS)m intermediate in Scheme 5-1, a tetrameric ring structure 
(Figure 43c).  Later, in a landmark x-ray crystallographic study, Kornberg and coworkers 
(Figure 43a)
43
 discovered Au-SR-Au staple motifs
45
 on the surface of gold nanoparticles 
protected by p-mercaptobenzoic acid (PMBA) (Figure 43b).  Further x-ray crystal 
structures of other monodisperse gold nanoparticles prepared by the Brust method or 
some variation on it displayed similar capping structures on the surface.  Gold thiolate 
capping structures had been predicted earlier, computationally, by Häkkinen and 
coworkers.
42
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Figure 43:  Nanoparticle and ring complex structures  (a) PMBA nanoparticle crystal 
structure proposed by Jadzinsky, et. al.,
43
 from Walter, et. al.
167
 Copyright 2008, National 
Academy of Sciences, reused with permission. (b) PMBA staple motifs, from Whetten 
and Price,
45
 Copyright 2007, American Association for the Advancement of Science, 
reused with permission, and (c) Au4Tiopronin4 cyclic structure (R group of tiopronin now 
shown), Amsterdam density functional theory prediction from Simpson, et. al.
166
 
Copyright 2010, American Chemical Society, reused with permission.  
 
Notably, the precursor material formed before the final borohydride reduction, whether a 
cyclic or chain polymer structure, bears structural similarity to the capping structures in 
the reported crystal structures.  Harkness and coworkers demonstrated that different 
ligands prefer different cyclic stoichiometries (some with equal  but greater or lesser 
numbers of gold and thiol per cycle), but that tiopronin prefers the cyclic tetramer (four 
gold atoms and four thiolate molecules) completely.
168
  Furthermore, these precursor 
structures can be liberated from gold nanoparticles and measured using MALDI-MS.  It 
is clear that gold nanoparticles are not always, and possibly never can be, a solid gold 
core surrounded by a ligand shell.  Instead, it appears that there is a solid grand core and a 
loose ligand-gold shell which structurally resembles the precursor material.  Better 
understanding of the precursor material and its formation, therefore, is important to the 
continued progress in the synthesis of Brust nanoparticles. 
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The ligand exchange and reduction of Au(III) complexes has been the subject of a small 
number of prior studies; consequently, discussion of some of the more prominent results 
is prudent.  Elding has studied the exchange and reduction of Au(III) halides.  Notably, as 
a possible analogue to this study, they fully characterized the ligand exchange kinetics 
and subsequent reduction of haloamminegold(III) with thiocyanate,
169
 with 
dimethylsulfide,
170
 and with thione containing ribonucleic acids.
171
 The general scheme 
that they deduced for the reaction of haloamminoaurate with thiocyanate, displayed in 
Scheme 5-2, seemed to proceed in a similar fashion to what was visually observed for the 
reaction of gold and tiopronin. 
 
Scheme 5-2: Reaction pathways for the exchange and reduction of haloamminegold(III) 
by thiocyanate, as proposed by Elmroth and coworkers.
169
 Copyright 1989, American 
Chemical Society, reused with permission. 
 
None of the literature reviewed
172-174
 reports kinetics and mechanism for the reaction of a 
terminal organic thiol or thiolate with Au(III)Cl4
-
, but the following Scheme 5-3 for this 
reaction was generated with the cited studies for other sulfur containing molecules in 
mind. 
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Scheme 5-3: Plausible reaction mechanism for the reaction of Au(III)Cl4
-
 with tiopronin 
featuring competitive ligand exchange and reduction. 
 
In the current study, the theories discussed above in the context of standard kinetic and 
mechanistic study of transition metal complexes, as presented by Wilkins,
175
 were 
applied to the reaction between Au(III)Cl4
-
 and tiopronin.  With the results, the research 
aimed to provide insights on the pre-reduction steps of small gold nanoparticle syntheses 
of similar to the Brust method.  Specifically, the Au(III)/tiopronin system was chosen as 
it leads to stable high-yield water-soluble clusters by straightforward methodology, as 
discussed in Chapter I.  Knowledge of the pre-reduction conditions will aid researchers in 
developing standardized and better informed synthetic methods and, ultimately, routes to 
new nanomaterials.  Indeed, Hainfeld and coworkers have already studied the variation in 
nanoparticle size with the variation in the size of the precursor polymer for the 
glutathione/tetrachloroaurate system.
176
  The hypotheses were motivated by Richard 
Feynman’s claim that “there is plenty of room at the bottom,” as studying the complexes 
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prior to nanoparticle formation represents the basement of the nanoparticle synthesis 
picture. 
 
Methods 
Materials 
For this section only, HAuCl4
- •3H2O was purchased from Sigma-Aldrich, along with 
optima methanol, 70% perchloric acid, and tiopronin.  Sodium perchlorate (biology 
grade) and sodium chloride were purchased from Fisher scientific. 
 
UV-Visible Spectroscopy Kinetics Experiments 
A Cary Bio-100 UV-Vis spectrophotometer was used to probe the initial rates, and full 
kinetic profiles of reactions between varying amounts of HAuCl4
- •3H2O and tiopronin.  
Stock solutions of gold in methanol were prepared, and dilutions of this stock in 
methanol or salt/methanol were measured into 1 cm quartz cuvettes, and initial spectra 
were obtained.  Then, an Eppendorf Research digital or Reference manual micropipette 
was used to inject an aliquot of a tiopronin stock solution in methanol or salt/methanol 
into the cuvette, followed by rapid mixing via blowing air through with a glass pipette 
and quickly shutting the instrument cover.  Keeping the room dark allowed for reduction 
of the interference from other light sources just post-injection.  Using the simple kinetics 
or scanning kinetics software packaged with the instrument, the change in the absorbance 
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peak at λmax (local) = 320 nm is observed over a period of 15 minutes or up to 3 hours 
depending on the speed of the individual reaction and what information was desired.  
Points were taken continuously for the first 1 to 3 minutes, and then every 30 seconds to 
1 minute thereafter.  In order to investigate medium effects, stock solutions of 100 mM 
NaCl in methanol, 100 mM sodium perchlorate in methanol, or 101 mM perchloric acid 
in methanol were occasionally used for dilution or added to achieve the desired 
concentrations/ionic strengths. 
 
Results and Discussion 
Preliminary Observations 
The reaction of Au(III)Cl4
-
 with tiopronin in methanol has been followed at various 
stoichiometries, and the products have been characterized.  At a [RSH]:[Au(III)] < 3:1, 
fading of the solution, suggesting the reduction of Au(III) to Au(I) is observed.  If 
allowed to stand longer, the solution returns to yellow and the deposition of gold metal on 
the reaction vessel confirms the disproportionation of Au(I) to Au(III) and Au metal, as 
described by Gammons and coworkers.
177
  At [RSH]:[Au(III)] ≥ 3:1, the solution fades 
over the course of about an hour to clear, followed by precipitation of a white solid over 
the course of subsequent hours.  Increasing [RSH]:[Au(III)] from 3:1 to 5:1 changes the 
appearance of the white precipitate from more powdery to more ribbon like.  It can be 
concluded from these observations that the stoichiometry of reaction is at least 3:1, which 
is consistent with the 4:1 ratio that is expected. 
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UV-Visible Spectroscopy   
Given the bright color of its complexes in solution, the spectroscopic determination of 
Au(III) is straightforward.  In the case of tetrachloroaurate(III), two absorbance maxima 
in the UV-Visible spectrum are readily apparent at 320 nm and 271 nm.  During 
reduction of Au(III) to Au(I) by tiopronin, the band at 320 nm decreased in absorbance 
intensity over time, and a saddle with the absorbance at 271 nm near 288 nm was 
observed.  A second saddle between the 271 nm absorbance maxium and a shoulder to 
the right of that peak was observed at about 250 nm.  Time resolved spectra are presented 
in Figure 44 below. 
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Figure 44:  Time resolved UV-Vis spectra of AuCl4
-
 undergoing reduction by tiopronin.  
For this specific experiment, the initial conditions were [tiopronin] = 16.9 mM, [HAuCl4] 
= 0.0955 mM, [HClO4] = 6.00 mM, [NaCl] = 1.00 mM, and [NaClO4] = 101 mM, all in 
methanol.  Spectra were collected at approximately 30 s intervals for the first 1 min, 
every 1 min for the next 30 min, and every 5 min for the next 145 min.  All spectra were 
collected at a scan rate of 20 nm/s with a spectral bandwidth of 2 nm.   The local 
absorbance maxima at 320 nm (inset, zoomed in) started at A = 0.442, initially increased 
to A = 0.445 for the second scan, and decreases to a minimum of A = 0.0833 after 110 
min of reaction time (±5 min).  Isosbestic points at 250 nm and 288 nm are circled in red. 
 
Upon further examination of the region around the saddle at 289 nm, the presence of an 
intermediate was apparent as the intensity just to right of the saddle initially increased, 
and just to the left initially decreased, as displayed in Figure 45. 
135 
 
 
Figure 45:  UV-Vis region containing the saddle at 289 nm for the gold(III)/tiopronin 
system.  Colored arrows and labels correspond with the start time of each scan from the 
reaction start time for the corresponding colored spectra.  Note the initial increase in 
intensity to the right of the saddle followed by a rapid decrease, and the opposite 
phenomenon on the left. 
 
Eventually, the direction of absorbance change became a decrease to the right of the 
saddle and an increase to the left of the saddle.  The presence of the two saddles in 
combination with the deviations in intensity change direction during the first 1 minute of 
reaction is consistent with a transition that originated from an intermediate species.  This 
intermediate species is probably a substitution product, but could possibly be a 5-
coordinate intermediate preceding the substitution product
178
 or an intermediate for the 
reduction process with a second or third thiol bound to a substituted thiol, or a 
combination of any or all of the mentioned species.  
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The nature of the absorbance changes and multiple isosbestic points presented problems 
with accurate spectroscopic determination of Au(III).  For instance, the non-zero 
absorbance upon completion of the reduction reaction at 320 nm could have been 
interpreted as an incomplete reaction, dynamic equilibrium, or interference from the tail 
of a transition not associated with Au(III).  Also, the changing dynamics of the 320 nm 
absorbance band suggests that a combination of interference from another transition 
and/or a change in extinction coefficient may have casued a significant deviation in 
accurate determination of Au(III) concentration from the spectrum.  Given few options to 
circumvent these difficulties, a kinetic analysis of the data was undertaken with the 
assumption that Au(III)Cl4
-
 was chiefly responsible for the absorbance band at 320 nm. 
When tetrabromoauric acid (HAuBr4) was analyzed by identical methodology, a 
complete disappearance of the absorbance band at 390 nm was observed upon reduction 
with tiopronin, as illustrated in Figure 46.  The kinetics of this system were difficult to 
evaluate quantitatively as the reaction was too fast to measure without a stop-flow 
system. 
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Figure 46:  Time resolved UV-Vis spectra of tetrabromoauric acid undergoing reduction 
by tiopronin. 
 
Given the fast kinetics and the lack of sufficient instrumentation to measure them 
accurately, the gold chloride system will be the focus of the discussion that follows. 
The overall process that can be monitored with UV-visible spectroscopy by observing the 
decrease in absorbance at 320nm which corresponds to the reduction of Au(III) (yellow) 
to Au(I) colorless in the presence of excess tiopronin.  Using Beer’s law, a calibration 
curve for Au(III)Cl4
-
 is easily obtained yielding an extinction coefficient of ε320nm = 4660 
M
-1 
cm
-1
, which is reasonably consistent with reported literature values.  The dynamic 
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reaction profiles of three reactions at variable [RSH] and fixed [Au(III)Cl4
-
] are shown 
below in Figure 47. 
   
 
Figure 47:  Dynamic reaction profiles of Au(III)Cl4
-
 with tiopronin in a 3:1 (green), 6:1 
(red), and 9:1 (blue) molar ratio. 
 
Treating this reaction as a pseudo first order process, the rate law is: 
 
 [  (   )         ]
  
  [  (   )         ]
 
 
(5-1) 
 
where t is time in seconds, k is the pseudo rate constant, y is an integer value from 0 to 2, 
and m is the integer order of reaction with respect to the corresponding species.  For 
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simplicity going forward, [Au(III)] will be considered as the concentration of all Au(III) 
species in solution.  Pseudo first order conditions are followed when the dynamic reaction 
profile can be fit to the following linear equation if the process is first order with respect 
to AuCl4
-
 ,  
     (   )        (   )      
(5-2) 
 
or to the following linear equation in the event that it is second order with respect to 
AuCl4
-
: 
 
   (   )  
 
 
   (   )  
    
(5-3) 
 
Fitted plots are displayed below in Figure 48. 
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Figure 48:  Plots to determine the order of reaction with respect to Au(III)Cl4
−
 in pseudo 
first order conditions, both first order (left) and second order (right).  Blue represents 
points from earlier time points in the reaction and red represents later time points in the 
reaction. 
 
As the entire profile would not fit to either equations 5-2 or 5-3 for the entire process, the 
common conclusion is that there are consecutive reactions occurring.  Indeed, if the plot 
is broken into two parts, linear fits are found for either first or second order for either 
time regime during the reaction course.  Discrimination of first and second order 
processes by this method can be difficult.  In the analysis that follows, only observation 
of the reduction process by the method of initial rates under pseudo first order conditions 
was attempted.  The first step in the process was to vary [Au(III)Cl4
−
] in deficiency with 
respect to tiopronin, shown in Figure 49 below.   
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Figure 49:  Plot to determine the reaction order and pseudo first order rate constant with 
respect to [Au(III)]. 
 
The relationship was nearly linear (R² = 0.988), but when examined more closely, it was 
apparent that the reaction order with respect to [Au(III)] was closer to m = 2/3.  In order 
to convert the pseudo rate constant, k, to the real rate constant(s), the concentration of 
tiopronin, [RSH], was systematically varied.  The rate data is presented in Table 10, and 
the variation of kAu(III) with [RSH] is displayed in Figure 50. 
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Table 10:  Rate data for the reaction of Au(III)Cl4
-
 with tiopronin in MeOH at unfixed 
ionic strength.  The percent difference between the initial rate calculated using the rate 
law and the observed initial rate is taken as a measure of the usefulness of the rate law 
within this concentration regime to predict the initial rate of the initial process. 
 
 
 
Figure 50: Plot to determine the order of reaction with respect to [RSH], n, and the 
overall rate constant, knet.  The linear relationship signifies n = 1 and the slope is thus 
interpreted as the overall 5/3 order rate constant. 
 
Vi 
(x 10-8 M s-1)
[RSH]/
[Au(III)]
[RSH]i 
(x 10-3 M)
[Au(III)]I
 (x10-3 M)
kAu(III) 
(x 10-5 M-
(2/3)s-1)
Vi,law
 (x10
-8 M s-1)
% difference
Vi,law:Vi
1.50 3.02 0.68 0.22 0.41 1.55 2.90%
2.94 6.71 1.35 0.20 0.85 2.89 -1.55%
4.59 9.67 2.03 0.21 1.29 4.46 -2.90%
6.30 11.68 2.71 0.23 1.66 6.35 0.68%
9.14 6.04 2.71 0.45 1.55 9.85 7.22%
14.65 3.92 2.71 0.69 1.87 13.14 -11.46%
3.77 25.39 2.71 0.11 1.67 3.78 0.30%
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The observed kinetic behavior corresponded with a reaction that was first order with 
respect to [RSH], and the overall second order rate constant was determined as the slope 
of the plot in Figure 48, according to the following equation: 
   (   )            
(5-4) 
where knet is the second order rate constant and the pseudo first order rate constant 
discussed earlier, k, has been re-labeled as kAu(III) for convenience.  Therefore, knet = 6.22 
x 10
-3
 M
-2/3
s
-1
  for the reaction at standard nanoparticle synthesis conditions (RSH:Au(III) 
< 5, room temperature, no adjustment to ion strength, no adjustment to pH). 
In the event of a non-zero y-intercept, the following equation is necessary to describe the 
full rate law: 
 
    (   ) 
  
      (   ) 
         (   )       
(5-5) 
 
where k1 and c describe a second process for the reduction that is independent of [RSH].  
However, the y-intercept is however insignificant compared to the variability of rates 
determined by the full rate law from the observed rates (k1[Au(III)] << % difference), and 
can be ignored.  It should be noted that Au(III) solutions degrade over time, and, given 
more accurate analytical methods, a small but measurable k1 value would not be 
unexpected (e.g. solvolysis).  That being said, a final rate law for the initial process in the 
reaction is determined to be: 
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    (   ) 
  
        (   ) 
         
(5-6) 
While this rate law is practical for determining reaction velocities under conditions used 
during the synthesis of gold tiopronin nanoparticles, there are a number of shortcomings 
in using it to predict a mechanism.  Furthermore, the the 2/3 order in [Au(III)] would 
imply an exotic mechanism, which raises skepticism. 
Here, it is prudent to consider the effect of medium and other particpants in the reaction.  
For instance, the variability of [H
+
] over the course of the reaction could have a varying 
medium or mechanistic effect on the rate, as both reagents are acidic, and, at some point, 
hydrogen atoms are lost from the tiopronin thiol groups, possibly as protons.  It is also 
suspected that the [H
+
] concentration effects solvolysis and esterification reactions 
between primary reactants and solvent molecules (methanolysis, hydrolysis,
179
 and 
methanol esterification).  Another similar issue is with the [Cl
-
], as chloride is liberated 
from AuCl4
-
 as tiopronin participates in equilibrium exchange reactions with gold prior to 
the final reduction.  This would lead to a rate constant of the type: 
        (   )     
             
(5-7) 
 
A handful of experiments were studied to assess the impact of [Cl
-
] and [H
+
] on the initial 
reaction under similar conditions to those above.  The results are summarized in Table 
11. 
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Table 11:  Rate data at fixed [RSH] and [Au(III)] with variable [H+] (adjusted with 
perchloric acid/MeOH solution) and [Cl-] (adjusted with sodium chloride/MeOH 
solution).  The concentrations are calculated assuming complete dissociation, although 
some ion pairing is expected to occur.  Blue highlights the experiments where [Cl-] was 
varied and pink highlights experiments where [H+] was varied, while an experiment with 
no added [H+] and [Cl-] is in white.  (a) indicates that while no [H+] was added, the 
exact [H+] concentration from dissociation of HAuCl4 and the carboxylic acid group of 
tiopronin was not determined. 
 
 
It was determined that the presence of both initial [H+] and [Cl-] retard the reaction rate, 
but not in a concentration dependent fashion (at least not within the range studied here).   
Initial [Cl-] reduces the rate of reaction to about 1/3 and [H+] reduces the rate to about 
2/3 of what it was without the presence of either species.  Reduction in rate with the 
addition of substitution side products was consistent with a mechanism where both 
species were on the product side of an equilibrium process pre-reduction, which was 
suspected on the basis of previously mentioned mechanistic work on Au(III) reduction 
reactions.  A variation of rate with concentration of either species might have been 
observed at lower concentrations of those species.  Importantly, that the effects of [H
+
] on 
rate might have been attributable to other processes or species generated in the stock 
solution, such as methyl perchlorates, methyl esterified tiopronin, or hydrolyzed AuCl4
-
, 
should be restated. 
Vi 
(x 10-8 M s-1)
[RSH]/
[Au(III)]
[RSH]i 
(x 10-3 M)
[Au(III)]i
 (x10-3 M)
[H+]i
(x10-3 M)
[Cl-]i 
(x10-3 M) relative rate
1.27 26.27 2.71 0.10 a 16.67 0.34
1.29 21.43 2.71 0.13 a 4.17 0.34
1.24 25.44 2.71 0.11 a 1.07 0.33
2.28 23.52 2.71 0.12 38.67 0.00 0.60
2.17 24.59 2.71 0.11 77.33 0.00 0.57
2.67 28.36 2.71 0.10 116.00 0.00 0.71
3.77 25.39 2.71 0.11 a 0.00 1.00
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Additionally, the total ionic strength of the solution effects the kinetics of any reaction, 
especially those between charged species.  In the current case, AuCl4
-
, Cl
-
, and H
+
 were 
all charged and likely were involved in the reaction.  Ionic strength influences the 
reaction by mediating collisions between charged and polar species.  The effect on rate 
constant was given by the following equation: 
           
       
   
      
    
(5-8) 
 
where k is the rate constant as a function of ionic strength µ, k0 is the rate constant at zero 
ionic strength, z is the charge on reactant A or B, and α and β are free parameters.  The -
βµ term is to correct for ion pairing effects.  This equation could be useful to either 
extrapolate rate constants determined at a given ionic strength to the reaction at low ionic 
strength, or to back out the ionic strength given the experimentally determined rate 
constant. 
Accomodations should be made if the total reaction chain is suspected to have pre-
reduction equilibria, or a final equilibrium state, since the reaction could very well exhibit 
a kinetically limited behavior at elevated concentrations of either reactant.  This 
phenomenon is known as saturation kinetics.  The initial reaction velocity, in this case, is 
given by a rate law of the form: 
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    (   ) 
  
     (   )  
    (   )      
        
 
(5-9) 
 
where a and b are experimentally determined parameters that relate to rate constants in 
different concentration regimes.  If         , then the second order reaction is 
observed, and      .  If         , then the reaction is mixed order.  Eventually, if 
        , then the reaction is first order in Au(III), with      ⁄ .  The values of a 
and b can be determined by plotting a linearized form of the rate law as follows: 
 
 
 
 
      
 
 
 
 
(5-10) 
 
where k will be considered knet for n = m = 1and the slope and intercept are interpreted as 
1/a and b/a, respectively.   
The experiments outlined in Table 12 were performed to evaluate saturation kinetics at 
fixed ionic strength.  Saturation behavior was apparent (via observation of a loss in 
linearity, R² = 0.9649) in a plot of kAu(III),1 versus [RSH] at higher [RSH] and higher 
[RSH]:[Au(III)], displayed in Figure 51. 
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Figure 51:  Saturation behavior was suspected when kAu(III),1 lost a linear relationship with 
[RSH] at higher [RSH]. 
 
Table 12:  Rate data for conditions designed to test saturation kinetics of the 
tiopronin/tetrachloroaurate system.  All experiments in 101 mM NaClO4 in methanol.  
kAu(III),1 is the first order rate constant in this table, not the fractional 2/3 order determined 
previously. Blue highlights data where [Au(III)] was varied and pink highlights data 
where [RSH] was varied.  The calculated rate data is described in the following text. 
 
Vi 
(x 10-8 M s-1)
[RSH]/
[Au(III)]
[RSH]i 
(x 10-3 M)
[Au(III)]I
 (x10-3 M)
kAu(III),1 
(x 10-3 s-1)
Vi,sat
 (x10
-8 M s-1)
% difference
Vi,sat:Vi
4.59 344 16.9 0.0492 0.932 7.72 40.6%
32.7 89.0 16.9 0.190 1.724 29.81 -9.8%
65.4 41.8 16.9 0.404 1.617 63.47 -3.1%
14.1 179 16.9 0.0945 1.488 14.83 5.2%
12.9 147 13.5 0.0922 1.399 12.66 -1.9%
8.04 73.2 6.76 0.0924 0.871 7.80 -3.1%
4.56 35.2 3.38 0.0961 0.474 4.59 0.7%
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The rate law determined previously was insufficient to characterize the reaction over a 
large [RSH] span, so the rate law in equation 5-9 was applied by determining coefficients 
a and b by using the linearized version, equation 5-10.  The plot is displayed in Figure 52. 
 
Figure 52:  Determination of parameters a and b for the saturation kinetics rate law.  The 
slope is 1/a and the intercept is b/a. 
 
The linear equation determined that the parameters are a = 0.162 ± 0.005 M
-1 
s
-1 
and b = 
44.3 ± 5.7 M
-1
.  This implies that the second order rate constant in the second order rate 
law, which is more closely followed at b[RSH] < 1, is k2nd = a = 0.162 ± 0.005 M
-1 
s
-1 
and 
when b[B] > 1 then the first order rate law is more closely followed with kAu(III) = a/b = 
3.66 x 10
-3
 ± 0.46 s
-1 
at the given ionic strength in methanol. 
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Referring back to Table 12, it is apparent that the saturation kinetics rate law, equation 5-
9, describes the data very accurately (on the basis of the % difference between the 
modeled and determined rates), with the exception of the reaction that was performed at 
the heaviest excess and highest concentration of RSH.  This deviation is likely due to a 
second saturation point being reached, arising from the second equilibrium step, which is 
not accounted for in the rate law.  A reaction scheme that can be associated with these 
observations, according to Wilkins,
180
 is one where there are two consecutive reactions 
with one element of reversibility.  For this reaction, that corresponds with Scheme 5-4. 
 
Scheme 5-4:  The Au(III)Cl4
-
 tiopronin reaction viewed as a one exchange equilibrium, 
one reduction process. 
 
Scheme 5-4 is a simplification of Scheme 5-5, which follows more closely the form of 
that proposed by Elding and coworkers. 
 
Scheme 5-5: The two consecutive exchange equilibrium, two simultaneous reduction 
mechanism for Au(III)Cl4
-
 and tiopronin. 
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Scheme 5-5 is difficult to evaluate because the determination of ligand exchange products 
is not possible with the current methodology as the UV-Visible spectrum of the 
exchanged products is not significantly different from the starting material.  This scheme 
is, however, supported by the rate retardation upon initial addition of Cl
-
 or H
+
. 
These Schemes are further supported by the fact that addition of Cl
-
 or H
+
 reduces the 
rate of reaction.  Examining the simplified Scheme 5-4, and using the following 
equations: 
     
   (   )(  )       
   (   )         
 
  
   
 
(5-11) 
 
    ( ) 
  
     (   )              (   )  
           (   )         
           
 
(5-12) 
 
where Ksub is the substitution reaction equilibrium constant, k = kAu(III) for the pseudo first 
order process (not the 2/3 order process), k1 is the substitution rate constant, k-1 is the 
dissociation rate constant, [Au(I)] represents all produced Au(I) species and [Au(III)] 
represents all Au(III) species,  and kred is the rate constant for the reduction of all Au(III) 
species to any Au(I) species, then equation 5-13 can be used to describe the system:   
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(5-13) 
 
where a = kredKsub and b = Ksub.  This equation is of the form of 5-9, therefore, kred = 3.66 
± 0.46 x 10
-3
 s
-1 
and Ksub = 44.3 M
-1
.  The accuracy of this rate law (equation 5-9) in 
predicting the observed initial rates is displayed in Table 12.  For all but the highest 
[RSH]:[Au(III)] (300:1), the model accurately predicted the initial rate within ±10%.  The 
error in the 300:1 experiment might suggest that a second saturation kinetics limit was 
reached, dictated by the second equilibrium in Scheme 5-5.  Experiments are ongoing to 
reproduce these results across a large range of [RSH] in identical media (excess [H
+
], [Cl
-
], and µ).  Studying the variation of initial rate with lower [Cl
-
] in order to determine 
equilibrium constants, such as Elding has done for the previously mentioned dimethyl 
sulfide and thiocyanate systems, is also desirable.
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Examination of the kinetics of the analogous bromide complex was also attempted.  The 
reaction happens too fast at room temperature in methanol to accurately measure the 
initial rates (t1/2 << 20s, significant conversion occurs during the mixing of solutions).  In 
one set of experiments, a negative reaction order with respect to gold was observed, but 
on the basis of the chloride experiments and given the speed of reaction, these results 
were disregarded.  There is much speculation in the nanoparticle synthesis community 
that AuBr4
-
 would be a useful starting material for Brust type syntheses due to the 
decreased force constant of Br
- 
with respect to Cl
-
 making for a more labile Au(III) 
complex,
181
 and also because Br
- 
complexes are less susceptible to hydrolysis 
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reactions.
182
  Preliminary investigations have determined that Au(III)Br4
-
 is reduced 
much faster by tiopronin than Au(III)Cl4
-
, and, furthermore, more readily goes to 
completion (100% conversion for Br
-
 as supposed to approximately 80% conversion for 
Cl
-
).  Differences in percent conversion were noted for our homemade HAuCl4 trihydrate 
with the HAuCl4 trihydrate purchased from Sigma-Aldrich.  These differences could arise 
from either the presence of nitrates (originating from nitric acid used in the original 
synthesis) or catalytic amounts of iron or palladium contaminants (arising from novice 
students using metal spatulas or contaminated spatulas for retrieval of tetrachloroauric 
acid) oxidatively driving the final conversion of Au(I)(RSH)2 to the polymeric or cyclic 
precursor material.  Water content and excess acid should also be considered as possible 
sources of the differing behavior between the two samples. 
In conclusion, a rate law that accurately describes the reaction at low [RSH]:[Au(III)] 
(equation 5-6), and a rate law that describes the reaction fairly accurately across a larger 
range of [RSH]:[Au(III)] (equation 5-9), were proposed.  The latter rate law suggests that 
this reaction is mechanistically similar to the general Scheme proposed by Elding and 
coworkers for various substitution/reduction reactions of Au(III) complexes.  In order to 
more completely support this mechanism, a thermodynamic study of this reaction would 
be necessary in order to observe whether the reduction proceeds via an inner-sphere or 
outer-sphere mechanism.  If exchange must necessarily precede reduction, then one 
would expect changes in entropy consistent with an inner-sphere electron transfer.  The 
development of a method to study the exchanged intermediates,    (   )(  )       , 
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both to prove their existence and to accurately determine equilibrium constants for the 
exchange processes (Scheme 5-5), would yield important data in the future. 
In the near future, study of this system will continue to be pursued.  It would be useful to 
set up collaboration with a research group in possession of a stop-flow instrument with 
temperature control in order to direct a proper kinetic evaluation with thermodynamic 
information.  Going forward, it would be of great interest to marry these studies with 
studies of the polymer or cyclic complex growth, much like Hainfeld and coworkers did 
with the glutathione/Au(III)Cl4
-
 system.
176
   It is reasonably expectable that by 
systematically varying pre-reduction reaction time, temperature, and starting materials to 
control the exact composition of the precursor species could have effects on the size and 
surface structure of the final nanoparticle.  These are experiments that could prove useful 
in explaining the previous work of the Murray research group where they varied Brust 
nanoparticle synthesis conditions to obtain different sized nanoparticles.
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CHAPTER VI 
SUMMARY OF CONCLUSIONS AND SUGGESTIONS FOR FUTURE WORK 
 
Summary of Conclusions 
As dicussed in Chapter I, thiolate protected gold nanoparticles have gathered much 
interest in the past decade due to their ease of synthesis, ability to be functionalized, their 
biological interactions, and unique electronic, optical, and chemical properties.  In the 
described research, we have utilized these properties to create functional nanomaterials 
with applications in biomimetics and nanomolecular electronics.  Additionally, 
fundamental aspects of nanoparticle synthesis and characterization were studied. 
A peptide functionalized tiopronin protected gold nanoparticle, with approximate average 
composition of Au696Tiopronin261(CSGSGNSELLSLINDMPITNDQKKLMSNN)4 was synthesized 
and found to strongly and specifically bind to the pharmaceutical monoclonal antibody 
Palivizumab in a quartz crystal microbalance immunoassay, as described in Chapters II 
and III.  The strength of the binding, as determined by a kinetic concentration-dependent 
study (Kd = 292 ± 177 nM) was competitive with a biomimetic peptide epitope scaffold 
which integrated the same linear peptide sequence (Kd = 87 nM)
125
 This biomimetic 
nanomaterial may prove useful as a novel subunit vaccine for the prevention of human 
respiratory syncytial virus, pending in vivo analysis. 
Alkanethiolate protected gold nanoparticles functionalized with molecular wire thiolate 
ligands were synthesized and evaluated using scanning electrochemical microscopy (see 
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Peterson et. al. 2006).  Nanoparticles functionalized with wire molecules were found to 
exhibit faster electron transfer kinetics than unfunctionalized nanoparticles, described in 
Chapter IV.  These “wired nanoparticles” might be useful in nanomolecular electronic 
devices.   
For the case of water soluble tiopronin protected gold nanoparticles, which are useful in 
biological studies such as that presented in Chapter III, the complexation and reduction 
process preceding the final reduction step in their synthesis was studied, and a rate law 
was determined in Chapter V.  In methanol/perchlorate solution, the reduction of 
tetrachloroauric acid trihydrate by tiopronin, as followed by UV-Visible spectroscopy, 
was found to follow saturation kinetics, consistent with a proposed mechanism where 
gold(III) is first complexed by one to two equivalents of tiopronin, followed by 
subsequent reduction by an additional equivalent of free tiopronin. 
Additional accomplishments discussed include a comparative study of thermal 
gravimetric analysis and elemental analysis of thiolate protected gold nanoparticles 
(Appendix A), the synthesis and characterization of water soluble dendrimer-thiolate 
protected gold nanoparticles (Appendix B), and attempts at alternative synthetic routes to 
a molecular wire ligand (Appendix D). 
In conclusion, a number number of studies with diverse applications were conducted 
which all utilized similar nanoparticle synthesis, functionalization, and characterization 
techniques.  The studies underscore the versatility and potential applicability of these 
novel nanomaterials in a variety of areas, from materials to life sciences.  Additionally, 
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new knowledge was gained on fundamental aspects of nanoparticle synthesis.  The 
knowledge should prove useful in future attempts to exploit the underlying chemistry of 
nanoparticle synthesis in order to create more well-defined or completely novel 
nanomaterials. 
 
Suggestions for Future Work 
Biomimetic Nanoparticles 
Many aspects of the biomimetic HRSV nanoparticle project elicit further investigation or 
methodological improvement.  These aspects include peptide design, epitope mapping 
strategies, nanostructural considerations, mimic detection techniques, and in vivo 
evaluation for antigenicity.  While some of these facets are currently under investigation 
for different systems, the HRSV biomimetic project is not currently active even though 
many avenues of research remain unexplored. 
The rate limiting step to designing a useful peptide for conjugation to a nanoparticle had 
always been the lack of any crystal structure data for either the F protein, the antibody, 
any complex related to the two.  Now that this data is available
88-90, 125
, and given the 
results obtained in Chapter II, much more informed decisions about peptide design in the 
context of nanoparticle biomimetics should be forthcoming.  Knowing the residues 
critical to Palivizumab-epitope binding and their spatial orientation should allow one to 
only select the most important parts of the primary sequence, or potentially add in 
discontinuous residues with an inert linker.  As was indicated previously, the desired 
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orientations and lengths of the two alpha helical sections known to be important to the 
binding interaction should be evaluated in the ELISA assay.  The specific effects of 
adding, removing, or replacing single amino acids would allow for the selection of the 
smallest, most efficient peptides to be used in nanoparticle studies as supposed to the 24 
amino acid sequence (not including any added linker residues) found most successful in 
the current study.  This might also add additional insight into the binding of the native 
proteins, further corroborating the previously mentioned crystal structure data. 
While the current research discussed the importance of peptide structural modifications 
beyond primary sequence variation such N and C terminal modification and linker 
chemical structure and length with regards to optimizing peptide efficacy in biomimetic 
design, the data collected was not systematic.  This was largely due to the desire to obtain 
a working mimic as a starting point.  Having found this starting point, a systematic 
variation of peptide structure is now appropriate.  The following systematic variations are 
prescribed: effect of C-terminal amination and N-terminal acetylation individually or in 
tandem versus unmodified termini for like primary sequences, directly comparing PEG 
spacers to inert amino acid spacers, and comparing chemically similar spaces of different 
lengths. 
Once ideal peptides have been designed, a number of structural changes can be 
investigated with regards to the final nanomaterial.  Nanoparticle core size, especially in 
the case of dual cysteine functionalized peptides, should have a significant effect.  In the 
case of a single cysteine containing peptide, the core size could affect the secondary 
structure of the peptide by modifying the interactions between neighboring ligands.   In 
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the case of a dual cysteine containing peptide, the core size is expected to have an effect 
on how far apart the cysteine residues space themselves (due to spacings between active 
sites and surface curvature versus the strain imparted to the peptide upon anchoring the 
cysteine thiol groups on the gold core), and, therefore, on the conformation of the formed 
peptide loop.
110
  Options for controlling the nanoparticle size are via synthetic conditions 
(for instance, ligand to metal ratio)
63
 or by post-synthetic size separation.
55, 183
 
Another exciting possibility, especially for this specific case, is the concept of 
functionalizing a nanoparticle with two (or more) peptides to represent a discontinuous 
epitope, suggested by Rutledge and coworkers.
92
  In the Palivizumab epitope, one should 
recall that the interacting residues are located on two alpha helices separated by an 
amorphous loop region, and a further residue on an entirely different region of the 
peptide.  If both helices are separately synthesized, and potentially a third peptide is 
synthesized with the other interacting residue, and they are subsequently place exchanged 
onto an appropriate sized nanoparticle, then the interacting residues could be placed at the 
appropriate spatial coordinates without the need for non-interacting amino acids.  
Finally, it would be prudent to evaluate this system with different methodologies.  In the 
context of the QCM, different antibody immobilization strategies should be evaluated, as 
spacing of antibodies in an immunoassay is critical in optimizing sensitivity.
128
  Also, 
QCM with dissipation measurement should provide additional information as to whether 
the binding is rigid, as would be expected for an antigen-antibody interaction.
184
  An 
instrument suited to this task is available from Q-Sense which also is equipped with an 
autosampler.  As manual QCM experiments are time intensive (typically 2 hours) and 
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subject to errors during sample change which lead to useless data sets, such as the 
introduction of air bubbles or pressure changes across the crystal face, a higher data yield 
might be attained with such an instrument.  Another consideration should be the 
validation of the QCM results with an additional analytical method such as ELISA or 
SPR. 
 
Wired Nanoparticles 
Currently, Dave Crisostomo is continuing with the research in wired nanoparticles.  As 
with the biomimetic nanoparticle project, a great deal of systematic changes should lead 
to important insights on structure-function relationship.  Currently, the research is 
focused on observing whether or not electron transfer kinetics of nanoparticles protected 
by alkanethiolate ligands of different lengths (for instance, hexanethiol versus 
octanethiol) are similarly affected by the introduction of a molecular wire ligand.  
Another interesting question is how the nanoparticle core size might affect electron 
transfer or the ability of the molecular wire ligands to modulate the electron transfer.  It is 
possible that a change in surface curvature could have a significant effect on the ability of 
the core itself to come in close proximity of an electrode surface.  It might also effect the 
chemical environment of the molecular wire ligand itself. 
Upon successful completion of these fundamental studies, integration of the “wired” 
nanomaterials into functional nanomolecular electronic devices is of great interest.  An 
idea proposed by David Cliffel is to integrate wired particles with Photosystem I (PSI).  
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In this context, the nanoparticles could store charge from photocurrent generated by 
covalently attached PSI which could later be discharged to a quantum dot to produce 
light.  The whole device is comparable to a nanoscale, battery-powered flashlight with 
wired nanoparticle capacitors. 
 
Nanoparticle Precursor Formation 
While the determined rate law for gold(III) chloride reduction by tiopronin in methanol 
accurately fit the data over a sufficient concentration range (much greater than typical 
synthetic conditions)
122
, collection of more data points to verify the saturation kinetics 
data is crucial.  Simply put, more data points are needed to prove the non-linear 
relationship at higher tiopronin concentrations.  Verification of this rate law is crucial to 
suggesting a mechanism for tiopronin gold nanoparticle precursor formation.  In order to 
measure the initial pre-reduction ligand exchange process, a spectrophotometer with a 
stop-flow system is required.  Such an experimental set-up would also allow us to 
interrogate the initial rates of reduction in the bromide system. 
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APPENDIX A 
THERMAL GRAVIMETRY-MASS SPECTROMETRY AND ELEMENTAL 
ANALYSIS OF TIOPRONIN PROTECTED GOLD NANOPARTICLES 
 
This research was conducted at the Center for Nanophase Materials Sciences, which 
is sponsored at Oak Ridge National Laboratory by the Division of Scientific User 
Facilities, U.S. Department of Energy.  This research was authorized upon successful 
submission and review of a rapid access proposal, ID CNMS2007-R19.  The experiments 
were held at the Macromolecular Complex Systems Group under the supervision of Dr. 
Joseph Pickel. 
 
Introduction 
Thermal gravimetric analysis is the easiest route to determining the percent organic 
composition of gold nanoparticles.  There has been debate about the identity of the 
burnoff material, and often times the average approximate molecular formulas 
determined for certain preparations are not reasonable with the current picture of how a 
nanoparticle should look.  Therefore, it was endeavored to characterize the thermal 
gravimetric plot with mass spectrometry.  The technique is occasionally referred to as 
temperature programmed desorption mass spectrometry (TPD-MS). 
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Methods 
Synthesis of Au216Tiopronin129  
Tiopronin MPCs were synthesized as previously described.
122
  5.25 g (15.4 mmol) 
HAuCl4  3H2O was dissolved in 500 mL 6:1 methanol:acetic acid and chilled in an ice 
bath for 30 minutes, giving a yellow solution.  7.56 g (46.2 mmol) tiopronin was then 
added to the solution, forming a ruby red intermediate.  Upon dissolution of the tiopronin, 
5.84 g (154 mmol) sodium borohydride in approximately 10 mL water was immediately 
and rapidly added to the mixture.  A violent, exothermic reaction results, leaving a black 
solution.  The solution is stirred overnight, yielding polydisperse nanometer sized 
clusters.  The resulting solution is rotary evaporated in vacuo to remove the methanol.  
The resulting precipitate/viscous acetic acid solution is redissolved in water, pH adjusted 
to 1 with concentrated hydrochloric acid and placed in dialysis tubing (cellulose ester, 
MWCO = 10 kDa).  The dialysis proceeds for 2 weeks changing the water at least twice 
daily until the water does visually turn a color.  
1
H NMR: 4.00 ppm broad singlet 
(tiopronin methylene on cluster), 3.76 ppm broad singlet (tiopronin CH on cluster), 1.66 
ppm very broad singlet (tiopronin methyl on cluster).  TEM: average particle diameter of 
2.2 nm  0.6 nm.  UV/Visible spectroscopy: no surface plasmon resonance band 
observable.  TGA: 33.134 weight percent organic (tiopronin).  Average formula: 
Au2167Tiopronin1294.  
 
 
164 
 
Synthesis of Hexanethiol Monolayer Protected Clusters 
1.5 g of tetraoctylammonium bromide (a phase transfer agent) was dissolved in 80 mL of 
toluene.  0.31 g of HAuCl4 was dissolved in 25 mL of water.  To the vigorously stirring 
tetraoctylammonium bromide solution, the gold solution was added slowly.  The 
resulting orange gold-containing organic phase was isolated and chilled in an ice bath for 
30 minutes and stirred vigorously.  0.38 g of NaBH4 was dissolved in 25 mL of water.  
To the stirring organic solution, 260 L of 1-hexanethiol was added.  Immediately, the 
NaBH4 solution was added over a period of 10 seconds.  The resulting black solution was 
stirred for 30 minutes on ice, and then additionally overnight at room temperature.  The 
organic phase was isolated and rotary evaporated to yield a black solid.  The solid was 
dissolved in a minimum of toluene and precipitated in 400 mL of ethanol at -20 C 
overnight.  The precipitate was collected on a fine glass frit and washed with ethanol and 
acetone.  Additional purification was accomplished by sonicating in acetonitrile for 15 
minutes, and again collecting on a glass frit and washing with ethanol and acetone.  1H 
NMR:  2.17 ppm, 1.45 ppm, 0.98 ppm broad peaks.  TEM: 2.8 nm  0.9 nm diameter.  
UV/Vis:  slight surface plasmon band observed at 520 nm.  TGA:  20.367 weight percent 
organic.  Average molecular formula: Au448Hexanethiol192. 
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Thermal Gravimetric-Mass Spectrometric Analysis 
TGA with mass spectrometric analysis of the evolved gases was accomplished using a 
TA Instruments 2950TGA equipped with Pfeiffer Thermostar Mass spectrometer.  Both 
ion selective trend scans and scanning bar graph scans were completed.  The purge gas 
was argon, and the temperature was ramped from room temperature up to 1000 °C.   
 
Elemental Analysis 
Samples were sent to Columbia Analytical Services for analysis of carbon, hydrogen, 
nitrogen, sulfur, oxygen, gold, and sodium.  Carbon, hydrogen, and nitrogen were 
analyzed by combustion with a WO3 catalyst, and detection by TC and IR.  Sulfur was 
analyzed by combustion with IR detection.  Oxygen was analyzed by pyrolysis with IR 
detection.  Sodium and gold were measured either by ICP-OES, ICP-MS, or AAS. 
 
Results and Discussion 
Thermogravimetric Analysis 
Thermogravimetric analysis for AuTiopronin and AuHexanethiol were compared 
qualitatively, as in Figure 53.  
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Figure 53:  Thermogravimetric profiles of gold hexanethiol cluster (red) and gold 
tiopronin cluster (black).  Differences in the total magnitude of percent weight loss may 
be due to size dependent properties, but the step-wise nature of the tiopronin cluster 
weight loss is characteristic of polar MPCs 
 
Whereas alkanethiol nanoparticles have a single mass loss step when heated under 
nitrogen, tiopronin nanoparticles exhibit two.  The shape of the curve is identical for 
thermal analysis of tiopronin ligand, although the temperature of each step is shifted 
slightly to lower temperature.  The assumption had always been that any thermal loss 
should be attributed strictly to loss of organic material, which made theoretical sense with 
what was understood about thiolate gold nanoparticles if composition calculations used 
burn off data up to 550 °C.  Once spectrum were run up to 800 °C, however, composition 
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calculations yielded thiols in excess of hypothesized surface gold atoms, which was 
inconsistent with expected compositions. 
 
Elemental Analysis 
The results of elemental analysis in terms of calculated molecular composition compared 
to results obtained with a combination of TGA and TEM by two different calculations are 
compared in Table 13. 
Table 13:  Elemental analysis-calculation compared to two different TGA-TEM 
calculations of molecular formula.  Found represents the found percentages from 
elemental analysis.  Expected are the percentages anticipated from the TGA-TEM 
calculations.  Errors are given for each individual element and for the totals percentages 
expected for tiopronin and inorganic material (sodium was factored in to investigate 
whether the final solids are heavily sodiated at the carboxylate groups despite the 
acidification pre-dialysis). 
 
 
The formula Au216(C5H9NO3S)146 was obtained from direct calculation of elemental 
analysis results and TEM core size calculations.  Au216(C5H9NO3S)129 was obtained from 
a combination of TGA and TEM assuming that all loss was attributed to tiopronin, and 
calculated
formula Au216(C5H9NO3S)146
% found expected error error net expected error error net
C 13.5 12.2 -10.7% 7.61 -77.4%
H 1.65 1.84 10.3% 1.15 -43.5%
N 3.04 2.84 -7.04% 1.78 -70.8%
S 6.82 6.50 -4.92% 4.07 -67.6%
O 10.8 9.74 -10.9% 6.08 -77.6%
Na 0.25 0.00 - 0.00 -
Au 65.5 66.9 2.09% 79.3 17.4%
total % 102 100 -1.54% -6.40% 100 -1.57% -56.0%
Au216(C5H9NO3S)129
-8.12%
1.72%
Au216(C5H9NO3S)68
-73.1%
17.1%
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Au216(C5H9NO3S)68 was calculated in the same way, except that it was assumed that the 
loss was due to a loss of AuTiopronin2 staple complexes from the surface.  If it is 
assumed that the elemental analysis gives a true total tiopronin loss, then the conclusion 
is that the all tiopronin calculation from TGA underestimates the tiopronin thiolate 
content by 8.12% while the staple calculation underestimates the content by 73.1%.  
Therefore, given the assumption, the all tiopronin loss method is more accurate than the 
staple calculation.  Consequently, it is not expected that Au atoms are lost from the 
sample during thermal analysis.  The underestimation could originate from ashing of the 
ligand on the pan, resulting in residual elemental carbon that was not factored into the 
total organic mass.  Ashing was expected from visual inspection of burned material.  
When the TGA was only run up to 550 °C, the residual material in the pan was black.  
Running the TGA up to 800 °C or higher resulted in what appeared to be purely solid 
gold flakes, consistent with a complete loss of organic matter.  In order to confirm the 
identity of the burn off during this final step, TPD-MS was used. 
 
TPD-MS of Tiopronin Gold Nanoparticles 
Therefore, TPD-MS was used to study the identity of the burn off material.  A TGA from 
the TPD-MS instrument is provided for comparison in Figure 54. 
169 
 
 
Figure 54:  Thermal gravimetric spectrum generated on the TG-MS instrument at 
Oakridge, under Argon purge. 
 
The magnitude of each loss is identical between the two analyses, but the shape of the 
final loss is different.  The difference in thermal gravimetric plot shape was likely due to 
an argon purge in the Oak Ridge instrument as supposed to a nitrogen purge with the 
VINSE instrument.  M/z of the burn off compound tracked with temperature is displayed 
in Figure 57, preceded by burn off for AuHexanethiol in Figure 55 and 56 for 
comparison. 
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Figure 55:  Selective ion scan of elemental and small molecule fragments thermally lost 
from AuHexanethiol nanoparticles.  The y-axis is total ion current at the selected m/z. 
 
Small room-temperature gas molecules are the easiest to observe in this technique.  
Notice how molecules or atoms associated with carbon and sulfur from hexanethiol spike 
at the beginning of the mass loss (Figure 53) and slowly taper off.  Total quantitative 
measurements of these ions are hampered by their natural presence in the chamber due to 
< 100% purging efficiency. 
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Figure 56:  Larger mass peaks thermally lost from AuHexanethiol nanoparticles.  The y-
axis is total ion current at the selected m/z, listed at right, in Da, with some m/z 
identified. 
 
Larger mass fragments were identifiable for this sample, including the intact ligand and 
some fragments thereof, noted in the key (charges on the ions not shown).  Some larger 
mass fragments could be identified for the AuTiopronin sample, but identification of the 
ions was not consistent with expectations (see Figure 55).  Therefore, only the small mass 
ions under oxidative (air) conditions are presented. 
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Figure 57:  Small mass fragments thermally lost from AuTiopronin nanoparticles.  The y-
axis is total ion current at the selected m/z.  This particular experiment was run in air 
instead of argon. 
 
For tiopronin, only small molecule masses were identifiable.  The loss that spans 600 to 
1000 °C tracks directly with carbon, supporting the idea that tiopronin ashes during the 
burning process.  This attributed to the carboxylate group, as molecules with carboxylate 
groups tend to have additional high temperature losses (as was observed with tiopronin 
and glutathione ligands without gold).  The hypothesized chemistry of this process, 
consistent with the observations, might be RCOOH  RH + CO2, CO2  O2 + C(s), C(s) 
+ O2.  
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APPENDIX B 
SYNTHESIS AND CHARACTERIZATION OF WATER SOLUBLE DENDRIMER 
PROTECTED GOLD NANOPARTICLES 
 
Introduction 
The aim was to prove that carboxylate terminated G1 dendrimers could be used to 
synthesize gold nanoparticle cored dendrimers (NCDs) by Brust-like methodology.  Here, 
to the best of our knowledge at the time of the study, the first example of a water soluble 
NCD is presented.  The following reaction was studied, in Scheme B-1. 
 
Scheme B-1:  Synthesis of gold nanoparticle cored dendrimers (AuNCD) 
 
 
 
Methods 
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Synthesis of (Aux(G1S)y) 
AuxG1SHy was synthesized using a modified Brust reaction.
1
  A solution of HAuCl4 · 
3H2O in 5 mL of 6:1 methanol:acetic acid was cooled to -70° C in a dry ice/acetone bath.  
To this cold solution was added 60 mg of AuG1SH in 3.5 mL 6:1 methanol:acetic acid.  
Upon allowing the solution to slowly warm to -30° C, the solution turned from yellow to 
a light brown-orange, indicating the formation of a Au(III)-G1SH complex.  To this 
solution was rapidly added a 25x molar excess (50 mg) of NaBH4 in 1 mL of deionized 
water.  CAUTION!  A violent exothermic reaction results from the reduction of Au(III) 
to Au
0
.  Upon reduction a black precipitate formed and was allowed to stir for 15 hrs.  
The solvent was removed by rotary evaporation, and the resulting black solid was 
resuspended in 0.5M NaOH.  Purification was accomplished by dialysis in 10,000 
MWCO tubing with MeOH:0.5M NaOH/H2O.  Dialysis proceeded for 5 days, with 
changes 4x daily.  NMR: Consistent with the ligand, desensitization of protons that 
would be closest to the gold core, consistent with other ligands on gold (Figure 58).  
UV/Vis: No resulting SPR band.  TEM: average diameter 1.3 ± 0.6 nm (Figure 59).  TGA 
analysis was obscured by the presence of salt, but was measured as 60.2% organic.  
Average formula Au186G1S50. 
Place Exchange 
G1SH was stirred with AuTiopronin nanoparticles in 50:50 MeOH:H2O (20 mg 
nanoparticle in 4 mL solvent, 30:1 G1SH:tiopronin feed ratio).  1H NMR is displayed in 
Figure 60.  Quantification was not possible due to solvent peaks. 
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Results 
 
Figure 58:  1H NMR of G1 dendrimer protecting a gold nanoparticle 
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Figure 59:  TEM micrograph and size distribution of AuG1S NCDs. 
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Figure 60:  
1
H NMR data G1 place exchanged onto AuTiopronin.  Green spectrum (top) 
is gold tiopronin nanoparticles, blue spectrum (middle) is G1SH, and red spectrum 
(bottom) is the place exchanged product. 
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APPENDIX C 
 
SYNTHETIC ROUTES TO P-MERCAPTOPHENYLETHYNYLBENZENE 
 
Methods 
Standard Route to p-thioacetylphenylethynylbenzene (PEPSAc)
157
 
 
This route was not practical in the current research, as the starting material (4-
iodophenylthioacetate) was not commercially available.  Therefore, the following 
syntheses were pursued before turning to the commercially available PEPEPSAc. 
 
Other routes to PEPSAc 
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Synthesis of PEPSAc Through a Solvent Free, Copper Free Sonogashira Coupling
185
 
0.5g BrPhSAc (2.16 mmol), 0.045g PdCl2(PPh3)2 (3 mol %), and 2.05 g TBAF (6.5 
mmol) were weighed into a 3 neck flask and purged with Ar.  290 µL of phenylacetylene 
(2.6 mmol) was added via syringe.  The reaction mixture was heated to 80 °C in an oil 
bath and moderately stirred for 18 hours.  The product was extracted in ether, washed 3x 
with water, dried over MgSO4, filtered, and evaporated.  The product was further 
purified on a silica gel column with DCM/hexanes.  The reaction yielded 0.49 g of a 
yellowish solid.  1H NMR:   Product appeared to be deprotected disulfide, but coupled to 
phenylacetylene.  The next reaction was chosen in order to work at a lower temperature 
so that disulfide formation might be avoided.   
 
Synthesis of PEPSAc Through a Copper Free, Amine Free Sonogashira Coupling
186
 
0.5g BrPhSAc (2.16 mmol), 0.045g Pd2(dba)3 (0.5 mol %), and 0.82 g TBAF (2.6 
mmol), and 11.3 g of PPh3 (2 mol%) were weighed into a 3 neck flask and purged with 
Ar.  6 mL of anhydrous THF was added via syringe.  290 µL of phenylacetylene (2.6 
mmol) was added via syringe.  The reaction mixture was moderately stirred for 24 hours 
at room temperature.  The product was extracted in ether, washed 3x with water, dried 
over MgSO4, filtered, and evaporated.  The product was further purified on a silica gel 
column with DCM/hexanes.  The reaction yielded 0.54 g of a yellow oil.  The correct 
product did not seem to be formed.  The next reaction was chosen to work at an 
intermediate temperature, and to follow more closely the original Sonogashira reaction.   
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Synthesis of PEPSAc Through a Standard Sonogashira Coupling
187
 
0.5g BrPhSAc (2.16 mmol), 0.027g PdCl2(PPh3)2 (0.039 mmol), and  0.023 g CuI 
(0.119 mmol) were weighed into a 3 neck flask and purged with Ar. 3 mL of anhydrous 
THF and 3 mL of anhydrous Hunig’s base was added via syringe.  290 µL of 
phenylacetylene (2.6 mmol) was added via syringe.  The reaction mixture was heated to 
50 °C in an oil bath and moderately stirred for 24 hours.  The product was extracted in 
ether, wahed 3x with water, dried over MgSO4,filtered, and evaporated.  The product was 
further purified on a silica gel column with DCM/hexanes.  An orange solid was 
obtained.  1H NMR: 7.55ppm, 7.36ppm, and 7.29 ppm, m, 9H (aromatic); 2.42 ppm, s, 
3H (thioacetate methyl group).  Yield: 42%, questionable purity.   
 
Iodine Exchange with p-bromothioanisole (BrPhSCH3)
188
 
 
 
An amount of 1.0g of BrPhSCH3 (4.92 mmol) was weighed into a 3 neck flask and 
purged with Ar.  The solid was dissolved in 30 mL anhydrous THF, added via syringe.  
This solution was cooled in a dry ice/acetone bath.  5.8 mL of 1.7 M tert-butyllithium in 
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heptanes was added.  CAUTION: tert-butyllithium should be handled with extreme 
caution as it readily acts with air and water in an extremely exothermic reaction capable 
of producing large flames.  This solution was stirred for 5 minutes.  1.37 g iodine (5.42 
mmol) was dissolved in 15 mL anhydrous THF.  The iodine solutions was added to the 
organolithium reagent via cannula.  The reaction was brought to room temperature and 
stirred for about 30 minutes.  The reaction was quenched with 20 mL of 1M HCl, and 2 
moderate scoops of sodium sulfite.  The solution was evaporated, and 20 mL of water 
was added.  The organic product was extracted into ether and washed 3x with water.  
Recrystallization from hot iso-octane/toluene yielded a blue-green crystalline product.   
1H NMR matches literature values. 
 
Synthesis of p-thiomethylphenylethynylbenzene (PEPSCH3) via Songoashira Coupling of 
IPhSCH3
157
 
 
0.3 g of IPhSCH3 from the previous reaction (1.27 mmol) and 0.010 g CuI (1.8 mol%) 
were weighted into a 3 neck flask and purged with Ar.  5.5 mL THF, 5.5 mL Hunig’s 
base, and 522 µL of phenylacetylene were added via syringe.  Then, 48.6 mg (0.6 mol %) 
PdCl2(PPh3)2 was quickly added, and the solution purged.  The solution was heated to 
50 °C in an oil bath and stirred overnight.  The product was extracted in ether, wahed 3x 
with water, dried over MgSO4,filtered, and evaporated.  Recrystallization from hot 
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hexanes yielded an orange solid. 1H NMR: 7.5 ppm, m, 2H; 7.42 ppm, d, 2H, J = 8.52 
Hz; 7.32 ppm, m, 3H; 7.19 ppm, d, J = 8.52 Hz (aromatic); 2.48 ppm, s, 3H (thiomethyl).  
GC/MS M
+•
 = 224.3 Da observed, pure product.  Deprotection of this product proved 
impractical by the methods of Young, Gauthier, and Coombs, and also by NaH reaction. 
 
Route from p-iodophenylethynylbenzene (PEPI) to  
p-triisopropylsilylphenylethynylbenzene (PEPSSiTIP) 
 
Synthesis of PEPI via Sonogashira Coupling of Diiodobenzene
189
 
 
Triethylamine was distilled over CaH2 under Ar.  1 g diiodobenzene (3.0 mmol), 28.3 mg 
PPh3 (0.1 mmol), and 8 mg CuI (10 mol%) were added to 180 mL of freshly distilled 
triethylamine.  Then, 12.4 mg Pd2dba3 (5 mol%) was quickly added.  100 µL of 
phenyacetylene was added (1.0 mmol).  The solution was stirred under Ar for 1.5 hours, 
the filtered, and evaporated.  The yellowish solid was the dissolved in dichloromethane 
and poured over an excess of silica gel.  The dichloromethane was then removed in 
vacuo, and the dry silica gel with the product absorbed onto it is loaded on top of a silica 
gel column.  Chromatography yields high purity crystals of diiodobenzene in hexanes, 
and high purity PEPI.  Yield 78% white flaky solid.  1H NMR: 7.69 ppm, d, 2H, J = 8.52 
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Hz; 7.53 ppm, 2H, m; 7.36 ppm, m, 3H; 7.26 ppm, d, 2H, J = 8.52 Hz, values match 
literature value.   
 
Synthesis of PEPSSiTIP from PEPI
190
 
 
 
0.9 g of PEPI from the previous reaction (2.96 mmol), 200 mg Pd(PPh3)4 (5.8 mol %), 
212 mg CsCO3 (3.69 mmol) were dissolved in 30 mL of toluene, previous dried over 
molecular sieves, and purged with Ar.  850 µL of TIPSiSH (3.83 mmol) was added via 
syringe.  The mixture was brought to 100 °C in an oil bath and stirred for 18 hours.  
Afterwards, 30 mL saturated NH4Cl was added, and the aqueous solution was extracted 
twice with diethyl ether.  The organic fractions were washed 3 times with water, and 
evaporated to yield a red oil with red/orange precipitate.  Residual solvent was removed 
with heating in vacuo.  The product was extracted into hexanes. 1H NMR: 7.54 ppm, m 
and 7.50 ppm, d, total 4H; 7.40 ppm, d, and 7.35 ppm, m, total 5H (aromatic); 1.12 ppm, 
m, 21H (triisopropyl silane protons).  Crude product could not be further purified on a 
column as the product decomposed.  Recrystallization strategies were not very 
successful. 
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Synthesis of p-iodotetramethylthiurylbenzene (IPhSTMT)
191
 
 
An amount of 1.0 g diiodobenzene (3.0 mmol) was weighed into a 3 neck flask and 
purged with Ar.  6 mL of freshly distilled THF was added.  The solution was chilled in an 
ice bath.  3.54 mL of 0.9M (as determined by iodine titration) iPrMgCl-LiCl solution was 
added.  CAUTION:  The Grignard reagent will react exothermically with air and water.  
The solution was allowed to warm to RT.  0.80 g of tetramethylthiuram disulfide was 
dissolved in 10 mL of freshly distilled dichloromethane and purged with Ar.  The 
Grignard solution was, again, cooled in an ice bath, and the thiuram solution was added 
cautiously.  The solution was filtered, evaporated, and eluted on a silica gel column with 
DCM/hexanes.  1H NMR 7.78 ppm, d, 2H, J = 8.44 Hz (aromatic close to iodine); 7.19 
ppm, d, 2H, J = 8.44 Hz (aromatic close to thiuram); 3.57 ppm, s, 3H, thiuram methyl a); 
3.50 ppm, s, 3H, (thiuram methyl b).    
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Synthesis of p-tetramethylthiurylphenylethynylbenzene (PEPSTMT) via Sonogashira 
Cross-Coupling of IPhSTMT 
 
 
0.47 g IPhSTMT from the previous synthesis (1.55 mmol), 121 mg Pd(PPh3)4 (10 
mol%), and 29 mg CuI (10 mol %) were dissolved in freshly distilled Hunig’s base 
(9mL) and THF (4mL), and purged with argon.  186 µL of phenylacetylene was syringed 
in, and the reaction was stirred for 24 hours at 100 °C.  The product was extracted in 
ether, washed 3x with water, dried over MgSO4, filtered, and evaporated.  The product 
was further purified on a silica gel column with DCM/hexanes.  1H NMR: 7.73 ppm, m, 
4H; 7.49 ppm, m, 5H (aromatic); 3.56 ppm, s, 3H (first thiuram methyl); 3.35 ppm, s, 3H 
(second thiuram methyl).  Reaction worked extremely well, but was irreproducible in 
later trials.  This was attributed this to humidity, as every repeat was performed in the 
summer, and a Schlenk line was not utilized (only argon balloons).   
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Deprotection of PEPSTMT to p-mercaptophenylethynylbenzene (PEPSH) 
The product above was deprotected by NaOH (24 mg), Zn (3 mg), H2O 1.8 mL, THF (3 
mL) and stirring for 3 hours, followed by quenching and acidifying with HCl.  A 
greenish, semi-crystallin solid was obtained and recrystallized once from iso-octane. 1H 
NMR 7.71 ppm, m, 2H; 7.59 ppm, m, 2H;  7.51 ppm, m, 3H; 7.07 ppm, m, 2H 
(aromatic); 2.34 ppm, bs, 1H (thiol).  Thiuram-like byproduct present, 3.62 ppm, bs, 6H 
(in thiuram it is at 3.60 ppm).    
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APPENDIX D 
PURIFICATION AND CHARACTERIZATION DATA FOR SYNTHETIC PEPTIDES 
USED IN THIS STUDY OR OTHERWISE DESIGNED AND PURIFIED 
 
Table 14:  Characterization data for peptides synthesized by this author.  The sequences 
are labeled as the single letter amino acid abbreviations, the identity of the termini 
(unlabeled termini indicates that both termini were left as the free amine or carboxylic 
acid, CONH2 is an amidated C terminus, and Ac is an acetylated N terminus), and (PEG)6 
indicates a hexaethyleneglycol spacer.  Retention times are from reverse phase, 
preparatory scale HPLC and represent the time (rounded to the nearest minute) at which 
collection of the highest absorbing fraction was began.  Calculated m/z values represent 
the value calculated for the most abundant isotope for reflectron mode, or the average 
mass for linear mode.  The most prevalent ions in the MALDI spectrum of the highest 
absorbing fraction were recorded.  [M + H] and [M + Na] were assumed to be indicative 
of a successful synthesis, while [M + O] is indicative of an oxidized methionine residue 
(not generally considered to effect peptide-antibody binding).  Mode indicates reflectron 
(R) or linear (L) time of flight for the MALDI characterization.   
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Sequence
retention
time (min)
ion
calculated 
m/z
observed 
m/z
error 
(ppm)
mode
yield 
(mg)
[M + H]+ 3609.7872 3609.8594 20.001179
[M + Na]+ 3631.7691 3631.592 -48.764113
[M + H2O]
+ 3627.79777 3627.8363 10.622147
[M + H]+ 3609.7872 3609.8196 8.9755983
[M + Na]+ 3631.7691 3631.8269 15.915109
[M + H]+ 3171.5676 3171.55733 -3.238146
[M + Na]+ 3193.5495 3193.6757 39.517158
39 [M + H]+ 3171.5676 3171.6936 39.727988 R 2.9
[M + H]+ 1769.8713 1769.4893 -215.834903
[M + Na]+ 1791.8532 1791.3846 -261.516959
[M + H]+ 1769.8713 1769.6119 -146.564329
[M + Na]+ 1791.8532 1791.3874 -259.954331
30 [M + Na]+ 2463.48454 2463.4374 -19.137120 R 12.3
30 [M + Na]+ 2463.48454 2463.7249 97.567489 R 11.2
Ac-NSELLSLINDGSGSC-CONH2 24 [M + Na]+ 1571.69874 1571.2008 -316.818984 R *
Ac-SELLSLINDMGSGSC-CONH2 27 [M + Na]+ 1588.69634 1588.2592 -275.158939 R *
Ac-ELLSLINDMPGSGSC-CONH2 26 [M + Na]+ 1598.71654 1598.7421 15.985323 R *
Ac-LLSLINDMPIGSGS-CONH2 27 [M + Na]+ 1582.75854 1582.4455 -197.783800 R *
Ac-LSLINDMPITGSGSC-CONH2 24 [M + Na]+ 1570.72214 1570.852 82.672801 R *
Ac-SLINDMPITNGSGSC-CONH2 23 [M + Na]+ 1571.68104 1571.4155 -168.955400 R *
Ac-LINDMPITNDGSGSC-CONH2 23 [M + Na]+ 1599.67594 1599.4242 -157.371873 R *
Ac-CSGSGNSELLSLINDMPITNDQKKLMSNN-CONH2 25 [M + Na]+ 3186.48454 3186.0723 -129.372666 R *
Ac-NSELLSLINDMPITNDQKKLMSNNGSGSC-CONH2 26 [M + Na]+ 3186.48454 3186.0175 -146.570301 R *
Ac-CSGSGNSELLSLINDMPITNDQKKLMSNNGSGSC-CONH2 26 [M + Na]+ 3579.97004 3574.18 -1617.344260 L *
CSGSGNSELLSLIND 31 [M + Na]+ 1530.67224 1530.2344 -286.046867 R 13.9
CSGSGSELLSLINDM 37 [M + Na]+ 1547.66974 1547.1988 -304.292309 R 13.3
CSGSGELLSLINDMP 35 [M + Na]+ 1557.69054 1557.0032 -441.258376 R 13.4
CSGSGLLSLINDMPI 38 [M + Na]+ 1541.73194 1541.5425 -122.877392 R 18.2
CSGSGLSLINDMPIT 30 [M + Na]+ 1528.68774 1528.663 -16.186432 R 17.4
CSGSGSLINDMPITN 26 [M + Na]+ 1530.65444 1530.7704 75.755831 R 11.5
CSGSGLINDMPITND 5 [M + Na]+ 1558.64934 1558.6397 -6.187408 R 10.7
CSGSGINDMPITNDQ 5 [M + Na]+ 1573.62384 1573.4026 -140.595226 R 27.1
CSGSGNDMPITNDQK 5 [M + H]+ 1566.6529 1566.8284 112.022261 R 13
CSGSGDMPITNDQKK 5 [M + H]+ 1580.7049 1581.0735 233.187105 R 22.2
CSGSGMPITNDQKKL 5 [M + H]+ 1578.762 1578.3384 -268.311500 R 19.6
[M + O]+ 1593.749 1594.3453 374.149254 R
[M + H]+ 1578.762 1578.3568 -256.656798 R
[M + Na]+ 1590.72324 1591.1441 264.568964 R
[M + H]+ 1568.7413 1569.0895 221.961390 R
[M + Na]+ 1591.68204 1591.0812 -377.489966 R
[M + H]+ 1569.7001 1570.0826 243.677120 R
[M + O]+ 1584.6871 1585.0651 238.532894 R
CSGSGNDQKKLMSNN 5 [M + Na]+ 1582.6954 1582.5573 -87.256209 R 24.2
H2N-C(PEG)6NSELLSLINDMPITNDQKKLMSNN(PEG)6C-CONH2
C(PEG)6KYNDKLPLYISNP(PEG)6C
39 R 5.6
37 6.9R
H2N-C(PEG)6NSELLSLINDMPITNDQKKLMSNN-CONH2
11.1R25
CKYNDKLPLYISNPC
26 14.2R
38 6.3R
23.6
32.1
25.9
5CSGSGPITNDQKKLM
5
5
CSGSGITNDQKKLMS
CSGSGTNDQKKLMSN
189 
 
APPENDIX E 
ADDENDUM TO “COLOR MY NANOWORLD” EXERCISE USED AT THE 
VANDERBILT SUMMER ACADEMY 
 
The Vanderbilt Summer Academy is a collaborative effort within Vanderbilt that invites 
gifted high school underclassmen to campus in order to learn about nanoscale science and 
engineering.  Every year, the research group of David Cliffel participates and teaches 
kids about gold nanoparticles through a brief lecture followed by a hands-on experience.  
For that section, an article from J.Chem. Ed from Mirkin and coworkers, entitled “Color 
my Nanoworld” is used, in which the students make citrate stabilized gold nanoparticles 
and study their properties colorimetrically.  In order to enhance this experience, I 
designed an addendum to the experience where the students study hexanethiol protected 
gold nanoparticles from a Brust synthesis.  The addendum is as follows: 
Brian Turner 
6-23-10 
Monolayer Protected Cluster 
Supplement for “Color my Nanoworld” 
Vanderbilt Summer Academy 
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Chemicals required 
 
1. Hexanethiol (C6SH) 
2. Tetraoctylammonium bromide (TOABr) 
3. Tetrachloroauric acid (HAuCl4) 
4. Sodium borohydride (NaBH4) 
5. Toluene 
6. Water 
 
Materials Required: 
 
1. Small glass vials. 
2. Gloves. 
3. Safety goggles. 
4. Tongs. 
5. Heat plates. 
6. Plastic droppers. 
7. Large tagged container for waste. 
8. Secondary waste container. 
 
Preparation of solutions: 
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1. C6SH: Use as is.  Will be delivered by micropipette. 
2. TOABr: For a 2 mM solution in toluene, add _____g of TOABr to _____ 
mL of toluene.  Can be prepared ahead of time. 
3. HAuCl4: Use the same 1 mM solution of HAuCl4 from “Color my 
Nanoworld.”  Again, this should be prepared immediately before the lab, or stored 
cold. 
4. NaBH4: For a 30 mM solution, dissolve _____g of NaBH4 in _____mL of 
water.  This solution should be prepared immediately before use.  It is possible 
that this solution loses its potency, and requires a new preparation part way 
through the lab. 
 
Procedure for the Preparation of 3nm Gold Hexanethiol Monolayer Protected Clusters 
(MPCs) 
 
1. In a small vial, add 1 dropper full of TOABr solution.  To this, add the 
aqueous HAuCl4 solution. 
2. Option A: Cap and shake the vial vigorously to temporarily mix the layers 
together.  Option B:  Use a dropper to mix the layers over and over.  Either 
method should be done until you have 1 red layer and 1 colorless layer (not 
faintly yellow). 
3. Use a pipet to remove the clear aqueous layer (which should be dilute 
hydrobromic acid).  The remaining layer should be toluene with 1mM 
tris(tetraoctylammonium) gold(III). 
4. To the red organic layer, add ____ µL of C6SH (3:1 molar excess).  
Subsequent reduction of gold(III) to gold(I) may be observed by a color change 
from red to colorless. 
5. Immediately upon fading of the red color, CAUTIOUSLY add 1 dropper 
full of NaBH4 solution (in the hood).  Continuously mix with the dropper.  
Capping and shaking is an option, but should be done carefully while holding the 
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lid on very tightly, and easing the lid off after reduction.  This should render a 
black solution. 
 
Concepts: 
 
1. It should be noted that these particles are more stable than the citrate 
particles because they are protected by covalently bonded layer of hexanethiolate 
molecules. 
2. Throughout the course of all of the experiments, the children have 
observed a variety of colors. 
a. RED from large particles scattering multiple wavelengths of light 
unequally and absorbing a specific wavelength of light. 
b. BLUE from larger particles aggregating and scattering and 
absorbing light differently. 
c. YELLOW from small gold complexes absorbing light by 
transferring charge between the metal and ligand. 
d. RED from small gold complexes absorbing light by transferring 
charge between the metal and a different ligand. 
e. BLACK or BROWN from differently sized smaller particles 
scattering light and absorbing a small portion of light. 
3. This is a good time to tell the kids about how scientists can use light to 
gain details about molecules and particles such as their size. 
 
The numbers are left blank so that the teaching assistants customize to suit the class.  
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